(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\TABLE OF CONTENTS
7$%/(2)&217(176 
/,672),17(;77$%/(6 
/,672),17(;7),*85(6
[ZIP_CODE]&2/6<1236,6 
*/266$5<2)$%%5(9,$7,216$1''(),1,7,212)7(506 
 ,1752'8&7,21 
 %DFNJURXQG
 7HQRIRYLU$ODIHQDPLGH7$)*6  
 *HQHUDO,QIRUPDWLRQ 
 3UHFOLQLFDO3KDUPDFRORJ\ DQG7R[LFRORJ\
 1RQFOLQLFDO3KDUPDFRNLQHWLFV 
 1RQFOLQLFDO7R[LFRORJ\ 
 &OLQLFDO7ULDOVRI(&)7$) 
 5DWLRQDOHIRU7KLV6WXG\ 
 5LVN%HQHILW$VVHVVPHQWIRUWKH6WXG\ 
 &RPSOLDQFH 
 2%-(&7,9(6 
 678'<'(6,*1
 (QGSRLQWV 
 6WXG\'HVLJQ 
 6WXG\7UHDWPHQWV 
 'XUDWLRQRI7UHDWPHQW 
 (QGRI6WXG\ 
 3RVW6WXG\&DUH 
 6RXUFH'DWD 
 6DP SOHVIRU2SWLRQDO([SORUDWRU\$VVHVVPHQWV 
 68%-(&73238/$7,21
 1XPEHURI6XEMHFWVDQG6XEMHFW6HOHFWLRQ 
 ,QFOXVLRQ&ULWHULD 
 ([FOXVLRQ&ULWHULD   
 ,19(67,*$7,21$/0(',&,1$/352'8&76  

 5DQGRPL]DWLRQ%OLQGLQJDQG7UHDWPHQW&RGHV 
 'HVFULSWLRQDQG+DQGOLQJRI(&)7$))'& 
 )RUPXODWLRQ 
 3DFNDJLQJDQG/DEHOLQJ 
 6WRUDJHDQG+DQGOLQJ 
 'RVDJHDQG$GPLQLVWUDWLRQRI(&) 7$))'& 
 3ULRUDQG&RQFRPLWDQW0HGLFDWLRQV 
 $FFRXQWDELOLW\IRU6WXG\'UXJ 
 6WXG\'UXJ5HWXUQRU'LVSRVDO 
 678'<352&('85(6
 6XEMHFW(QUROOPHQWDQG7UHDWPHQW$VVLJQPHQW 
 3UHWUHDWPHQW$VVHVVPHQWV 
 6FUHHQLQJ9 LVLW 
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\ 'D\9LVLW 
 5DQGRPL]DWLRQ 
 7UHDWPHQW$VVHVVPHQWV 
 7UHDWPHQW9LVLWV:HHNVDQG  
 7UHDWPHQW$VVHVVPHQWV:HHN 
 7UHDWPHQW$VVHVVPHQWV:HHNDQGÃ­7UHDWPHQW*URXS21/< 7UHDWPHQW$VVHVVPHQWV :HHNVDQG 
 3RVW WUHDWPHQW$VVHVVPHQWV
 (DUO\6WXG\'UXJ'LVFRQWLQXDWLRQ(6''9LVLW 
 'D\)ROORZXS9LVLW 
 $VVHVVPHQWVIRU3UHPDWXUH'LVFRQWLQXDWLRQIURP6WXG\ 
 &ULWHULDIRU'LVFRQWLQXDWLRQRI6WXG\7UHDWPHQW 
 2WKHU(YDOXDWLRQV 
 %ORRGDQG8ULQH6WRUDJH 
 %RQH6DIHW\DQG,QIOD[COMPANY_003]WLRQ 
 0DUNHUVRI3ODWHOHW)XQFWLRQDQG&RDJXODWLRQ 
 0DUNHUVRI5HQDO7XEXODU)XQFWLRQ 
 (QGRI6WXG\ 
 3RVW6WXG\&DUH 
 9LURORJLF)DLOXUH 
 0DQDJH PHQWRI9LURORJLF)DLOXUH  
 5HVLVWDQFH$QDO\VLVDW6XEMHFWV/DVW9LVLW 
 $'9(56((9(176$1'72;,&,7<0$1$*(0(17
 'HILQLWLRQVRI$GYHUVH(YHQWV$GYHUVH5HDFWLRQVDQG6HULR XV$GYHUVH(YHQWV 
 $G YHUVH(YHQWV 
 6HULRXV$GYHUVH(YHQWV 
 &OLQLFDO/DERUDWRU\$EQRUPDOLWLHVDQG2WKHU$EQRUPDO$VVH VVPHQWVDV
$GYHUVH(YHQWVRU6HULRXV$GYHUVH(YHQWV 
 $VVHVVPHQWRI$GYHUVH(YHQWVDQG6HULRXV$GYHUVH(YHQWV 
 $VVHVVPHQWRI&DXVDOLW\IRU6WXG\'UXJVDQ G3URFHGXUHV
 $VVHVVPHQWRI6HYHULW\   
 ,QYHVWLJDWRU5HTXLUHPHQWVDQG,QVWUXFWLRQVIRU5HSRUWLQJ$G YHUVH(YHQWVDQG6HULRXV
$GYHUVH(YHQWVWR*LOHDG 

 $G YHUVH(YHQWV 
 6HULRXV$GYHUVH(YHQWV 
 (OHFWURQLF6HULRXV$GYHUVH(YHQWH6$(5HSRUWLQJ3URFHVV 
 *LOHDG5HSRUWLQJ5HTXLUHPHQWV 
 6SHFLDO6LWXDWLRQV5HSRUWV 
 'HILQLWLRQVRI6SHFLDO6LWXDWLRQV 
 ,QVWUXFWLRQVIRU5HSRUWLQJ6SHFLDO6LWXDWLRQV 
 7R[LFLW\0DQDJHPHQW 
 *UDGHVDQG/DERUDWRU\$EQRUPDOLW\RU&OLQLFDO(YHQW 
 *UDGH/DERUDWRU\$EQRUPDOLW\RU&OLQLFDO(YHQW 
 *UDGH/DERUDWRU\$EQRUPDOLW\RU&OLQLFDO(YHQW 
 0DQDJHPHQWRI+\SHUELOLUXELQHPLDLQ3DWLHQWV5HFHLYLQJ$W D]DQDYLU
 0DQDJHPHQWRI3RVVLEOH$EDFDYLU+\SHUVHQVLWLYLW\5HDFWLRQ 
 0DQDJHPHQWRI3RWHQWLDO1HSKURWR[LFLW\
 67$7,67,&$/&216,'(5$7,216 
 $QDO\VLV2EMHFWLYHVDQG(QGSRLQWV 
 $QDO\VLV2EMHFWLYHV 
 3ULPDU\(QGSRLQW 
 6HFRQGDU\(QGSRLQW 
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\ $QDO\VLV&RQYHQWLRQV 
 $QDO\VLV6HWV 
 'HP RJUDSKLF'DWDDQG%DVHOLQH&KDUDFWHULVWLFV
 (IILFDF\$QDO\VLV 
 3ULPDU\$QDO\VLV 
 6HFRQGDU\$QDO\VHV 
 6DIHW\$QDO\VLV 
 ([WHQWRI([SRVXUH 
 $GYHUVH(YHQWV 
 /DERUDWRU\(YDOXDWLRQV 
 2WKHU6DIHW\(YDOXDWLRQV 
 %LRPDUNHU$QDO\VLV 
 6DPSOH6L]H 
 5([ZIP_CODE],%,/,7,(6
 ,QYHVWLJDWRU5HVSRQVLELOLWLHV 
 *RRG&OLQLFDO3UDFWLFH 
 ,QVWLWXWLRQDO5HYLHZ%RDUG,5%,QGHSHQGHQW(WKLFV&RP PLWWHH,(&
5HYLHZDQG$SSURYDO 
 ,QIRUPHG&RQVHQW 
 &RQILGHQWLDOLW\ 
 6WXG\ )LOHVDQG5HWHQWLRQRI5HFRUGV 
 &DVH5HSRUW)RUPV 
 ,QVSHFWLRQV 
 3URWRFRO&RPSOLDQFH 
 6SRQVRU5HVSRQVLELOLWLHV 
 3URWRFRO0RGLILFDWLRQV 
 6WXG\5HSRUWDQG3XEOLFDWLRQV 
 -RLQW,QYHVWLJDWRU6SRQVRU5HVSRQVLELOLWLHV  
 3D\PHQW5HSRUWLQJ 

 $FFHVVWR,QIRUPDWLRQIRU0RQLWRULQJ 
 $FFHVVWR,QIRUPDWLRQIRU$XGLWLQJRU,QVSHFWLRQV 
 6WXG\'LVFRQWLQXDWLRQ 
 5()(5(1&(6 
 $33(1',&(6
$SSHQGL[ ,QYHVWLJDWRU6LJQDWXUH3DJH$SSHQGL[ 6WXG\3URFHGXUHV7DEOH 
$SSHQGL[ 0DQDJHPHQWRI&OLQLFDODQG/DERUDWRU\$GYHUVH(YHQWV 
$SSHQGL[ *6,*UDGLQJ6FDOHIRU6HYHULW\RI$GYHUVH(YHQWVDQG/ DERUDWRU\$EQRUPDOLWLHV
$SSHQGL[ 3UHJQDQF\3UHFDXWLRQV'HILQLWLRQIRU)HPDOHRI&KLOG EHDULQJ3RWHQWLDODQG
&RQWUDFHSWLYH5HTXLUHPHQWV 
$SSHQGL[ 'HILQLWLRQVRI+,95HODWHG'LVHDVH&'&*XLGHOLQHV^`
LIST OF IN-TEXT TABLES
7DEOH $OORZDEOH$QWLUHWURYLUDO$JHQWVRI3UH([LVWLQJ5HJLPH Q
7DEOH 'LVDOORZHG$JHQWV 
7DEOH 3ULRUDQG&RQFRPLWDQW0HGLFDWLRQV
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\LIST OF IN-TEXT FIGURES
)LJXUH 6WXG\6FKHPD 
)LJXUH 0DQDJHPHQWRI9LURORJLF)DLOXUH 
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\PROTOCOL SYNOPSIS
[COMPANY_009] Sciences, Inc.
[ADDRESS_1050267]
Foster City, CA [ZIP_CODE]
Study Title: $3KDVHE5DQGRPL]HG2SHQ/DEHO6WXG\WR(YDOXDWHWKH
6DIHW\DQG(IILFDF\ RI6ZLWFKLQJIURP5HJLPHQV&RQVLVWLQJRI
$EDFDYLU/DPLYXGLQH$%&7&SOXVD7KLUG$QWLUHWURYLUDO$JHQWWRWKH(OYLWHJUDYLU&RELFLVWDW(PWULFLWDELQH7HQRIRYLU$ODIHQDPLGH(&)7$))L[HG'RVH&RPELQDWLRQ)'&LQ9LURORJLFDOO\6XSSUHVVHG+,9,QIHFWHG$GXOW6XEMHFWV
IND Number:
EudraCT Number:Clinical Trials.gov 
Identifier:

7%'
Study Centers Planned: $SSUR[LPDWHO\FHQWHUVLQ(XURSHDQG1RUWK$PHULFD
Objectives: 7KHSULPDU\REMHFWLYHRIWKLVVWXG\LV
ï‚·7RHYDOXDWHWKHHIILFDF\RIVZLWFKLQJWR(&)7$))'&
UHODWLYHWRFRQWLQXLQJRQDEDVHOLQHUHJLPHQFRQVLVWLQJRI
$%&7&SOXVDWKLUGDQWLUHWURYLUDODJHQWLQPDLQWDLQLQJ+,951$FRSLHVP/DW:HHNXVLQJ)'$VQDSVKRWDOJRULWKPLQYLURORJLFDOO\VXSSUHVVHG+,9LQIHFWHGDGXOWVXEMHFWV
7KHVHFRQGDU\REMHFWLYHVRIWKLVVWXG\DUH
ï‚·7RHYDOXDWHWKHSURSRUWLRQRIVXEMHFWVPDLQWDLQLQJYLURORJLFDO
UHVSRQVHGHILQHGDV+,951$FRSLHVP/
)'$VQDSVKRWDQDO\VLVDW:HHNVDQG
ï‚·7RHYDOXDWHFKDQJHVIURPEDVHOLQHLQ&'FHOOFRXQWVDW
:HHNVDQG
ï‚·7RHYDOXDWHWKHVDIHW\DQGWROHUDELOLW\RIWKHWZRWUHDWPHQWJURXSVRYHUDQGZHHNV
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\Study Design: 5DQGRPL]HGRSHQODEHOPXOWLFHQWHUVWXG\WRHYDOXDWHWKHVDIHW\
DQGHIILFDF\RIVZLWFKLQJIURP$%&7&SOXVDWKLUGDQWLUHWURYLU DO
DJHQWWR(&)7$))'&LQYLURORJLFDOO\VXSSUHVVHG+,9LQIHFWHGDGXOWVXEMHFWV
6XEMHFWVZLOOEHUDQGRPL]HGLQDUDWLRWRRQHRIIROORZLQJ
WUHDWPHQWJURXSV5DQGRPL]DWLRQ ZLOOEHVWUDWLILHGE\DJH
\HDUVRUÂ•\HDUV
ï‚·Treatment Group 1: 6ZLWFKIURP$%&7&SOXVD
WKLUGDQWLUHWURYLUDODJHQWWR(&)7$))'&Q 
ï‚·Treatment Group 2: &RQWLQXHRQWKHFXUUHQWUHJLPHQRI
$%&7&SOXVDWKLUGDQWLUHWURYLUDODJHQWIRUZHHNV
IROORZHGE\DGHOD\HGVZLWFKWR(&)7$))'&Q 
1XPEHURI6XEMHFWV3ODQQHG$SSUR[LPDWHO\VXEMHFWV$WOHDVWVXEMHFWVÂ•\HDUVROGZLOOEHHQUROOHG
7DUJHW3RSXODWLRQ +,9LQIHFWHGVXEMHFWVÂ•\HDUVROGZKRDU HYLURORJLFDOO\
VXSSUHVVHG+,951$FRSLHVP/RQDVWDEOH$%&7&FRQWDLQLQJUHJLPHQSOXVDWKLUGDJHQWIRUÂ•FRQVHFXWLYHPRQWKVSULRUWRVFUHHQLQJ
'XUDWLRQRI7UHDWPHQW $GD\VFUHHQLQJSHULRGIROORZHGE\ZHHNVRQVWXG\DQGD
'D\)ROORZ8SYLVLWDIWHUFRPSOHWLRQRIVWXG\
'LDJQRVLVDQG0DLQ(OLJLELOLW\&ULWHULD+,9LQIHFWHGDGXOWVXEMHFWVZKRPHHWWKHIROORZLQJFULWHULDZLO OEH
JLYHQWKHRSWLRQWRSDUWLFLSDWHLQWKHVWXG\
ï‚·&XUUHQWO\UHFHLYLQJ$%&7&SOXVDWKLUGDQWLUHWURYLUDO$59
DJHQWIRUÂ•FRQVHFXWLYHPRQWKVSUHFHGLQJWKHVFUHHQLQJYLVLW6XEMHFWPXVWEHRQWKHLUILUVWRUVHFRQG$59UHJLPHQ$OORZHGWKLUGDQWLUHWURYLUDODJHQWVLQFOXGH/39U$79579$79&2%,RU$79&2%,)'&'59579'59&2%,
RU'59&2%,)'&()9539193(755$/RU'7*
ï‚·'RFXPHQWHGSODVPD+,951$OHYHOVFRSLHVP/IRU
Â•PRQWKVSUHFHGLQJWKHVFUHHQLQJYLVLWPHDVXUHGDWOHDVWWZLFHXVLQJWKHVDPHDVVD\,QWKHSUHFHGLQJPRQWKVSULRUWRVFUHHQLQJRQHHSLVRGHRIÂ³EOLSÂ´+,951$!DQGFRSLHVP/LVDFFHSWDEOHRQO\LI+,951$LVFRSLHVP/LPPHGLDWHO\EHIRUHDQGDIWHUWKHÂ³EOLSÂ´
ï‚·3ODVPD+,951$FRSLHVP/DWVFUHHQLQJYLVLW
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\ï‚·'RFXPHQWHGKLVWRULFDOJHQRW\SHSULRUWRVWDUWLQJLQLWLDO$59
WKHUDS\$57VKRZLQJQRNQRZQUHVLVWDQFHWRWHQRIRYLU
GLVRSUR[LOIXPDUDWH7')RUHPWULFLWDELQH)7&LQFOXGLQJEXWQRWOLPLWHGWRWKHSUHVHQFHRIUHYHUVHWUDQVFULSWDVHUHVLVWDQFHPXWDQWV. 509,RUWK\PLGLQH
DQDORJDVVRFLDWHGPXWDWLRQV7$0V7$0VDUH0/'1.5/:7<).4(15,IDKLVWRULFDOJHQRW\SHLVQ RWDYDLODEOHVXEMHFWZLOOKDYHSURYLUDOJHQRW \SH
DQDO\VLVIRUDUFKLYHGUHVLVWDQFHDWVFUHHQLQJYLVLW
ï‚·$GHTXDWHUHQDOIXQFWLRQGHILQHGDVKDYLQJDQHVWLPDWHG
JORPHUXODUILOWUDWLRQUDWHRIÂ•P/ PLQDVFDOFXODWHGE\
&RFNFURIW*DXOWH*)5
&*
6WXG\3URFHGXUHV
)UHTXHQF\$IWHUVFUHHQLQJVWXG\YLVLWVZLOORFFXUDW'D\DQG:HHNVDQG6XEMHFWVLQ7UHDWPHQW*URXSZLOODOVRKDYHDVWXG\YLVLWDW:HHNVDQGZKLFKDUHIRXUDQGHLJKWZHHNVDIWHUVZLWFKLQJWRWKH(&)7$))'&UHVSHFWLYHO\$GYHUVHHYHQWVDQGFRQFRPLWDQWPHGLFDWLRQVZLOOEH 
DVVHVVHGDWHDFKYLVLW
/DERUDWRU\DQDO\VHVKHPDWRORJ\FKHPLVWU\DQGXULQDO\VLV
+,951$&'FHOOFRXQWDVVHVVPHQWRIDGYHUVHHYHQWVDQGFRQFRPLWDQWPHGLFDWLRQVDQGFRPSOHWHRUV\PSWRPGLUHFWHGSK\VLFDOH[DPLQDWLRQVZLOOEHSHUIRUPHGDWDOOVWXG\YLVLWV
&DOFXODWHGFUHDWLQLQHFOHDUDQFHIDVWLQJJOXFRVHKHPDWRORJ\
VHUXPFKHPLVWU\XULQHFKHPLVWU\DQGXULQDO\VLVWHVWVZLOOEHSHUIRUPHGDWDOOYLVLWV
)DVWLQJOLSLGSDQHOWRWDOFKROHVWHURO7&KLJKGHQVLW\DQGOR Z
GHQVLW\OLSRSURWHLQV+'//'/DQGWULJO\FHULGHV7*ZLOOEH
FROOHFWHGDW'D\DQG:HHNV7UHDWPHQW*URXSVXEMHFWVRQO\DQG
%ORRGDQGXULQHIRUVHOHFWHGHYDOXDWLRQVRIERQHDQGUHQDOVDIHW\ 
LQIOD[COMPANY_003]WLRQSODWHOHWIXQFWLRQDQGFRDJXODWLRQZLOOEHFROOHFW HGDW
'D\:HHNVDQGDOOVXEMHFWVDQGDOVRDW
:HHNVDQGIRU7UHDWPHQW*URXSVXEMHFWVRQO\
Test Product, Dose, and Mode of Administration:(OYLWHJUDYLUPJFRELFLVWDWPJHPWULFLWDELQHPJWHQRIRYLUDODIHQDPLGHPJ(&)7$))'&DGPLQLVWHUHGRUDOO\RQFHGDLO\ZLWKIRRG
Reference Therapy, Dose, and Mode of Administration:$%&7&DEDFDYLUPJODPLYXGLQHPJSOXVDWKLUGDQWLUHWURYLUDODJHQWIRURUDODGPLQLVWUDWLRQDFFRUGLQJWRSUHVFULSWLRQ
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\Criteria for Evaluation:
6DIHW\ 7KHVDIHW\DQGWROHUDELOLW\RIWKHWUHDWPHQWUHJLPHQVZLOOEH
DVVHVVHGZLWKDGYHUVHHYHQWDQGFOLQLFDOODERUDWRU\WHVWV
LQFOXGLQJVHOHFWHGHYDOXDWLRQVRIERQH DQGUHQDOVDIHW\
LQIOD[COMPANY_003]WLRQSODWHOHWIXQFWLRQDQGFRDJXODWLRQDW:HHNVDQG
(IILFDF\ 3ULPDU\HQGSRLQW
ï‚·+,951$ FRSLHVP/DW:HHN)'$VQDSVKRWDQDO\VLV
6HFRQGDU\HQGSRLQWV
ï‚·+,951$FRSLHVP/DW:HHNVDQG
)'$VQDSVKRWDQDO\VLV
ï‚·&KDQJHVLQ&'FHOOFRXQWDW:HHNVDQG
+HDOWK5HODWHG4XHVWLRQQDLUHV+HDOWKUHODWHGTXHVWLRQQDLUHVZLOOEHDGPLQLVWHUHGLQFOXGLQJWKH
$GKHUHQFH9LVXDO$QDORJXH6FDOH9$6+,97UHDWPHQW
6DWLVIDFWLRQ+,9764(4'0HGLFDO2XWFRPH6WXG\6KRUW)RUP6)DQG)XQFWLRQDO$VVHVVPHQWRI&KURQLF,OOQHVV
7KHUDS\)DWLJXHVFDOH)$&,7)
Statistical Methods: 7KHSULPDU\HYDOXDWLRQRIWKH)'$GHILQHGVQDSVKRWHQGSRLQWDW
:HHNZLOOEHHYDOXDWHGE\FRQVWUXFWLQJDWZRVLGHGH[DFW
FRQILGHQFHLQWHUYDOIRUWKHGLIIHUHQFHLQWUHDWPHQWJURXSUHVSRQVHUDWHV(&)7$))'&PLQXVFRQWUROWRGHWHUPLQHLIWKHORZHUERXQGLVJUHDWHUWKDQ6XSHULRULW\ZLOOEHGHFODUH G
SYDOXHZLOOEHFDOFXODWHGLIWKHORZHUERXQGRIWKH
FRQILGHQFHLQWHUYDOLVJUHDWHUWKDQ
'HVFULSWLYHVWDWLVWLFVZLOOEHSURYLGHGIRUWKHVHFRQGDU\HQGSR LQWV
LQFOXGLQJ&' DGYHUVHHYHQWVDQGFOLQLFDOODERUDWRU\ GDWDE\
WUHDWPHQWJURXSV
6DPSOH6L]H :LWKVXEMHFWVUDQGRPL]HGWRVZLWFKWRWKH(&) 7$))'&DW
'D\DQGVXEMHFWVUDQGRPL]HGWRWKHGHOD\HGVZLWFKJURXS
WKHORZHUOLPLWRIWKHREVHUYHGRQHVLGHGFRQILGHQFHLQWHUYDOZLOOEHH[SHFWHGWREHJUHDWHUWKDQLHQRQLQIHULRULW\ 
PDUJLQRIZLWK!SRZHUZKHQWKHSHUFHQWDJHRIUHVSRQGHUVLQERWKWUHDWPHQWJURXSVIRUWKHSULPDU\HQGSRLQWLV
DWOHDVWDW:HHN
6XEMHFWVÂ•\HDUVRIDJHZLOOEHLQFOXGHGLQDSUHSODQQHG
FURVVVWXG\ SRROHGDQDO\VLVRIWKHVDIHW\HIILFDF\DQGHIIHFW RQ
FDUGLRYDVFXODUDQGLQIOD[COMPANY_003]WRU\ELRPDUNHUV(&)7$))'&LQ6WXGLHV*686DQG*686
7KLVVWXG\ZLOOEHFRQGXFWHGLQDFFRUGDQFHZLWKWKHJXLGHOLQHVRI*RRG&OLQLFDO3UDFWLFH*&3
LQFOXGLQJDUFKLYLQJRIHVVHQWLDOGRFXPHQWV
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\GLOSSARY OF ABBREVIATIONS AND DEFINITION OF TERMS
ï‚°& GHJUHHV&HOVLXV
ï‚°) GHJUHHV)DKUHQKHLW
7& ODPLYXGLQH
$%& DEDFDYLU
$( DGYHUVHHYHQW
$,'6 $FTXLUHG,PPXQH'HILFLHQF\6\QGURPH
$/7 DODQLQHDPLQRWUDQVIHUDVH
$1& DEVROXWHQHXWURSKLOFRXQWV
$129$ DQDO\VLVRIYDULDQFH
$59 DQWLUHWURYLUDO
$67 DVSDUWDWHDPLQRWUDQVIHUDVH
$75 $WULSODÂŠ()9)7&7')
$79 DWD]DQDYLU
$8& DUHDXQGHUWKHSODVPDVHUXPSHULSKHUDOEORRGPRQRQXFOHDUFHOOFRQFHQWUDWLRQYHUVXVWLPHFXUYH
$8&ODVW DUHDXQGHUWKHSODVPDFRQFHQWUDWLRQWLPHFXUYHIURPWLPHWRW KHODVWPHDVXUDEOHFRQFHQWUDWLRQ
$8&WDX DUHDXQGHUWKHSODVPDFRQFHQWUDWLRQWLPHFXUYHDWWKHHQGRIWK HGRVLQJLQWHUYDO
$9 DUWLRYHQWULFXODU%0' ERQHPLQHUDOGHQVLW\%81 EORRGXUHDQLWURJHQ
&%& FRPSOHWHEORRGFRXQW
&. FUHDWLQHNLQDVH&, FRQILGHQFHLQWHUYDO&/
FU FUHDWLQLQHFOHDUDQFH
&PD[ WKHPD[LPXPREVHUYHGVHUXPSODVPDSHULSKHUDOEORRGPRQRQXFOHDU3%0&FRQFHQWUDWLRQ
RIGUXJ
&16 FHQWUDOQHUYRXVV\VWHP
&2%,FR FRELFLVWDW&3. FUHDWLQHSKRVSKRNLQDVH
&5) FDVHUHSRUW IRUPV
&52 FRQWUDFWRUFOLQLFDOUHVHDUFKRUJDQL]DWLRQ
&65 FOLQLFDOVWXG\UHSRUW&7; W\SHFROODJHQFURVVOLQNHG&WHORSHSWLGH&<3 F\WRFKURPH3'', GUXJGUXJLQWHUDFWLRQ
'++6 'HSDUWPHQWRI+HDOWKDQG+XPDQ6HUYLFHV
'1$ GHR[\ULERQXFOHLFDFLG'59 GDUXQDYLU'63+ 'UXJ6DIHW\DQG3XEOLF+HDOWK
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\'7* GROXWHJUDYLU
';$ GXDOHQHUJ\;UD\DEVRUSWLRPHWU\
(&* HOHFWURFDUGLRJUDP
('& HOHFWURQLFGDWDFDSWXUH
H&5) HOHFWURQLFFDVHUHSRUWIRUPV
H*)5 HVWLPDWHGJORPHUXODUILOWUDWLRQUDWH
()9 HIDYLUHQ]
(9* HOYLWHJUDYLU
(&)7') HOYLWHJUDYLU(9*PJFRELFLVWDW&2%,PJHPWU LFLWDELQH)7&PJ
WHQRIRYLUGLVRSUR[LOIXPDUDWH7')PJVLQJOHWDEOHWUHJLPHQ
(&)7$) HOYLWHJUDYLU(9*PJFRELFLVWDW&2%,PJHPWU LFLWDELQH)7&PJ
WHQRIRYLUDODIHQDPLGH7$)PJVLQJOHWDEOHWUHJLPHQ
(6'' HDUO\VWXG\ GUXJGLVFRQWLQXDWLRQ
)$6 IXOODQDO\VLVVHW
)'$ 8QLWHG6WDWHV)RRGDQG'UXJ$GPLQLVWUDWLRQ
)'& IL[HGGRVHFRPELQDWLRQ
)7& HPWULFLWDELQH
)7$) HPWULFLWDELQHWHQRIRYLUDODIHQDPLGH
)7&7') HPWULFLWDELQHWHQRIRYLUGLVRSUR[LOIXPDUDWH
*&3 *RRG&OLQLFDO3UDFWLFH*XLGHOLQHV
**7 JD[COMPANY_003]JOXWDP\OWUDQVIHUDVH
*6, *LOHDG6FLHQFHV,QF
*6 WHQRIRYLUDODIHQDPLGH7$)/$ODQLQH 1>6>>5 DPLQR+SXULQ\O
PHWK\OHWKR[\@PHWK\O@SKHQR[\SKRVSKLQ\O@PHWK\OHWK\OHVWHU
+$$57 KLJKO\DFWLYHDQWLUHWURYLUDOWKHUDS\
+%V$J KHSDWLWLV%YLUXVVXUIDFHDQWLJHQVHURORJ\
+%9 KHSDWLWLV%YLUXV
+%V$J KHSDWLWLV%VXUIDFHDQWLJHQ
+&9 KHSDWLWLV&YLUXV
+&9$E KHSDWLWLV&YLUXV DQWLERG\
+'3( KLJKGHQVLW\SRO\HWK\OHQH
+,9 KXPDQLPPXQRGHILFLHQF\YLUXV
+/*7 KLJKOHYHOJURXSWHUP
+/7 KLJKOHYHOWHUP
+63 K\VWHURVDOSLQJRJUDP
,% LQYHVWLJDWRUÂ¶VEURFKXUH
,&+ ,QWHUQDWLRQDO&RQIHUHQFH RQ+DUPRQLVDWLRQ
,'0& ,QGHSHQGHQW'DWD0RQLWRULQJ&RPPLWWHH
,(& ,QGHSHQGHQW(WKLFV&RPPLWWHH
,1' ,QYHVWLJDWLRQDO1HZ'UXJ$SSOLFDWLRQ
,15 LQWHUQDWLRQDOQRUPDOL]HGUDWLR
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\,167, LQWHJUDVHVWUDQGWUDQVIHULQKLELWRU
,03 ,QYHVWLJDWLRQDO0HGLFLQDO3URGXFW
,5% LQVWLWXWLRQDOUHYLHZERDUG
,8' LQWUDXWHULQHGHYLFH
,:56 LQWHUDFWLYHZHEUHVSRQVHV\VWHP
.6 .DSRVLÂ¶VVDUFRPD
/'+ ODFWDWHGHK\GURJHQDVH
//1 ORZHUOLPLWRIWKHQRUPDOUDQJH
//7 ORZOHYHOWHUP
/39 ORSLQDYLU
0HG'5$ 0HGLFDO'LFWLRQDU\IRU5HJXODWRU\$FWLYLWLHV
0J PLOOLJUDP
0LQ PLQXWH
PP+J PLOOLPHWHUVPHUFXU\
09& PDUDYLURF
1157, QRQQXFOHRVLGHUHYHUVHWUDQVFULSWDVHLQKLELWRU
1>W@57, QXFOHRVWLGHUHYHUVHWUDQVFULSWDVHLQKLELWRU
12$(/ QRREVHUYHGDGYHUVHHIIHFWOHYHO
157, QXFOHRVLGHQXFOHRWLGHUHYHUVHWUDQVFULSWDVHLQKLELWRU
193 QHYLUDSLQH
313 SURFROODJHQ7\SH1WHUPLQDOSURSHSWLGH
3%0&V SHULSKHUDOEORRGPRQRQXFOHDUFHOOV
3, SURWHDVHLQKLELWRU
3. SKDUPDFRNLQHWLF
37 SUHIHUUHGWHUP
4' RQFHGDLO\
5$/ UDOWHJUDYLU
5%& 5HGEORRGFHOOV
51$ ULERQXFOHLFDFLG
539 ULOSLYLULQH
579U ULWRQDYLU
6$'5 VHULRXVDGYHUVHGUXJUHDFWLRQ
6$( VHULRXVDGYHUVHHYHQW
62& V\VWHPRUJDQFODVV
623 VWDQGDUGRSHUDWLQJSURFHGXUH
67% 6WULELOGÂŠ(9*&2%,)7&7')(&)7')6LQJOH7DEOHW5HJLPHQ675
675 VLQJOHWDEOHWUHJLPHQ
686$5 6XVSHFWHG8QH[SHFWHG6HULRXV$GYHUVH5HDFWLRQ7$) WHQRIRYLUDODIHQDPLGH*6 
7$)IXPDUDWH WHQRIRYLUDODIHQDPLGHIXPDUDWH*6 
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\7') WHQRIRYLUGLVRSUR[LOIXPDUDWH
7)9 WHQRIRYLU
7)9'3 WHQRIRYLUGLSKRVSKDWH7)9SS
7PD[ WKHWLPHREVHUYHGWLPHSRLQWRIPD[LPXPREVHUYHGFRQFHQWUDWLRQRIGUXJ
8*7 XULGLQHJOXFXURQRV\OWUDQVIHUDVH
8/1 XSSHUOLPLWRIWKHQRUPDOUDQJH
86 8QLWHG6WDWHV
95 YLURORJLFUHERXQG
:%& ZKLWHEORRGFHOOV
ï¬] WHUPLQDOHOLPLQDWLRQUDWHFRQVWDQWHVWLPDWHGE\OLQHDUUHJUHVV LRQRIWKHWHUPLQDOHOLPLQDWLRQ
SKDVHRIWKHVHUXPSODVPDFRQFHQWUDWLRQRIGUXJYHUVXVWLPHFXUYH
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\1. INTRODUCTION
1.1. Background
+,9LQIHFWLRQLVDOLIHWKUHDWHQLQJDQGVHULRXVGLVHDVHWKDWLVRIPDMRUSXEOLFKHDOWKLQWHUHVW
DURXQGWKHZRUOG7KHUHDUHPLOOLRQSHRSOHZRUOGZLGHDQGDSSUR[LPDWHO\PLOOLRQSHRSOHLQWKH86OLYLQJZLWK+,9
^`^`:LWKLQ:HVWHUQDQG&HQWUDO(XURSHLWLVHVWLPDWHG
WKDWWKHUHDUHRYHULQGLYLGXDOVOLYLQJZLWK+,9DQGQHZLQIHFWLRQVLQ
^`
,IOHIWXQWUHDWHGRUVXERSWLPDOO\WUHDWHG+,9LQIHFWLRQLVFKDUDFWHUL]HGE\GHWHULRUDWLRQLQLPPXQHIXQFWLRQWKHVXEVHTXHQWRFFXUUHQFHRIRSSRUWXQLVWLFLQIHFWLRQVDQGPDOLJQDQFLHVXOWLPDWHO\UHVXOWLQJLQGHDWK7KHUDSHXWLFVWUDWHJLHVIRUWKHW UHDWPHQWRI+,9GLVHDVHKDYHEHHQ
VLJQLILFDQWO\DGYDQFHGE\WKHDYDLODELOLW\RIKLJKO\DFWLYHDQWLUHWURYLUDOWKHUDS\+$$57WKHLQWURGXFWLRQRI+$$57ZDVDVVRFLDWHGZLWKDGUDPDWLFGHFUHDV HLQDFTXLUHGLPPXQH
GHILFLHQF\V\QGURPH$,'6UHODWHGPRUELGLW\DQGPRUWDOLW\
^`^`^`
7KHSULPDU\JRDOVRI$59WKHUDS\IRU+,9LQIHFWLRQDUHWRUHG XFH+,9DVVRFLDWHGPRUELGLW\
DQGSURORQJWKHGXUDWLRQDQGTXDOLW\RIOLIHUHVWRUHDQGSUHVH UYHLPPXQRORJLFIXQFWLRQ
PD[LPDOO\DQGGXUDEO \VXSSUHVVSODVPD+,9YLUDOORDGDQGSUHYHQ W+,9WUDQVPLVVLRQ
7KH'++6JXLGHOLQHVOLVWHPWULFLWDELQHWHQRIRYLU'))7&7')DVDSUHIHUUHGQXFOHRVWLGHUHYHUVHWUDQVFULSWDVHLQKLELWRU157,1W57,EDFNERQHLQFRPELQDW LRQZLWKHLWKHU
FRELFLVWDWERRVWHGHOYLWHJUDYLU>(9*&2%,@DGPLQLVWHUHGDV(9* &2%,)7&7')UDOWHJUDYLU
GROXWHJUDYLURUGDUXQDYLUULWRQDYLUDVDQLQLWLDO$59UHJLPHQ
^`$OWKRXJK+$$57KDV
GUDPDWLFDOO\LPSURYHGWKHSURJQRVLVRISDWLHQWVLQIHFWHGZLWK+, 9HUDGLFDWLRQRIWKHYLUXVLV
QRWSRVVLEOHZLWKFXUUHQWO\DYDLODEOHWKHUDSLHV/RQJWHUPYLUD OVXSSUHVVLRQDQGSUHYHQWLRQRI
GUXJUHVLVWDQFHDUHJRDOVRIVXFFHVVIXOWKHUDS\,QUHJLPHQVRIFRPSDUDEOHHIILFDF\WKHWRWDOSLOOEXUGHQGRVLQJIUHTXHQF\DQGFRQFHUQVDERXWVDIHW\DQGVLGHHI IHFWVDUHJHQHUDOO\WKHPRVW
VLJQLILFDQWREVWDFOHVWRDFKLHYLQJKLJKDGKHUHQFH
^`^`^`
7HQRIRYLUGLVRSUR[LOIXPDUDWH7')LVDSUHIHUUHG157,DPRQJU HFRPPHQGHGUHJLPHQVIRU
WUHDWPHQWQDwYH+,9SRVLWLYHSDWLHQWVEXWLVDVVRFLDWHGZLWKQ HSKURWR[LFLW\DQGUHGXFHGERQH
PLQHUDOGHQVLW\ ^`/LIHORQJDQWLUHWURYLUDOWUHDWPHQWDQGWKHLQFUHDVLQJFRPRUELG LWLHVEHLQJ
UHFRJQL]HGDQGWUHDWHGLQ+,9SRVLWLYHSDWLHQWVFUHDWHVDQXUJH QWQHHGWRLPSURYHWKHVDIHW\
SURILOHRIUHJLPHQVWKDWPRVWHIIHFWLYHO\VXSSUHVV+,9UHSOLFDWLRQ7HQRIRYLUDODIHQDPLGH7$)LVQRYHORUDOSURGUXJRIWHQRIRYLU7)9DQXFOHRWLGHDQDORJWKDWLQKLELWV+,9UHYHUVHWUDQVFULSWLRQ*LOHDGKDVFRIRUPXODWHG7$)ZLWKWKHLQWHJUDVHVWUDQGWUDQVIHULQKLELWRUHOYLWHJUDYLU(9*FRELFLVWDW&2%,DQGHPWULFLWDELQH)7& LQWRDIL[HGGRVHFRPELQDWLRQ
)'&&RPSDUHGWR7')WKHXVHRI7$)LQWKH(&)7$))'&SURYLG HVHQKDQFHGO\PSKDWLF
GHOLYHU\RIWHQRIRYLUUHVXOWLQJLQKLJKHULQWUDFHOOXODUOHYHOV RIWKHDFWLYHSKRVSKRU\ODWHGPRLHW\
WHQRIRYLUGLSKRVSKDWHDQGORZHUV\VWHPLFFLUFXODWLQJOHYHOVRI WHQRIRYLU7KHVHIHDWXUHV
WUDQVODWHLQWRDQLPSURYHGWROHUDELOLW\DQGVDIHW\SURILOHHVS HFLDOO\ZLWKUHVSHFWWRUHQDODQG
ERQHVDIHW\
^`
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\1.2. Tenofovir Alafenamide (TAF, GS-7340)
1.2.1. General Information
7HQRIRYLUDODIHQDPLGH*67$)RU/$ODQLQH N>S>> RDPLQR HSXULQ\O
PHWK\OHWKR[\@PHWK\O@SKHQR[\SKRVSKLQ\O@PHWK\OHWK\OHVWHULVDQLQYHVWLJDWLRQDORUDO
SURGUXJRIWHQRIRYLU7)9DQXFOHRWLGHDQDORJWKDWLQKLELWV+,9UHYHUVHWUDQVFULSWLRQ7)9LVPHWDEROL]HGLQWUDFHOOXODUO\WRWKHDFWLYHPHWDEROLWHWHQRIRYLUGLSKRVSKDWH7)9'3DFRPSHWLWLYHLQKLELWRURI+,9UHYHUVHWUDQVFULSWDVH57WKDW WHUPLQDWHVWKHHORQJDWLRQRIWKH
YLUDO'1$FKDLQ,QWKHGHYHORSPHQWRI7$)WKUHHIRUPVRIWKHGUXJVXEVWDQFHKDYHEHHQXVHGLQYDULRXVVWXGLHV*6V\QRQ\PIRU*6DVWKHIUHHED VH*6V\QRQ\PIRU
7$)PRQRIXPDUDWHDQG*6DVWKHKHPLIXPDUDWH*6DOVRNQRZQDV7$)IXPDUDWHLVFRQVLGHUHGFRPSDUDEOHEDVHGRQSK\VLFDOFKHPLFDOSURSHUWLHVWR*6WKDWKDVEHHQXVHGLQSUHYLRXVVWXGLHVDQGDQXPEHURIRQJRLQJ VWXGLHV*6ZDVDOVR
XVHGLQWKH3KDVHVWXG\*686DQGLVEHLQJXVHGLQV HYHUDORQJRLQJ3KDVHVWXGLHV
IRUH[DPSOH*686DQG*686*6DQ G*6H[LVWDV
WKHIUHHEDVH7$)*6LQEORRGDQGELRORJLFDOIOXLGV
)RUIXUWKHULQIRUPDWLRQRQ7$)UHIHUWRWKHFXUUHQWLQYHVWLJDW RUÂ¶VEURFKXUHIRU(&)7$))'&
1.2.2. Preclinical Pharmacology and Toxicology
 3ULPDU\3KDUPDFRG\QDPLFV
7$)LVPHWDEROL]HGWR7)9DQXFOHRWLGHDQDORJLHDQXFOHRV LGHPRQRSKRVSKDWHDQDORJ
ZKLFKLVQRWGHSHQGHQWRQDQLQWUDFHOOXODUQXFOHRVLGHNLQDVHDF WLYLW\IRUWKHILUVWVWHSLQWKH
FRQYHUVLRQWRWKHDFWLYHPHWDEROLWH7)9GLSKRVSKDWH7)9'37KHFHOOXODUHQ]\PHV
UHVSRQVLEOHIRU7)9PHWDEROLVPWRWKHDFWLYHGLSKRVSKRU\ODWHGI RUPDUHDGHQ\ODWHNLQDVH$.
^`DQGQXFOHRWLGHGLSKRVSKDWHNLQDVHZKLFKDUHKLJKO\DFWLYHDQG XELTXLWRXV$.H[LVWVDV
PXOWLSOHLVR]\PHV$.WR$.ZLWKWKHSKRVSKRU\ODWLRQRI7)9P HGLDWHGPRVWHIILFLHQWO\E\
$.
7KHLQWUDFHOOXODUPHWDEROLVPRI7$)DQG7)9DUHFRQVLVWHQWZLWKWKHIROGHQKDQFHPHQWLQ
DQWL+,9DFWLYLW\LQFHOOFXOWXUHRI7$)RYHU7)90HWDEROLVPRI7$)ZDVDOVRVWXGLHGLQGLIIHUHQWKXPDQEORRGO\PSKRF\WHVXESRSXODWLRQV&'DQG&' 7FHOOV1.FHOOV%FHOOV
DQGPDFURSKDJHVPRQRF\WHV7$)LVPHWDEROL]HGLQVLGHKRVWFHOOVWRWKHDFWLYHPHWDEROLWH7)9'3&RQFHQWUDWLRQRIWKHDFWLYHPHWDEROLWH7)9'3ZDVVXEVW DQWLDOLQDOOFHOOSRSXODWLRQV
 6DIHW\3KDUPDFRORJ\
7$)PRQRIXPDUDWH*6KDVEHHQHYDOXDWHGWRGHWHUPLQHSRWHQWLDOHIIHFWVRQWKH
FHQWUDOQHUYRXVV\VWHP5UHQDOV\VWHP5FDUGL RYDVFXODU'DQG
JDVWURLQWHVWLQDOV\VWHPV56LQJOHGRVHVGLGQRWLQGXFH SKDUPDFRORJLFHIIHFWVRQWKH
FHQWUDOQHUYRXVV\VWHPRIWKHUDWPJNJWKHUHQDOV\VWH PRIWKHUDWPJNJRUWKH
FDUGLRYDVFXODUV\VWHPRIWKHGRJPJNJ7$)PRQRIXPDUDWH DWPJNJUHGXFHG
GLVWDOWUDQVLWDQGLQFUHDVHGVWRPDFKZHLJKWVVWDUWLQJKRXUVS RVWGRVLQJZLWKUHYHUVLELOLW\
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\EHJLQQLQJE\KRXUVDIWHUGRVLQJ7KH12(/IRUJDVWURLQWHVWLQD OPRWLOLW\ZDVPJNJ
7KH,&IRUWKHLQKLELWRU\HIIHFWRI7$)IXPDUDWH*6RQK(5*SRWDVVLXPFXUUHQW
ZDVHVWLPDWHGWREHJUHDWHUWKDQÈ0
$OOQRQFOLQLFDOSKDUPDFRNLQHWLFH[SHULPHQWVLQWKLVVHFWLRQZHU HSHUIRUPHGXVLQJ
7$)PRQRIXPDUDWH*6DQGDOOVWXG\GDWDGHVFULEHGLQW KLVVHFWLRQUHIOHFWWKHGRVDJH
RIWKHPRQRIXPDUDWH)RUUHIHUHQFHPJRI7$)PRQRIXPDUDWHLVHTXLYDOHQWWRPJRIWKH
*6IUHHEDVH7$)
3ODVPDSKDUPDFRNLQHWLFVRIWKHLQWDFWSURGUXJ7$)IROORZLQJRU DODGPLQLVWUDWLRQRI
*6LQGRJVDQGPRQNH\VGHPRQVWUDWHGUDSLGDEVRUSWLRQZL WKSHDNSODVPD
FRQFHQWUDWLRQVEHWZHHQDQGKRXUV3HDN7)9SODVPDFRQFHQWUDWLRQVRFFXUUHGIROORZLQJ
7$)DEVRUSWLRQZLWK7)97 PD[YDOXHVEHWZHHQWRKRXUVLQUDWVGRJVDQGPRQNH\V
7)9SODVPDFRQFHQWUDWLRQVGHFOLQHGZLWKDWHUPLQDOKDOIOLIHRIWRKRXUVLQUDWVIDVWHG!KRXUVLQGRJVIDVWHGDQGWRKRXUVLQ[LOCATION_006]HVXVPRQ NH\V
7KHWLVVXHGLVWULEXWLRQDQGUHFRYHU\RI>
&@UDGLRODEHOHG*6ZDVH[DPLQHGLQEHDJOH
GRJV5DGLRDFWLYLW\ZDVGHWHFWHGLQDOOWLVVXHVH[FHSWEUDLQZ LWKWKHPDMRULW\SUHVHQWLQWKH
FRQWHQWVRIWKHJDVWURLQWHVWLQDOWUDFWOLYHUNLGQH\DQGODUJ HLQWHVWLQH7LVVXHFRQFHQWUDWLRQV
ZHUHWKHKLJKHVWLQNLGQH\3%0&VOLYHUODUJHLQWHVWLQHDQGELOH6LJQLILFDQWFRQFHQWUDWLRQVRI7)9UHODWHGUDGLRDFWLYHPDWHULDOZHUHREVHUYHGLQO\PSKQRGHVVXJJHVWLQJWKDW7$)PD\EHVHOHFWLYHO\FOHDYHGWRWHQRIRYLULQWKHFHOOVRIWKHO\PSKRUHWL FXODUV\VWHP7KHSULPDU\URXWHRI
HOLPLQDWLRQRIWHQRIRYLULVUHQDOH[FUHWLRQRIXQFKDQJHGGUXJEDVHGRQ,9VWXGLHVRIWHQRIRYLU)ROORZLQJRUDODGPLQLVWUDWLRQRI*6DSSUR[LPDWHO\RIDUDGLRODEHOHGGRVHLVUHFRYHUHGLQGRJXULQHLQKUV7HQRIRYLUZDVWKHPDMRUVSHFLHVSUHVHQWLQWKHXULQHZLWKDERXWRI7$)DOVRSUHVHQW%LOLDU\H[FUHWLRQRIWHQRI RYLULQGRJVDQGIHFDOHOLPLQDWLRQ
RIWHQRIRYLULQUDWVDQGGRJVDUHQHJOLJLEOH
7HQRIRYLUZDVWKHRQO\VSHFLHVIRXQGLQWKHLQWHVWLQDOFRQWHQWVDQGIHFHV,QKXPDQV\VWHPV
7$)LVPHWDEROL]HGE\K\ GURO\WLFFOHDYDJHDQGWRDOHVVHUH[WHQWE\&<3$FDWDO\]HG
R[LGDWLRQ$'$VDUHVXOWRIWKHOLPLWHGPHWDEROLVPRI7$)E\&<3$LQKLELWLRQRULQGXFWLRQRIWKLVHQ]\PHVKRXOGKDYHOLWWOHFRQVHTXHQFHRQ7$)H[SRVXUHLQYLYR7$)KDVOLPLWHGSRWHQWLDOWRDOWHU&<3HQ]\PHDFWLYLW\WKURXJKLQKLELWL RQDQGGRHVQRWLQKLELW8*7$
IXQFWLRQ,QDGGLWLRQ7$)LVQRWDQDFWLYDWRURIHLWKHUWKHDU\ OK\GURFDUERQUHFHSWRU$K5RU
KXPDQSUHJQDQH;UHFHSWRU3;57KHVHIHDWXUHVFRPELQHGZLWKW KHUHODWLYHO\ORZSODVPD
H[SRVXUHVRI7$)LQKXPDQVVXJJHVWWKDWWKHSRWHQWLDORI7$)WRFDXVHRUEHDIIHFWHGE\FOLQLFDOO\UHOHYDQWGUXJGUXJLQWHUDFWLRQVLVYHU\ORZ
1.2.3. Nonclinical Pharmacokinetics
$OOQRQFOLQLFDO3.H[SHULPHQWVZHUHSHUIRUPHGXVLQJ7$)PRQRIXPDUDWH*6DQGDOO
VWXG\GDWDGHVFULEHGLQWKLVVHFWLRQUHIOHFWWKHGRVDJHRIWKH PRQRIXPDUDWH)RUUHIHUHQFH
PJRI7$)PRQRIXPDUDWHLVHTXLYDOHQWWRPJRIWKH*6 IUHHEDVH7$)
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\.H\UHVXOWVIURPQRQFOLQLFDODEVRUSWLRQGLVWULEXWLRQPHWDEROLVPDQGH[FUHWLRQVWXGLHVRI7$)
DUHDVIROORZV
ï‚·)ROORZLQJRUDODGPLQLVWUDWLRQLQGRJVDQGPRQNH\V7$)GHPRQVWU DWHGUDSLGDEVRUSWLRQ
ZLWKSHDNSODVPDFRQFHQWUDWLRQVEHWZHHQDQGKRXUV7KHUHDIWHU7$)SODVPD
FRQFHQWUDWLRQVGHFOLQHGUDSLGO\ZLWKDWHUPLQDOKDOIOLIHRIOH VVWKDQKRXU
7HQRIRYLUDODIHQDPLGHH[SRVXUH& PD[DQG$8&YDOXHVZDVQRQOLQHDUZLWKGRVHDQGJUHDWHU
WKDQH[SHFWHGZLWKLQFUHDVLQJGRVH5HSHDWGRVHVWXGLHVLQUDWV DQGPRQNH\VVKRZHGQR
FKDQJHLQSKDUPDFRNLQHWLFVRYHUWLPH
ï‚·3HDN7)9SODVPDFRQFHQWUDWLRQVRFFXUUHGIROORZLQJ7$)DEVRUSWLRQZLWK7)97 PD[YDOXHV
EHWZHHQWRKRXUVLQUDWVGRJVDQG PRQNH\V
ï‚·)ROORZLQJRUDODGPLQLVWUDWLRQRI>&@UDGLRODEHOHG7$)WRGRJVDPHDQWRWDOUHFRYHU\RI
UDGLRDFWLYLW\DWKRXUVRIZDVGHPRQVWUDWHG5DGLRDFWLYLW \ZDVGHWHFWHGLQDOOWLVVXHV
H[FHSWEUDLQZLWKWKHPDMRULW\SUHVHQWLQWKHFRQWHQWVRIWKHJ DVWURLQWHVWLQDOWUDFWOLYHU
NLGQH\DQGODUJHLQWHVWLQH7LVVXHFRQFHQWUDWLRQVZHUHWKHKLJ KHVWLQNLGQH\SHULSKHUDO
EORRGPRQRQXFOHDUFHOOV3%0&VOLYHUODUJHLQWHVWLQHDQGELOH$GGLWLRQDOVWXGLHVLQGRJV7)9FRQFHQWUDWLRQVLQ3%0&VIROORZLQJRUDODGPLQLVWUDWLRQRI7$)ZHUHDSSUR[LPDWHO\IROGJUHDWHUWKDQREVHUYHGLQSODVPDZLWKDQHVWLPDWHGW
Ã²RIJUHDWHUWKDQKRXUV
ï‚·7KHPDMRUURXWHRIHOLPLQDWLRQRI7$)UHODWHGUDGLRDFWLYLW\ZDV YLDIHFHVZLWK
DSSUR[LPDWHO\RIWKHGRVHUHFRYHUHGLQIHFHVWKURXJKKRXUVSRVWGRVH7KHSULPDU\URXWHRIHOLPLQDWLRQRI7)9LVUHQDOH[FUHWLRQRIXQFKDQJHGGUXJEDVHGRQ,9VWXGLHVRI
7)9
ï‚·7HQRIRYLUDODIHQDPLGHKDVEHHQIRXQGWREHDVXEVWUDWHIRULQWHVWLQDOHIIOX[WUDQVSRUWDQGLQ
QRQFOLQLFDOVWXGLHVLWVLQWHVWLQDODEVRUSWLRQZDVLQFUHDVHGE\ WKHWUDQVSRUWLQKLELWRU
F\FORVSRULQ$
ï‚·1RVLJQLILFDQWLQKLELWLRQRIKXPDQGUXJPHWDEROL]LQJF\WRFKURPH 3&<3HQ]\PHV
XULGLQHGLSKRVSKDWHJOXFXURQ\OWUDQVIHUDVH8*7$RUWUDQVSRUWHUVLQFOXGLQJ3JO\FRSURWHLQEUHDVWFDQFHUUHVLVWDQFHSURWHLQRUJDQLFDQLRQ WUDQVSRUWLQJSRO\SHSWLGH
2$73%DQG2$73%ZDVREVHUYHGZLWK7$)LQYLWUR
ï‚·7HQRIRYLUDODIHQDPLGHGLGQRWDFWLYDWHKXPDQSUHJQDQH;UHFHSWRUK3;5RU
DU\OK\GURFDUERQUHFHSWRU$K5
ï‚·7HQRIRYLUDODIHQDPLGHZDVQRWDVXEVWUDWHIRUGUXJPHWDEROL]LQJ &<3HQ]\PHVH[FHSWIRU
&<3$ZKLFKPHWDEROL]HGWKHFRPSRXQGVORZO\
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\1.2.4. Nonclinical Toxicology
.H\UHVXOWVIURPQRQFOLQLFDOWR[LFRORJ\VWXGLHVRI7$)DUHDVI ROORZV
ï‚·%DVHGRQ7)9H[SRVXUHWKHQRREVHUYHGDGYHUVHHIIHFWOHYHOV1 2$(/VLQWKHPRQWKUDW
PRQWKGRJDQGPRQWKPRQNH\VWXGLHVSURYLGHDQG IROGVDIHW\PDUJLQV
UHVSHFWLYHO\IRUDKXPDQGRVHRIPJGD\
ï‚·,QFKURQLFVWXGLHVLQUDWVERQHDWURSK\RIPHWDSK\VHDOFDQFHO ORXVERQHDQGNLGQH\V
NDU\RPHJDO\ ZHUHWKHSULPDU\WDUJHWRUJDQVDIWHUZHHNVRIWUHDWPHQWZLWK7$)
PJNJGD\KRZHYHUHIIHFWVZHUHQRWVHHQDWORZHUGRVHV7HQRIRYLUDODIHQDPLGHDOVR
DSSHDUHGWRLQFUHDVHELRFKHPLFDOPDUNHUVRIERQHWXUQRYHUDQGG HFUHDVHVHUXP
GLK\GUR[\DQGK\GUR[\YLWDPLQ'DWGRVHVRIPJNJGD \DQGDERYH
ï‚·,QFKURQLFVWXGLHVLQGRJVDIWHUPRQWKVRIWUHDWPHQWDWGRVHV XSWR7$)PJNJGD\
WKHKLJKGRVHZDVUHGXFHGIURPWRPJNJGD\GXHWRWKHR FFXUUHQFHRIGHDWKVHYHUH
FOLQLFDOVLJQVDQGUHGXFHGERG\ZHLJKWWKHSULPDU\WDUJHWRUJDQVZHUHNLGQH\VOLJKWWRPRGHUDWHUHQDOWXEXODUGHJHQHUDWLRQDQGNDU\RPHJDO\D QGERQH
GHFUHDVHGERQHPLQHUDOGHQVLW\>%0'@LQPHWDSK\VHDOFDQFHOORXVE RQH
ï‚·7HQRIRYLUDODIHQDPLGHKDGQRGLVFHUQDEOHHOHFWURFDUGLRJUDSKHII HFWDWWKHORZGRVHRI
PJNJGD\7KHUHZDVVRPHHYLGHQFHDWDQGPJNJGD\IR UDQHIIHFWWRVOLJKWO\
SURORQJ35LQWHUYDOV
ï‚·$IWHUPRQWKVRIWUHDWPHQWVRPHGRJVDGPLQLVWHUHGWKHKLJKHVWGRVHRI7$)PJNJGD\KDGPLQLPDOPRQRQXFOHDUFHOOLQILOWUDWLRQLQW KHSRVWHULRUXYHD
FRQVLGHUHGVHFRQGDU\WRJHQHUDOGHELOLWDWLRQWKLVILQGLQJGLG QRWRFFXULQDQLPDOVJLYHQ
ORZHUGRVHVDQGLWKDVQRWRFFXUUHGLQRWKHUDQLPDOVWXGLHV
ï‚·7KHUHZHUHQRFOHDUWUHDWPHQWUHODWHGHIIHFWVREVHUYHGLQPRQNH\VIROORZLQJGD\VRI
7$)WUHDWPHQWDWDQGPJNJGD\LQFOXGLQJQRFKDQJHVLQPLWRFKRQGULDOIXQFWLRQDQG
PLWRFKRQGULDO'1$PW'1$FRQWHQWLQWKHOLYHUNLGQH\DQGVNH OHWDOPXVFOHDQG
FKDUDFWHUL]DWLRQRIO\PSKRF\WHSRSXODWLRQV
ï‚·7HQRIRYLUDODIHQDPLGHZDVQRWJHQRWR[LFLQHLWKHULQYLWURRUL QYLYRDVVD\V
7HQRIRYLUDODIHQDPLGHKDGQRDGYHUVHHIIHFWVRQPDOHRUIHPDOHIHUWLOLW\SDUDPHWHUVLQUDWV7KHUHZDVQRHIIHFWRQIHWDOYLDELOLW\RUIHWDOGHYHORSPHQWLQSUHJQDQWUDWVDGPLQLVWHUHGGRVHVRI7$)XSWRPJNJGD\RULQSUHJQDQWUDEELWVDGPLQLVWHUHG7$)XSWRPJNJGD\WKHKLJKHVWGRVHVZHUHPDWHUQDOO\WR[LF
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\1.2.5. Clinical Trials of E/C/F/TAF
&OLQLFDOWULDOVXVLQJWHQRIRYLUDODIHQDPLGHFRIRUPXODWHGLQWRW KH(&)7$))'&LQFOXGH
ï‚·GS-US-292-0101D3KDVHKHDOWK\YROXQWHHUVWXG\HYDOXDWLQJWKHUHODWLYHELRDYDLODELOLW\RI
(9*)7&7)9DQG&2%,DGPLQLVWHUHGDV(&)7$)675UHODWLYHW R(&)7')RU7$)
FRPSOHWHG
ï‚·GS-US-292-0103D3KDVHKHDOWK\YROXQWHHUVWXG\WRHYDOXDWHWKHSKDUPDFRNLQHWLFVDQGUHODWLYHELRDYDLODELOLW\RIWKH(&)7$)675UHODWLYHWRWKHLQGLYLGXDOFRPSRQHQWVDW
*6GRVHVRIPJ675RUPJ6LQJOH$JHQW6$FRPSOHWHG
ï‚·GS-US-292-0110D3KDVHUDQGRPL]HGRSHQODEHOVLQJOHGRVHWKUHHWUHDWPH QW
WKUHHSHULRGVL[VHTXHQFHFURVVRYHUVWXG\RIWKHHIIHFWRIIRRGRQWKH7$)FRPSRQHQWRIWKH(&)7$)675FRPSOHWHG
ï‚·GS-US-292-0102D3KDVHUDQGRPL]HGGRXEOHEOLQGHGVWXG\RIWKHVDIHW\DQGH IILFDF\RI
(&)7$)675YHUVXV(&)7')675LQ+,9LQIHFWHGDQWLUHWUR YLUDOWUHDWPHQWQDLYH
DGXOWVFRPSOHWHG
ï‚·GS-US-292-0106D3KDVHRSHQODEHOVWXG\RIWKHSKDUPDFRNLQHWLFVVDIHW\ DQG
DQWLYLUDODFWLYLW\RIWKH(OYLWHJUDYLU&RELFLVWDW(PWULFLWDELQH 7HQRIRYLU$ODIHQDPLGH
(&)7$)VLQJOHWDEOHWUHJLPHQ675LQ+,9LQIHFWHGDQWLU HWURYLUDOWUHDWPHQWQDLYH
DGROHVFHQWVFRPSOHWHG
ï‚·GS-US-292-0104 DQGGS-US-292-01113KDVHUDQGRPL]HGGRXEOHEOLQGHGVWXG\RIWKH
VDIHW\DQGHIILFDF\RI(&)7$)675YHUVXV(&)7')675LQ+, 9LQIHFWHG
DQWLUHWURYLUDOWUHDWPHQWQDLYHDGXOWVFRPSOHWHG
ï‚·GS-US-292-0109D3KDVHRSHQODEHOVWXG\WRHYDOXDWHVZLWFKLQJIURPD7')FRQWDLQLQJ
FRPELQDWLRQUHJLPHQWRD7$)FRQWDLQLQJFRPELQDWLRQVLQJOHWDEO HWUHJLPHQ675LQ
YLURORJLFDOO\VXSSUHVVHG+,9SRVLWLYHVXEMHFWVFRPSOHWHG
ï‚·GS-US-292-0112D3KDVH2SHQODEHO6DIHW\6WXG\RI(OYLWHJUDYLU&RELFLVWDW(PWULFLWDELQH7HQRIRYLU$ODIHQDPLGHVLQJOHWDEOHWUHJLPHQLQ+,9
SRVLWLYHSDWLHQWVZLWKPLOGWRPRGHUDWHUHQDOLPSDLUPHQWFRPSOHWHG
ï‚·GS-US-292-0117D3KDVHWZRSDUWVWXG \WRHYDOXDWHWKHHIILFDF\ RI
7HQRIRYLU$ODIHQDPLGHYHUVXVSODFHERDGGHGWRDIDLOLQJUHJLPHQ IROORZHGE\WUHDWPHQWZLWK
(OYLWHJUDYLU&RELFLVWDW(PWULFLWDELQH7HQRIRYLU$ODIHQDPLGHLQ+,9SRVLWLYHDQWLUHWURYLUDOWUHDWPHQWH[SHULHQFHGDGXOWVRQJRLQJ
ï‚·GS-US-292-0119D3KDVHRSHQODEHOVWXG\WRHYDOXDWHVZLWFKLQJIURPRSWLPL]HGVWDEOH
DQWLUHWURYLUDOUHJLPHQVFRQWDLQLQJGDUXQDYLUWR(OYLWHJUDYLU&RELFLVWDW(PWULFLWDELQH
7HQRIRYLU$ODIHQDPLGH(&)7$)VLQJOHWDEOHWUHJLPHQ675SOXVGDUXQDYLU'59LQWUHDWPHQWH[SHULHQFHG+,9SRVLWLYHDGXOWVRQJRLQJ
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\6WXG\*686LVD3KDVHVWXG\RIVXEMHFWVHYDOXDWL QJWKHUHODWLYHELRDYDLODELOLW\
RIWZRGLIIHUHQWIRUPXODWLRQVRI(&)7$)675HDFKZLWK7$)GRVHRIPJRUPJYHUVXV
(&)7')675RU7$)PJDORQH([SRVXUHVRI(9*&2%,DQG)7&ZHUHFRPSDUDEOHEHWZHHQ(&)7$)YV(&)7')UHJDUGOHVVRIIRUPXODWLRQPRQRO D\HURUELOD\HU
,QFRQWUDVW7$)H[SRVXUHVZHUHaIROGKLJKHUDQGFRUUHVSRQG LQJWHQRIRYLUH[SRVXUHV
aIROGKLJKHUZKHQDGPLQLVWHUHGDV(&)7$)PJYV7$)6 $PJIRUERWK
IRUPXODWLRQVRIWKH(&)7$)OLNHO\PHGLDWHGE\LQKLELWLRQRI 3JSPHGLDWHGLQWHVWLQDO
VHFUHWLRQRI7$)E\&2%,
6WXG\*686LVDFRPSOHWHGUDQGRPL]HGDFWLYHFRQWURO OHG3KDVHVWXG\FRPSDUHV
(&)7$)PJYHUVXV6WULELOG
ÂŠ67%(&)7')LQWUHDWPHQWQDwYH+,9LQIHFWHG
VXEMHFWV$W:HHNWKH(&)7$)GHPRQVWUDWHGSRWHQWDQWLYLU DOHIILFDF\+,951$
FRSLHVP/VLPLODUWR67%>@YV>@XVLQJWKHVQDSVKRW
DOJRULWKPLQWKH(&)7$)JURXSQRSDWLHQWKDGHPHUJHQWUHVLVWDQFHWRRUPRUHFRPSRQHQWVRIWKH(&)7$),PSRUWDQWO\(&)7$)GHPRQVWUDWHGDSRWHQWL DOEHQHILWRYHU(&)7')LQ
WHUPVRIUHQDODQGERQHVDIHW\VPDOOHUPHGLDQGHFUHDVHVLQH*) 5P/PLQDW:HHN
(&)7$)YV(&)7')>3DQGVPDOOHUPHGLDQSHUFHQWDJHGHFUHDVHVLQ%0'DW:HHNVSLQH(&)7$)YV(&)7')>3@KLSYV>3@
6WXG\*686LVDFRPSOHWHG3KDVHKHDOWK\YROXQWHHUV WXG\ZKLFKHYDOXDWHGWKH3.
DQGUHODWLYHELRDYDLODELOLW\RIWKH(&)7$)675UHODWLYHWRWKHLQGLYLGXDOFRPSRQHQWVDW7$)
GRVHVRI675RUPJ6$5HVXOWVLQGLFDWHWKDWZKHQGRVHGDVWKH(&)7$)PJ6757$)DQG7)9H[SRVXUHVZHUHFRPSDUDEOHWRWKRVHREVHUYHGZLWK7$)PJGRVHGDORQH([SRVXUHVRI(9*&2%,DQG)7&ZHUHDOVRFRPSDUDEOHEHWZHHQWKH675DQGLQGLYLGXDOO\GRVHGIRUPXODWLRQV
,QWZRFRQWUROOHGGRXEOHEOLQGSKDVHVWXGLHV*686 DQG*686
WUHDWPHQWQDLYH+,9LQIHFWHGSDWLHQWVZHUHUHFUXLWHGZLWKDQHV WLPDWHGFUHDWLQLQHFOHDUDQFHRI
P/SHUPLQRUKLJKHUIURPRXWSDWLHQWFHQWHUVLQFRXQWU LHV3DWLHQWVZHUHUDQGRPO\
DVVLJQHGWRUHFHLYHRQFHGDLO\RUDOWDEOHWVFRQWDLQLQJPJHOYLWHJUDYLUPJ
FRELFLVWDWPJHPWULFLWDELQHDQGPJWHQRIRYLUDODIHQDPLGH(&)7$)RUPJWHQRIRYLUGLVRSUR[LOIXPDUDWH(&)7')ZLWKPDWFKLQJSODFHER5DQGRPL]DWLRQZDVGRQHE\DFRPSXWHUJHQHUDWHGDOORFDWLRQVHTXHQFHEORFNVL]HDQGZDVVWUDWLILHGE\+,951$&'FRXQWDQGUHJLRQ86$RUH[86$,QYHVWLJDWRUVSDWLHQWVVWXG\VWDIIDQGWKRVHDVVHVVLQJRXWFRPHVZHUHPDVNHGWRWUHDWPHQWJURXS$OOSDUWLFLSDQWVZKRU HFHLYHGRQHGRVHRIVWXG\GUXJ
ZHUHLQFOXGHGLQWKHSULPDU\LQWHQWLRQWRWUHDWHIILFDF\DQGVDIHW\DQDO\VHV7KHPDLQRXWFRPHVZHUHWKHSURSRUWLRQRISDWLHQWVZLWKSODVPD+,951$OHVVWKDQ FRSLHVSHUP/DW:HHN
DVGHILQHGE\WKH86)RRGDQG'UXJ$GPLQLVWUDWLRQ)'$VQDSVKRW DOJRULWKP
SUHVSHFLILHGQRQLQIHULRULW\ PDUJLQRIDQGSUHVSHFLILHGUH QDODQGERQHHQGSRLQWVDW
ZHHNV7KHUHZHUHSDWLHQWVZKRUHFHLYHGWUHDWPHQWJL YHQ(&)7$)DQG
JLYHQ(&)7')(&)7$)ZDVQRQLQIHULRUWR(&)7')Z LWKRI
SDWLHQWVLQWKH7$)JURXSDQGRISDWLHQWVLQWKH 7')JURXSKDYLQJSODVPD
+,951$OHVVWKDQFRSLHVSHUP/DGMXVWHGGLIIHUHQFH &,WR
3DWLHQWVJLYHQ(&)7$)KDGVLJQLILFDQWO\VPDOOHUPHDQVHUXPFUHDWLQLQHLQFUHDVHVWKDQWKRVH
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\JLYHQ(&)7')YVPJG/SVLJQLILFDQWO\OHVV SURWHLQXULD
PHGLDQFKDQJHÂ±YVSDQGDVLJQLILFDQWO\VPDOOHUGHFUHDVHLQ
ERQHPLQHUDOGHQVLW\DWVSLQHPHDQFKDQJHYVS DQGKLSYV
SDWZHHNV,QWHUSUHWDWLRQWKURXJKZHHNVPRUHWK DQRISDWLHQWVJLYHQ
(&)7$)RU(&)7')KDG YLURORJLFDOVXFFHVV5HQDODQGERQHHIIHFWVZHUHVLJQLILFDQWO\
UHGXFHGLQSDWLHQWVJLYHQ(&)7$)
6WXG\*686LVDFRPSOHWHGSKDVHVWXG\GHVLJQHGWRH YDOXDWHWKHVDIHW\HIILFDF\
DQGWROHUDELOLW\RIVZLWFKLQJWR(&)7$)LQ+,9LQIHFWHGSDWL HQWVZKRDUHYLURORJLFDOO\
VXSSUHVVHGRQUHJLPHQVFRQWDLQLQJ7')3DWLHQWVPHHWLQJWKHLQFOXVLRQFULWHULDRIDQSODVPD
+,951$OHVVWKDQFRSLHVSHUP/IRUÂ•ZHHNVRQVWDEOH7')EDVHGUHJLPHQZLWKHVWLPDWHGFUHDWLQLQHFOHDUDQFH!P/PLQZHUHUDQGRPO\DVVLJQHGWRVZLWFKWR(&)7$)Q RUPDLQWDLQWKHLU7')EDVHGUHJLPHQQ 7KHUHJLPHQVDWEDVHOLQHZHUH(&)7')Q ()9)7&7')Q DQG579ERRVWHG$7 9)7&7')
Q 7KHPDLQRXWFRPHVZHUHWKHSURSRUWLRQRISDWLHQWVZLWK SODVPD+,951$OHVVWKDQ
FRSLHVSHUP/DW:HHNDVGHILQHGE\WKH86)RRGDQG'UXJ$ GPLQLVWUDWLRQ)'$
VQDSVKRWDOJRULWKPSUHVSHFLILHGQRQLQIHULRULW\PDUJLQRI DQGSUHVSHFLILHGUHQDODQG
ERQHHQGSRLQWVDWZHHNV,QWKLVVWXG\RIYLURORJLFDOO\ VXSSUHVVHGSDWLHQWVVZLWFKLQJWR
(&)7$)ZDVQRQLQIHULRUDQGVWDWLVWLFDOO\VXSHULRUWRFRQWLQ XLQJ7')EDVHGUHJLPHQZLWK
RI(&)7$)SDWLHQWVDQGRISDWLHQWVPDLQWDLQLQJDQ7')EDVHGUHJLPHQKDYLQJSODVPD+,951$OHVVWKDQFRSLHVSHUP/DW:HHNDGMXVWH GGLIIHUHQFH&,
WR3DWLHQWVVZLWFKLQJWR(&)7$)KDGVLJQLILFDQWLPSURYHPHQWVLQVHUXPFUHDWLQLQHSDQGH*)5SWKDQWKRVHPDLQWDLQLQJ7')EDVHGU HJLPHQ7KHUHZHUHQR
*UDGHVHUXPFUHDWLQLQHLQFUHDVHVLQSDWLHQWVWKDWVZLWFKHG WR(&)7$)7KHGLIIHUHQFHLQ
ERQHPLQHUDOGHQVLW\FKDQJHVIURPEDVHOLQHWRZHHNVVLJQLILF DQWO\IDYRUHGWKHSDWLHQWV
VZLWFKLQJWR(&)7$)ZLWKLQFUHDVHVREVHUYHGFRPSDUHGPDLQWDL QLQJDQ7')EDVHGUHJLPHQV
ZKHUHWKHUHZHUHGHFUHDVHVLQPHDQFKDQJHLQ%0'VSLQHYVSDQGKLSÂ±YVS7KHUHZHUHIHZHUGLVFRQWLQXDWLRQVGXHWRDGYHUVHHYHQWVLQWKHSDWLHQWVVZLWFKLQJWR(&)7$)FRPSDUHGWRFRQWLQXLQJ7')EDVH GUHJLPHQYV
1.3. Rationale for This Study
/LWWOHGDWDH[LVWUHSRUWLQJRQWKHVDIHW\DQGHIILFDF\LQVZLWF KLQJIURPDQDEDFDYLUODPLYXGLQH
$%&7&SOXVDWKLUGDQWLUHWURYLUDODJHQWWRDVLPSOHRQFHGD LO\WDEOHWRI(&)7$))'&LQ
DGXOWSDWLHQWVZKRDUHYLURORJLFDOO\VXSSUHVVHG7KLVVWXG\VHHNVWRHQUROODODUJHQXPEHURI
VXEMHFWVWRDGGUHVVWKLVJDSLQWKHFOLQLFDOOLWHUDWXUH$VSDUWRIWKHHQUROOPHQWXSWRVXEMHFWVZKRDUH\HDUVRUROGHUZLOOEHHQUROOHG6LQFH6WXG\*686 HQUROOHGDUHODWLYHO\
\RXQJHUSRSXODWLRQWKLVVWXG\ZLOODOVRVHUYHWRSURYLGHGDWD RQWKHVDIHW\DQGHIILFDF\RI
(&)7$))'&LQDQROGHUSRSXODWLRQDQREMHFWLYHLQNHHSLQJZ LWKWKHDJLQJRIWKH
+,9LQIHFWHGSRSXODWLRQ
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\1.4. Risk/Benefit Assessment for the Study
3RWHQWLDOULVNVRIDSDWLHQWÂ¶VVWXG\LQYROYHPHQWLQFOXGHVZLWFKLQJWRDQXQIDPLOLDUUHJLPHQZLWK
SRWHQWLDOORVVRIYLURORJLFFRQWURODQGRUQHZDGYHUVHHYHQWVWK HLQFRQYHQLHQFHRIPRUHIUHTXHQW
FOLQLFYLVLWVDQGODERUDWRU\EORRGGUDZVDQGWKHDVVRFLDWHGSDLQDQGGLVFRPI[INVESTIGATOR_13318]RISKOHERWRP\6WUDWHJLHVWRPLWLJDWHWKHVHULVNVLQFOXGHFORVHPRQLWRULQJRIYLUDOORDG&'7FHOOFRXQWDQGRWKHUODEYDOXHVDVZHOODVPRQLWRULQJRIDGYHUVHHYHQWV3DUDPHWHUVIRUGLVFRQWLQXDWLRQRIWKHVWXG\GUXJGXHWRDGYHUVHHYHQWVRUODFNRIHIILFDF\ZLOOEHZHOOGHILQHGDQGFORVHO\IROORZHG
3RWHQWLDOEHQHILWVPD\LQFOXGHWKHSDWLHQWUHFHLYLQJD)'&DQWLUHWURYLUDO(&)7$)UHJLPHQWKDW
LVPRUHFRQYHQLHQWOHDGLQJWRLPSURYHGDGKHUHQFHZLWKSRWHQWLD OO\IHZHUDGYHUVHHYHQWVWKDQ
WKHFXUUHQWUHJLPHQ
&RQVLGHULQJWKHDERYHWKHEHQHILWULVNEDODQFHIRUWKLVVWXG\L VFRQVLGHUHGSRVLWLYH
1.5. Compliance
7KLVVWXG\ZLOOEHFRQGXFWHGLQFRPSOLDQFHZLWKWKLVSURWRFRO *RRG&OLQLFDO3UDFWLFH*&3
DQGDOODSSOLFDEOHUHJXODWRU\UHTXLUHPHQWV
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\2. OBJECTIVES
7KHSULPDU\REMHFWLYHRIWKLVVWXG\LV
ï‚·7RHYDOXDWHWKHHIILFDF\RIVZLWFKLQJWR(&)7$))'&UHODWLYH WRFRQWLQXLQJRQDEDVHOLQH
UHJLPHQFRQVLVWLQJRI$%&7&SOXVDWKLUGDQWLUHWURYLUDODJHQW LQPDLQWDLQLQJ+,951$
FRSLHVP/DW:HHNXVLQJ)'$VQDSVKRWDOJRULWKPLQYLURORJLFDOO\VXSSUHVVHG
+,9LQIHFWHGDGXOWVXEMHFWV
7KHVHFRQGDU\REMHFWLYHVRIWKLVVWXG\DUH
ï‚·7RHYDOXDWHWKHSURSRUWLRQRIVXEMHFWVPDLQWDLQLQJYLURORJLFDOUHVSRQVHGHILQHGDV
+,951$FRSLHVP/)'$VQDSVKRWDQDO\VLVDW:HHNVDQG
ï‚·7RHYDOXDWHFKDQJHVIURPEDVHOLQHLQ&'FHOOFRXQWVDW:HHNV DQG
ï‚·7RHYDOXDWHWKHVDIHW\DQGWROHUDELOLW\ RIWKHWZRWUHDWPHQWJUR XSVRYHUDQGZHHNV
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\3. STUDY DESIGN
3.1. Endpoints
7KHSULPDU\HQGSRLQWRIWKLVVWXG\LV
ï‚·3URSRUWLRQRIVXEMHFWVZLWK+,951$FRSLHVP/DW:HHNDV GHILQHGE\WKH
)'$VQDSVKRWDOJRULWKP
7KHVHFRQGDU\HIILFDF\HQGSRLQWVRIWKLVVWXG\DUH
ï‚·3URSRUWLRQRIVXEMHFWVZLWK+,951$FRSLHVP/ DW:HHNVDQGDVGHILQHGE\
WKH)'$VQDSVKRWDOJRULWKP
ï‚·7KHFKDQJHIURPEDVHOLQHLQ&'FHOOFRXQWVDW:HHNVDQG
3.2. Study Design
7KLVSURWRFROGHVFULEHVDUDQGRPL]HGRSHQODEHOPXOWLFHQWHUVW XG\WRHYDOXDWHWKHVDIHW \DQG
HIILFDF\RIVZLWFKLQJIURP$%&7&SOXVDWKLUGDQWLUHWURYLUDODJ HQWDVSUHVFULEHGE\
WKH,QYHVWLJDWRUWR(&)7$))'&WDEOHWFRPSDUHGWRVWD\LQJRQWKHLUFXUUHQWUHJLPHQLQ+,9
LQIHFWHGDGXOWVXEMHFWVZKRDUHYLURORJLFDOO\VXSSUHVVHG+,9 51$FRSLHVP/RQD
VWDEOHUHJLPHQFRQWDLQLQJ$%&7&IRUÂ•FRQVHFXWLYHPRQWKVSULRUWRVFUHHQLQJ
3.3. Study Treatments
$W'D\DOOVXEMHFWVZLOOEHUDQGRPL]HGWRRQHRIWZRJU RXSVHLWKHUVZLWFKLPPHGLDWHO\
IURP$%&7&WR(&)7$))'&WUHDWPHQW7UHDWPHQW*URXSRUF RQWLQXLQJRQWKHLU
H[LVWLQJUHJLPHQIRUZHHNVIROORZHGE\DGHOD\HGVZLWFKWR( &)7$))'&
7UHDWPHQW*URXS5DQGRPL]DWLRQZLOOEHVWUDWLILHGE\DJH\HDUVRUÂ•\HDUV
ï‚·Treatment Group 1: ,PPHGLDWHVZLWFKIURP$%&7&SOXVDWKLUGDQWLUHWURYLUDODJHQW WR
(&)7$))'&Q 
ï‚·Treatment Group 2: &RQWLQXHRQWKHFXUUHQWUHJLPHQRI$%&7&SOXVD
WKLUGDQWLUHWURYLUDODJHQWIRUZHHNVIROORZHGE\DGHOD\HGVZL WFKWR(&)7$))'&
Q 
$OORZHGWKLUGDQWLUHWURYLUDODJHQWVLQFOXGH
Antiretroviral Class Agents
%RRVWHG3,$79&2%,RU$79&2%,)'&'59&2%,RU'59&2%,)'&
'59579/39U$79579
1157, ()9(75193539
,167, '7*5$/
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\4. SUBJECT POPULATION
4.1. Number of Subjects and Subject Selection
$SSUR[LPDWHO\VXEMHFWVZKRPHHWWKHHOLJLELOLW\FULWHULDZL OOEHHQUROOHG
4.2. Inclusion Criteria6XEMHFWVPXVWPHHWDOORIWKHIROORZLQJLQFOXVLRQFULWHULDWREHHOLJLEOHIRUSDUWLFLSDWLRQLQWKLV
VWXG\
 7KHDELOLW\WRXQGHUVWDQGDQGVLJQDZULWWHQLQIRUPHGFRQVHQW IRUPZKLFKPXVWEHREWDLQHG
SULRUWRLQLWLDWLRQRIVWXG\SURFHGXUHV
 $JHÂ•\HDUV &XUUHQWO\UHFHLYLQJ$%&7&SOXVDWKLUGDQWLUHWURYLUDO$59DJH QWIRU
Â•FRQVHFXWLYHPRQWKVSULRUWRWKHVFUHHQLQJYLVLW6XEMHFWVPXVWEHRQWKHLU
ILUVWRUVHFRQG$59UHJLPHQ5HIHUWR7DEOH IRUDOORZHGWKLUGDJHQWVRIWKH
FXUUHQWUHJLPHQ
 'RFXPHQWHGSODVPD+,951$OHYHOVFRSLHVP/IRUÂ•PRQWKVSUHFHGLQJWKH
VFUHHQLQJYLVLWPHDVXUHGDWOHDVWWZLFHXVLQJWKHVDPHDVVD\
D ,QWKHSUHFHGLQJPRQWKVSULRUWRVFUHHQLQJRQHHSLVRGHRI Â³EOLSÂ´
+,951$!DQGFRSLHVP/LVDFFHSWDEOHRQO\LI+,951$LV
FRSLHVP/LPPHGLDWHO\EHIRUHDQGDIWHUWKHÂ³EOLSÂ´
E 7RGHWHUPLQHYLURORJLFVXSSUHVVLRQLQWKHSUHFHGLQJPRQWKVSULRUWRVFUHHQLQJWKH
ORZHUOLPLWRITXDQWLILFDWLRQ//24E\WKHORFDO+,951$DVV D\PD\EHXVHGRQO\LI
LWV//24LVJUHDWHUWKDQFRSLHVP/HJ//24RIFRSLHVP/ 
 3ODVPD+,951$OHYHOFRSLHVP/DWVFUHHQLQJYLVLW
 'RFXPHQWHGKLVWRULFDOJHQRW\SHSULRUWRVWDUWLQJLQLWLDO$59 WKHUDS\$57VKRZLQJQR
NQRZQUHVLVWDQFHWR7')RU)7&LQFOXGLQJEXWQRWOLPLWHGWRWKHSUHVHQFHRIUHYHUVH
WUDQVFULSWDVHUHVLVWDQFHPXWDQWV.509,RUWK\PLGLQHDQ DORJDVVRFLDWHGPXWDWLRQV
7$0V7$0VDUH 0/'1.5/: 7<).4(15,IDKLVWRULFDO
JHQRW\SHLVQRWDYDLODEOHVXEMHFWZLOOKDYHSURYLUDOJHQRW\SHDQDO\VLVIRUDUFKLYHGUHVLVWDQFHDWVFUHHQLQJYLVLW
 1RUPDO(&*RULIDEQRUPDOGHWHUPLQHGE\WKH,QYHVWLJDWRUWR EHQRWFOLQLFDOO\VLJQLILFDQW
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\ $GHTXDWHUHQDOIXQFWLRQ
(VWLPDWHG*)5Â•P/PLQDFFRUGLQJWRWKH&RFNFURIW*DXOWIRUP XODH*)5 &*IRU
FUHDWLQLQHFOHDUDQFH ^`
0DOH Â±DJHLQ\HDUVÃ®ZWLQNJ ï€½&/FUP/PLQ
Ã®VHUXPFUHDWLQLQHLQPJG/
)HPDOH Â±DJHLQ\HDUVÃ®ZWLQNJÃ® ï€½&/FUP/PLQ
Ã®VHUXPFUHDWLQLQHLQPJG/
 +HSDWLFWUDQVDPLQDVHV$67DQG$/7Â”Ã®XSSHUOLPLWRIQRUPDO8/1
7RWDOELOLUXELQÂ”PJG/RUQRUPDOGLUHFWELOLUXELQVXEMHFWVZLWKGRFXPHQWHG
*LOEHUWÂ¶VV\QGURPHRUZLWKDWD]DQDYLUDVVRFLDWHGK\SHUELOLUXELQH PLDPD\KDYHWRWDOELOLUXELQ
XSWRÃ®8/1
$GHTXDWHKHPDWRORJLFIXQFWLRQ
ï‚·$EVROXWHQHXWURSKLOFRXQWÂ•PP
ï‚·3ODWHOHWVÂ•PP
ï‚·+HPRJORELQÂ•JG/
$IHPDOHVXEMHFWLVHOLJLEOHWRHQWHUWKHVWXG\LILWLVFRQ ILUPHGWKDWVKHLV
D 1RWSUHJQDQWFRQILUPHGE\DQHJDWLYHVHUXPSUHJQDQF\WHVWZKL FKLVUHTXLUHGIRUIHPDOH
VXEMHFWVXQOHVVSHUPDQHQWO\VWHULOHRUJUHDWHUWKDQWZR\HDUVSRVWPHQRSDXVDO
E 1RWQXUVLQJ/DFWDWLQJIHPDOHVPXVWDJUHHWRGLVFRQWLQXHQXUVLQJEHIRUHWKHVWXG\GUXJLV
DGPLQLVWHUHG
F 2IQRQFKLOGEHDULQJSRWHQWLDOHJZRPHQZKRKDYHKDGDK\VW HUHFWRP\KDYHKDGERWK
RYDULHVUHPRYHGRUPHGLFDOO\GRFXPHQWHGRYDULDQIDLOXUHRUDUH SRVWPHQRSDXVDOZRPHQ
!\HDUVRIDJHZLWKFHVVDWLRQIRUÂ•PRQWKVRISUHYLRXVO\ RFFXUULQJPHQVHV
G 2IFKLOGEHDULQJSRWHQWLDODVGHILQHGLQ $SSHQGL[DQGDJUHHVWRXWLOL]HWKHSURWRFRO
VSHFLILHGPHWKRGRIFRQWUDFHSWLRQRUEHQRQ KHWHURVH[XDOO\DFWLYHRUSUDFWLFHVH[XDO
DEVWLQHQFHDVGHILQHGLQ $SSHQGL[IURPVFUHHQLQJWKURXJKRXWWKHGXUDWLRQRIVWXG\
WUHDWPHQWDQGIRUGD\VIROORZLQJGLVFRQWLQXDWLRQRIVWXG\GU XJV
H )HPDOHVXEMHFWVZKRXWLOL]HKRUPRQDOFRQWUDFHSWLYHDVRQHRI WKHLUELUWKFRQWUROPHWKRGV
PXVWKDYHXVHGWKHVDPHPHWKRGIRUDWOHDVWWKUHHPRQWKVSULRU WRVWXG\GRVLQJ
0DOHVXEMHFWVPXVWDJUHHWRVSHFLILHGKLJKO\HIIHFWLYHPHWKRG RIFRQWUDFHSWLRQDVGHILQHG
LQ$SSHQGL[GXULQJKHWHURVH[XDOLQWHUFRXUVHRUEHQRQKHWHURVH[XDOO\DFWLYHRUSUDFWLFH
VH[XDODEVWLQHQFHIURPILUVWGRVHWKURXJKRXWWKHVWXG\SHULRGDQGIRUGD\VIROORZLQJWKH
ODVWVWXG\GUXJGRVH
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\Table 4-1. Allowable Antiretroviral Agents of Pre-Existing Regimen
Antiretroviral Class Agents
%RRVWHG3,$79&2%,RU$79&2%,)'&'59&2%,RU'59&2%,)'&
'59579/39U$79579
1157, ()9(75193539
,167, '7*5$/
4.3. Exclusion Criteria
6XEMHFWVZKRPHHWany RIWKHIROORZLQJH[FOXVLRQFULWHULDDUHQRWWREHHQUROOHGLQWKLVVWXG\
 3UHYLRXVXVHRIDQ\DSSURYHGRUH[SHULPHQWDOLQWHJUDVHVWUDQGWUDQVIHULQKLELWRU,167,
IRUDQ\OHQJWKRIWLPHLIWKHFXUUHQWUHJLPHQFRQWDLQVD3,U
 6XEMHFWVZLOOKDYHQRHYLGHQFHRISUHYLRXVYLURORJLFIDLOXUH RQD3,URU,167,EDVHG
UHJLPHQZLWKRUZLWKRXWUHVLVWDQFHWRHLWKHUFODVVRI$59
 $QHZ$,'6GHILQLQJFRQGLWLRQGLDJQRVHGZLWKLQWKHGD\VSULRUWRVFUHHQLQJ
H[FHSW&'FHOOFRXQWDQGRUSHUFHQWDJHFULWHULDUHIHUWR $SSHQGL[
 +HSDWLWLV&YLUXVWKDWZRXOGUHTXLUHWKHUDS\GXULQJWKHVWXG\
 3RVLWLYH+HSDWLWLV%VXUIDFHDQWLJHQ+%V$J 6XEMHFWVZLWKFOLQLFDOHYLGHQFHRIGHFRPSHQVDWHGFLU[LOCATION_006]RVLVD VFLWHVHQFHSKDORSDWK\
YDULFHDOEOHHGLQJ
 )HPDOHVZKRDUHEUHDVWIHHGLQJ 3RVLWLYHVHUXPSUHJQDQF\WHVW +DYHDQLPSODQWHGGHILEULOODWRURUSDFHPDNHU&XUUHQWDOFRKRORUVXEVWDQFHXVHMXGJHGE \WKH,QYHVWLJDWRU WRSRWHQWLDOO\LQWHUIHUHZLWK
VXEMHFWVWXG\FRPSOLDQFH
$KLVWRU\RIPDOLJQDQF\ZLWKLQWKHSDVW\HDUVSULRUWRVF UHHQLQJRURQJRLQJPDOLJQDQF\
RWKHUWKDQFXWDQHRXV.DSRVL
VVDUFRPD.6EDVDOFHOOFDUFLQRPDRUUHVHFWHGQRQLQYDVLYH
FXWDQHRXVVTXDPRXVFDUFLQRPD6XEMHFWVZLWKFXWDQHRXV.6DUHHO LJLEOHEXWPXVWQRWKDYH
UHFHLYHGDQ\V\VWHPLFWKHUDS\IRU.6ZLWKLQGD\VRI'D\YLVLWDQGPXVWQRWEHDQWLFLSDWHGWRUHTXLUHV\VWHPLFWKHUDS\GXULQJWKHVWXG\
$FWLYHVHULRXVLQIHFWLRQVRWKHUWKDQ+,9LQIHFWLRQUHTXLULQJSDUHQWHUDODQWLELRWLFRU
DQWLIXQJDOWKHUDS\ZLWKLQGD\VSULRUWR'D\
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\$Q\RWKHUFOLQLFDOFRQGLWLRQRUSULRUWKHUDS\WKDWLQWKHR SLQLRQRIWKH,QYHVWLJDWRUZRXOG
PDNHWKHVXEMHFWXQVXLWDEOHIRUWKHVWXG\RUXQDEOHWRFRPSO\ZLWKGRVLQJUHTXLUHPHQWV
3DUWLFLSDWLRQLQDQ\RWKHUFOLQLFDOWULDOLQFOXGLQJREVHUYDWLRQDOWULDOVZLWKRXWSULRUDSSURYDO
IURPWKHVSRQVRULVSURKLELWHGZKLOHSDUWLFLSDWLQJLQWKLVWULD O
.QRZQK\SHUVHQVLWLYLW\WRWKHVWXG\GUXJWKHPHWDEROLWHVRU IRUPXODWLRQH[FLSLHQWV
6XEMHFWVUHFHLYLQJRQJRLQJWKHUDS\ZLWKDQ\RIWKHPHGLFDWLRQVLQ 7DEOHLQFOXGLQJGUXJV
QRWWREHXVHGGXHWRWKHSRWHQWLDOIRULQWHUDFWLRQZLWK7&&2%,(9*)7&RU7$)
IRU7&&2%,(9*RU)7&UHIHUWRWKHLQGLYLGXDODJHQWVÂ¶3UHVFU LELQJ,QIRUPDWLRQIRU
7$)UHIHUWRWKH(&)7$))'&,QYHVWLJDWRUÂ¶V%URFKXUHRUVXEMHFWVZLWKDQ\NQRZQDOOHUJLHVWRWKHH[FLSLHQWVRI(&)7$))'&WDEOHWV
Table 4-2. Disallowed Agents
Drug Class Agents Disallowed*
$OSKD$GUHQHUJLF5HFHSWRU$QWDJRQLVWV $OIX]RVLQ
&DOFLXP&KDQQHO%ORFNHUV %HSULGLO
$QWLFRQYXOVDQWV3KHQREDUELWDO3KHQ\WRLQ&DUEDPD]HSLQH
2[FDUED]HSLQH
$QWLKLVWDPLQHV $VWHPL]ROH7HUIHQDGLQH
$QWLP\FREDFWHULDOV 5LIDPSLQ5LIDSHQWLQH5LIDEXWLQ
(UJRW'HULYDWLYHV(UJRWDPLQH(UJRQRYLQH
'LK\GURHUJRWDPLQH
0HWK\OHUJRQRYLQH
(UJRPHWULQH
*,0RWLOLW\$JHQWV &LVDSULGH
+HUEDO1DWXUDO6XSSOHPHQWV 6W-RKQÂ¶V:RUW(FKLQDFHD
+0*&R$5HGXFWDVH,QKLELWRUV 6LPYDVWDWLQ/RYDVWDWLQ
,QKDOHG%HWD$JRQLVW 6DOPHWHURO
1HXUROHSWLFV 3LPR]LGH
3KRVSKRGLHVWHUDVH ,QKLELWRUV 6LOGHQDILOIRU3$+
6HGDWLYHV+\SQRWLFV 2UDOO\DGPLQLVWHUHG0LGD]RODP7ULD]RODP
*$GPLQLVWUDWLRQRIDQ\RIWKHDERYHPHGLFDWLRQVPXVWEHGLVFRQWLQXHGDWOHDVWGD\VSULRUWRWKH'D\YLVLWDQGIRUWKH
GXUDWLRQRIWKHVWXG\
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\5. INVESTIGATIONAL MEDICINAL PRODUCTS
5.1. Randomization, Blinding and Treatment Codes
6XEMHFWVZLOOEHUDQGRPL]HGLQDUDWLRWR7UHDWPHQW*URXS RU7UHDWPHQW*URXS
5DQGRPL]DWLRQZLOOEHVWUDWLILHGE\DJH \HDUVRUÂ•\HDUV 
ï‚·Treatment Group 1: ,PPHGLDWHVZLWFKIURP$%&7&SOXVDWKLUGDQWLUHWURYLUDODJHQWWR
(&)7$))'&Q DSSUR[LPDWHO\
ï‚·Treatment Group 2: &RQWLQXHRQWKHFXUUHQWUHJLPHQRI$%&7&SOXVD
WKLUGDQWLUHWURYLUDODJHQWIRUZHHNVIROORZHGE\DGHOD\HGVZLWFKWRIL[HGGRVHUHJLPHQ
FRQVLVWLQJRI(&)7$))'&Q DSSUR[LPDWHO\
7KLVLVDQRSHQODEHOVWXG\
6XEMHFWVZLOOEHDVVLJQHGDVFUHHQLQJQXPEHUDWWKHWLPHRIFRQVHQW
2QFHHOLJLELOLW\KDVEHHQFRQILUPHGHDFKVXEMHFWZLOOEHDVVLJ QHGDXQLTXHVXEMHFWQXPEHUXVLQJ
,QWHUDFWLYH:HE5HVSRQVH6\VWHP,:562QFHDVXEMHFWQXPEHUK DVEHHQDVVLJQHGLWZLOOQRW
EHUHDVVLJQHGWRDQ\RWKHUVXEMHFW7KHVXEMHFWQXPEHUDVVLJQPHQWDQGUDQGRPL]DWLRQPD\EH
SHUIRUPHGXSWRGD\VSULRUWRWKHLQFOLQLF'D\YLVLWSURYLGH GWKDWDOOVFUHHQLQJSURFHGXUHV
KDYHEHHQFRPSOHWHGDQGVXEMHFWHOLJLELOLW\KDVEHHQFRQILUPHG
Randomization and baseline visit cannot occur until subject eligibility has been confirmed.
,:56ZLOODVVLJQRSHQODEHOVWXG\GUXJERWWOHQXPEHUVDWHDFKVW XG\YLVLWIRUVXEMHFWVLQ
7UHDWPHQW*URXSDQGDW:HHNDQGRQZDUGVIRUVXEMHFWVLQ7UH DWPHQW*URXS All Day [ADDRESS_1050268] dose of 
the study drug,QLWLDWLRQRIWUHDWPHQWZLWKWKHVWXG\GUXJPXVWWDNHSODFHZL WKLQKRXUVDIWHU
WKH'D\YLVLWIRUVXEMHFWVLQ7UHDWPHQW*URXSDQGZLWKLQKRXUVDIWHUWKH:HHNYLVLWIRU
7UHDWPHQW*URXS
5.2. Description and Handling of E/C/F/TAF FDC
5.2.1. Formulation
(&)7$))'&WDEOHWVDUHFDSVXOHVKDSHGILOPFRDWHGJUHHQWDE OHWVDQGDUHGHERVVHGZLWK
Â³*6,Â´RQRQHVLGHRIWKHWDEOHWDQGÂ³Â´RQWKHRWKHUVLGHRIWKHWDEOHW(&)7$))'&WDEOHWV
FRQWDLQPJRI(9*PJRI&2%,PJRI)7&DQGPJRI7$)DVPJRI
7$)IXPDUDWH
,QDGGLWLRQWRWKHDFWLYHLQJUHGLHQWVWKHWDEOHWVFRQWDLQVLOLFR QGLR[LGHFURVFDUPHOORVHVRGLXP
K\GUR[\SURS\OFHOOXORVHODFWRVHPRQRK\GUDWHPDJQHVLXPVWHDUDW HPLFURFU\VWDOOLQHFHOOXORVH
DQGVRGLXPODXU\OVXOIDWHDVLQDFWLYHLQJUHGLHQWVDQGDUHILOP FRDWHGZLWKLQGLJRFDUPLQH
DOXPLQXPODNHSRO\HWK\OHQHJO\FROSRO\YLQ\ODOFRKROWDOFWL WDQLXPGLR[LGHDQG\HOORZLURQ
R[LGH
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\5.2.2. Packaging and Labeling
(&)7$))'&WDEOHWVDUHSDFNDJHGLQZKLWHKLJKGHQVLW \SRO\HWK\OHQH+'3(ERWWOHV
(DFKERWWOHFRQWDLQVWDEOHWVVLOLFDJHOGHVLFFDQWDQGSRO\HV WHUSDFNLQJPDWHULDO(DFKERWWOHLV
HQFORVHGZLWKDZKLWHFRQWLQXRXVWKUHDGFKLOGUHVLVWDQWSRO\S URS\OHQHVFU HZFDSZLWKDQ
LQGXFWLRQVHDOHGDOXPLQXPIDFHGOLQHU
6WXG\GUXJ VWREHGLVWULEXWHGWRFHQWHUVLQSDUWLFLSDWLQJFRX QWULHVVKDOOEHODEHOHGWRPHHW
DSSOLFDEOHUHTXLUHPHQWVRIWKH8QLWHG6WDWHV)RRGDQG'UXJ$GPLQLVWUDWLRQ)'$(8
*XLGHOLQHWR*RRG0DQXIDFWXULQJ3UDFWLFH$QQH[,QYHVWLJDWLRQDO0HGLFLQDO3URGXFWVDQGRURWKHUORFDOUHJXODWLRQV
5.2.3. Storage and Handling
(&)7$))'&WDEOHWVVKRXOGEHVWRUHGDWFRQWUROOHGURRPWHPSHUDWXUHRIÂƒ&Âƒ)
H[FXUVLRQVDUHSHUPLWWHGEHWZHHQÂƒ&DQGÂƒ&Âƒ)DQGÂƒ) 6WRUDJHFRQGLWLRQVDUH
VSHFLILHGRQWKHODEHO8QWLOGLVSHQVHGWRWKHVXEMHFWVDOOERWWOHVRIVWXG\GUXJVKRXOGEHVWRUHGLQDVHFXUHO\ORFNHGDUHDDFFHVVLEOHRQO\WRDXWKRUL]HGVLWHS HUVRQQHO
7RHQVXUHWKHVWDELOLW\DQGSURSHULGHQWLILFDWLRQVWXG\GUXJVKRXOGQRWEHVWRUHGLQDFRQWDLQHURWKHUWKDQWKHFRQWDLQHULQZKLFKWKH\ZHUHVXSSOLHG
&RQVLGHUDWLRQVKRXOGEHJLYHQWRKDQGOLQJSUHSDUDWLRQDQGGLVSRVDOWKURXJKPHDVXUHVWKDW
PLQLPL]HGUXJFRQWDFWZLWKWKHERG\$SSURSULDWHSUHFDXWLRQVVK RXOGEHIROORZHGWRDYRLGGLUHFW
H\HFRQWDFWRUH[SRVXUHWKURXJKLQKDODWLRQZKHQKDQGOLQJ
5.3. Dosage and Administration of E/C/F/TAF FDC
(&)7$))'&WDEOHWVZLOOEHSURYLGHGE\*LOHDG6FLHQFHV
(OYLWHJUDYLUPJFRELFLVWDWPJHPWULFLWDELQHPJWHQRIR YLUDODIHQDPLGHPJ
(&)7$))'&ZLOOEHDGPLQLVWHUHGRUDOO\RQFHGDLO\ZLWKIRR GDWDSSUR[LPDWHO\WKHVDPH
WLPHHDFKGD\
5.4. Prior and Concomitant Medications
7KHXVHRIPHGLFDWLRQVIRUWKHWUHDWPHQWRI+,9RWKHUWKDQWKH VWXG\WUHDWPHQW
LH(&)7$)RU$%&7&SOXVDWKLUGDQWLUHWURYLUDODJHQWLVSURKLELWHG0HGLFDWLRQVOLVWHGLQ
WKHIROORZLQJWDEOHDQGXVHRIKHUEDOQDWXUDOVXSSOHPHQWVDUHH[FOXGHGRUVKRXOGEHXVHGZLWKFDXWLRQZKLOHVXEMHFWVDUHSDUWLFLSDWLQJLQWKHVWXG\GXHWRSRWHQWLDOGUXJGUXJLQWHUDFWLRQV
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\Table 5-1. Prior and Concomitant Medications
Drug Class Agents Disallowed Use Discouraged and To Be Used With Caution
$FLG5HGXFLQJ$JHQWV$QWDFLGV&RQFHQWUDWLRQRIVWXG\GUXJPD\GHFUHDVHZLWK
DQWDFLGV6XEMHFWVPD\QRWWDNHDQWDFLGV
HJ7XPV0\ODQWDWKHXOFHUPHGLFDWLRQVXFUDOIDWH
&DUDIDWHRUYLWDPLQRUPLQHUDOVXSSOHPHQWVWKDW
FRQWDLQFDOFLXPLURQRU]LQFIRUDPLQLPXPRIKRXUV
EHIRUHDQGKRXUVDIWHUDQ\GRVHRIVWXG\GUXJ
$OSKD$GUHQHUJLF5HFHSWRU$QWDJRQLVWV$OIX]RVLQ
$QDOJHVLFV7UDPDGRO3URSR[\SKHQH
&RQFHQWUDWLRQVPD\LQFUHDVHZLWKVWXG\GUXJV
FOLQLFDOPRQLWRULQJLVUHFRPPHQGHG
$QWLDU[LOCATION_006]\WKPLFV$PLRGDURQH)OHFDLQLGH4XLQLGLQH3URSDIHQRQH
6\VWHPLF/LGRFDLQH0H[LOHWLQH'LVRS\UDPLGH
&RQFHQWUDWLRQVPD\LQFUHDVHZLWKVWXG\GUXJV
UHVXOWLQJLQDSRWHQWLDOIRUFDUGLDFDU[LOCATION_006]\WKPLDV
FOLQLFDODQG(&*PRQLWRULQJLVUHFRPPHQGHG
&DOFLXP&KDQQHO%ORFNHUV %HSULGLO)HORGLSLQH1LIHGLSLQH1LFDUGLSLQH9HUDSDPLO
'LOWLD]HP$PORGLSLQH
&RQFHQWUDWLRQVPD\LQFUHDVHZLWKVWXG\GUXJV
&OLQLFDODQG(&*PRQLWRULQJRIVXEMHFWV
LVUHFRPPHQGHG
'LJR[LQ'LJR[LQ
&RQFRPLWDQWXVHPD\UHVXOWLQLQFUHDVHGOHYHOVXVH
ZLWKFDXWLRQDQGZLWKDSSURSULDWHPRQLWRULQJRI
VHUXPGLJR[LQOHYHOV'LJR[LQWKHUDS\VKRXOGEH
LQLWLDWHGDWWKHORZHUGRVHDQGWKHGRVHVKRXOGEH
WLWUDWHGWRFOLQLFDOUHVSRQVH
$QWLEDFWHULDOV&ODULWKURP\FLQDQG7HOLWKURP\FLQ
&RQFHQWUDWLRQVPD\EHDOWHUHGZLWKVWXG\GUXJV
FRQVLGHUDQDOWHUQDWLYH
$QWLFRDJXODQWV:DUIDULQ&RQFHQWUDWLRQVPD\LQFUHDVHRUGHFUHDVH
ZLWKVWXG\GUXJVDSSURSULDWH,15
,QWHUQDWLRQDO1RUP DOL]HG5DWLRPRQLWRULQJ
LVUHFRPPHQGHG
$QWLFRQYXOVDQWV3KHQREDUELWDO3KHQ\WRLQ
&DUEDPD]HSLQH
2[FDUED]HSLQH(WKRVX[LPLGH'LYDOSURH[/DPRWULJLQH
&RQFHQWUDWLRQVPD\LQFUHDVHZLWKVWXG\GUXJV
FOLQLFDOPRQLWRULQJLVUHFRPPHQGHG
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\Drug Class Agents Disallowed Use Discouraged and To Be Used With Caution
$QWLGHSUHVVDQWV6HOHFWLYHVHURWRQLQUHXSWDNHLQKLELWRUV665,V
$GRVHUHGXFWLRQPD\EHUHTXLUHGIRUPRVWGUXJVRI
WKLVFODVVZLWKWKHH[FHSWLRQRIVHUWUDOLQH
7ULF\FOLFV
&RQFHQWUDWLRQVPD\LQFUHDVHRUGHFUHDVHZLWKVWXG\
GUXJV&RQFHQWUDWLRQPRQLWRULQJLVUHFRPPHQGHG
WRHQVXUHDGHTXDWHFOLQLFDOUHVSRQVH
7UD]RGRQH
&RQFRPLWDQWXVHZLWK&<3$LQKLELWRUVUHVXOWVLQ
LQFUHDVHGFRQFHQWUDWLRQVDQGDGYHUVHHYHQWVGRVH
UHGXFWLRQVKRXOGEHFRQVLGHUHG
$QWLIXQJDOV.HWRFRQD]ROHDQG,WUDFRQD]ROH
&RQFRPLWDQWXVHZLWKVWXG\GUXJPD\UHVXOWLQDQ
LQFUHDVHLQFRQFHQWUDWLRQV'DLO\GRVHRI
NHWRFRQD]ROHDQGLWUDFRQD]ROHVKRXOGEHUHVWULFWHG
WRPJ6XEMHFWVUHFHLYLQJNHWRFRQD]ROHRU
LWUDFRQD]ROHVKRXOGEHPRQLWRUHGIRUDGHTXDWH
FOLQLFDOUHVSRQVH
9RULFRQD]ROH
&RQFRPLWDQWXVHZLWKVWXG\GUXJPD\UHVXOWLQDQ
LQFUHDVHLQFRQFHQWUDWLRQV&OLQLFDOPRQLWRULQJPD\
EHQHHGHG
$QWLJRXW&ROFKLFLQH
&RQFHQWUDWLRQVPD\LQFUHDVHZLWKVWXG\GUXJV
'RVHUHGXFWLRQVRIFROFKLFLQHPD\EHUHTXLUHG
6KRXOGQRWEHFRDGPLQLVWHUHGLQSDWLHQWVZLWK
UHQDORUKHSDWLFLPSDLUPHQW
7UHDWPHQWRI*RXW)ODUH
PJWDEOHWÃ®GRVHIROORZ HGE\PJ
KDOIWDEOHWKRXUODWHU7U HDWPHQWFRXUVHPD\EH
UHSHDWHGQRHDUOLHUWKDQGD\V
3URSK\OD[LVRI*RXW)ODUHV
,IWKHRULJLQDOUHJLPHQZDVPJWZLFHDGD\
WKHUHJLPHQVKRXOGEHDGMXVWHGWRPJRQFHD
GD\,IWKHRULJLQDOUHJLPHQZDVPJRQFHDGD\
WKHUHJLPHQVKRXOGEHDGMXVWHGWRPJ
RQFHHYHU\RWKHUGD\
7UHDWPHQWRI)DPLOLDO0HGLWHUUDQHDQ)HYHU
0D[LPXPGDLO\GRVHRIPJ
PD\EHJLYHQDVPJWZLFHDGD\
$QWLKLVWDPLQHV $VWHPL]ROH7HUIHQDGLQH
$QWLP\FREDFWHULDOV5LIDPSLQ5LIDSHQWLQH
5LIDEXWLQ
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\Drug Class Agents Disallowed Use Discouraged and To Be Used With Caution
È•%ORFNHUV0HWRSURORO7LPRORO
&OLQLFDODQG(&*PRQLWRULQJRIVXEMHFWVLV
UHFRPPHQGHG$GRVHGHFUHDVHPD\EHQHHGHG
&RUWLFRVWHURLGV,QKDOHG1DVDO&RQFRPLWDQWXVHRILQKDOHGIOXWLFDVRQHDQGVWXG\
GUXJVPD\LQFUHDVHSODVPDFRQFHQWUDWLRQVRI
IOXWLFDVRQH8VHLVQRWUHFRPPHQGHGXQOHVVWKH
SRWHQWLDOEHQHILWWRWKHVXEMHFWRXWZHLJKVWKHULVNV
RIFRUWLFRVWHURLGVLGHHIIHFWV$OWHUQDWLYHVVKRXOGEH
FRQVLGHUHGSDUWLFXODUO\IRUORQJWHUPXVH
&RUWLFRVWHURLGV6\VWHPLF6\VWHPLFGH[DPHWKDVRQHD&<3$LQGXFHUPD\
VLJQLILFDQWO\GHFUHDVHHOYLWHJUDYLUDQGFRELFLVWDW
SODVPDFRQFHQWUDWLRQVZKLFKPD\UHVXOWLQORVVRI
WKHUDSHXWLFHIIHFWDQGGHYHORSPHQWRIUHVLVWDQFH$OWHUQDWLYHFRUWLFRVWHURLGVVKRXOGEHFRQVLGHUHG
8VHRI3UHGQLVRQHDVDVWHURLGEXUVWÂ”ZHHNRIXVH
VKRXOGEHPRQLWRUHGDSSURSULDWHO\
(QGRWKHOLQ5HFHSWRU$QWDJRQLVWV%RVHQWDQ
&RDGPLQLVWUDWLRQPD\OHDGWRGHFUHDVHGHOYLWHJUDYLU
H[SRVXUHVDQGORVVRIWKHUDSHXWLFHIIHFWDQG
GHYHORSPHQWRIUHVLVWDQFH$OWHUQDWLYHHQGRWKHOLQ
UHFHSWRUDQWDJRQLVWVPD\EHFRQVLGHUHG
(UJRW'HULYDWLYHV(UJRWDPLQH(UJRQRYLQH
'LK\GURHUJRWDPLQH
0HWK\OHUJRQRYLQH
(UJRPHWULQH
*,0RWLOLW\$JHQWV &LVDSULGH
+HUEDO1DWXUDO6XSSOHPHQWV6W-RKQÂ¶V:RUW
(FKLQDFHD
+0*&R$5HGXFWDVH,QKLELWRUV6LPYDVWDWLQ/RYDVWDWLQ$WRUYDVWDWLQ
&RQFHQWUDWLRQVPD\LQFUHDVHZLWKVWXG\GUXJV
6WDUWZLWKWKHORZHVWGRVHJUDGXDOLQFUHDVHLQGRVH
PD\EHWDLORUHGWRFOLQLFDOUHVSRQVH&DUHIXO
PRQLWRULQJIRUVLJQVDQGV\PSWRPVRIPXVFOH
ZHDNQHVVRUP\RSDWK\LQFOXGLQJ[LOCATION_006]DEGRP\RO\VLV
,PPXQRVXSSUHVVDQWV&\FORVSRULQH5DSDP\FLQ6LUROLPXV7DFUROLPXV
&RQFHQWUDWLRQVPD\LQFUHDVHZLWKVWXG\GUXJV
7KHUDSHXWLFPRQLWRULQJVKRXOGEHFRQVLGHUHG
,QKDOHG%HWD$JRQLVW 6DOPHWHURO
1HXUROHSWLFV 3LPR]LGH3HUSKHQD]LQH5LVSHULGRQH7KLRULGD]LQH
$GRVHGHFUHDVHPD\EHQHHGHG
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\Drug Class Agents Disallowed Use Discouraged and To Be Used With Caution
2SLDWHV0HWKDGRQH
0HWKDGRQHH[SRVXUHVDUHXQDIIHFWHGXSRQ
FRDGPLQLVWUDWLRQZLWKHOYLWHJUDYLUDQGFRELFLVWDW
1RGRVHDGMXVWPHQWRIPHWKDGRQHLVUHTXLUHGXSRQ
FRDGPLQLVWUDWLRQZLWKVWXG\GUXJV
0HSHULGLQH3HWKLGLQH
'RVDJHLQFUHDVHDQGORQJWHUPXVHDUHQRW
UHFRPPHQGHGGXHWRLQFUHDVHGOHYHOVRIPHWDEROLWH
QRUPHSHULGLQHZKLFKKDVDQDOJHVLFDQG
&16VWLPXODQWHJVHL]XUHVDFWLYLWLHV
%XSUHQRUSKLQH
&RQFHQWUDWLRQVRIEXSUHQRUSKLQHDQG
QRUEXSUHQRUSKLQHDUHPRGHVWO\LQFUHDVHGDQG
FRQFHQWUDWLRQVRIQDOR[RQHDUHPRGHVWO\GHFUHDVHG
ZKHQFRDGPLQLVWHUHGZLWKHOYLWHJUDYLUDQGFRELFLVWDW
ZLWKQRHIIHFWRQRSLRLGSKDUPDFRG\QLPFV
7KHFRQFHQWUDWLRQFKDQJHVDUHQRWFRQVLGHUHG
FOLQLFDOO\UHOHYDQWDQGQRGRVHDGMXVWPHQWRI
EXSUHQRUSKLQHQDOR[RQHLVUHTXLUHGXSRQ
FRDGPLQLVWUDWLRQZLWKVWXG\GUXJV
3KRVSKRGLHVWHUDVH ,QKLELWRUV 6LOGHQDILOIRU3$+3XOPRQDU\$UWHULDO+\SHUWHQVLRQ
7DGDODILO
&DXWLRQVKRXOGEHH[HUFLVHGLQFOXGLQJ
FRQVLGHUDWLRQRIGRVHUHGXFWLRQZKHQ
FRDGPLQLVWHUHGIRUWUHDWPHQWRISXOPRQDU\DUWHULDO
K\SHUWHQVLRQ
(UHFWLOH'\VIXQFWLRQ
6LOGHQDILO9DUGHQDILO7DGDODILO
,WLVUHFRPPHQGHGWKDWDVLQJOHGRVHRI6LOGHQDILO
QRPRUHWKDQPJLQKRXUV9DUGHQDILOQR
PRUHWKDQPJLQKRXUVRU7DGDODILOQRPRUH
WKDQPJLQKRXUVEHFRDGPLQLVWHUHG
6HGDWLYHV+\SQRWLFV2UDOO\DGPLQLVWHUHG
0LGD]RODP7ULD]RODP%XVSLURQH&ORUD]HSDWH'LD]HSDP(VWD]RODP
)OXUD]HSDP=ROSLGHP
$GRVHGHFUHDVHPD\EHQHHGHGIRUWKHVHGUXJV
&OLQLFDOPRQLWRULQJLVUHFRPPHQGHG
6KRXOGVXEMHFWVKDYHDQHHGWRLQLWLDWHWUHDWPHQWZLWKDQ\H[FO XGHGFRQFRPLWDQWPHGLFDWLRQWKH
*LOHDG0HGLFDO0RQLWRUPXVWEHFRQVXOWHGSULRUWRLQLWLDWLRQRIWKHQHZPHGLFDWLRQ,QLQVWDQFHV
ZKHUHDQH[FOXGHGPHGLFDWLRQLVLQLWLDWHGSULRUWRGLVFXVVLRQZ LWKWKH0HGLFDO0RQLWRUWKH
,QYHVWLJDWRUPXVWQRWLI\*LOHDGDVVRRQDVKHVKHLVDZDUHRIW KHXVHRIWKHH[FOXGHGPHGLFDWLRQ
$GGLWLRQDOO\,QYHVWLJDWRUVVKRXOGUHIHUWRWKHSURGXFWSDFNDJH LQVHUWVRIWKHRWKHUDQWLUHWURYLUDO
PHGLFDWLRQVIRUFRQWUDLQGLFDWLRQVUHODWHGWRWKHLUXVH
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\5.5. Accountability for Study Drug
7KHLQYHVWLJDWRULVUHVSRQVLEOHIRUHQVXULQJDGHTXDWHDFFRXQWDE LOLW\RIDOOXVHGDQGXQXVHGVWXG\
GUXJ7KLVLQFOXGHVDFNQRZOHGJHPHQWRIUHFHLSWRIHDFKVKLSPHQW RIVWXG\GUXJTXDQWLW\DQG
FRQGLWLRQ$OOXVHGDQGXQXVHGVWXG\GUXJGLVSHQVHGWRVXEMHFWV PXVWEHUHWXUQHGWRWKHVLWH
7KH,QYHVWLJDWRURUGHVLJQHHZLOOEHUHVSRQVLEOHIRUPDLQWDLQ LQJDQDFFXUDWHLQYHQWRU\
RQVWXG\GUXJ DFFRXQWDELOLW\UHFRUGVRIWKHGDWHVDQGTXDQWLWLH VRIDOOVWXG\GUXJUHFHLYHG
GLVSHQVHGDQGUHWXUQHG(DFKGRVHRIWKHVWXG\GUXJDGPLQLVWHUHGDWWKHVWXG\FHQWHUZLOOEH
DGPLQLVWHUHGE\TXDOLILHGVWXG\FHQWHUSHUVRQQHO(DFKGRVHRI WKHVWXG\GUXJDGPLQLVWHUHGDWWKH
VWXG\FHQWHUZLOOEHDGPLQLVWHUH GE\TXDOLILHGVWXG\ FHQWHUSHUVRQQHO7KHUHTXLUHPHQWVRIDOO
DSSOLFDEOHGUXJGLVSHQVLQJODZVZLOODSSO\WRDOOGRVHVRIVWXG \GUXJGLVSHQVHGE\WKH
,QYHVWLJDWRURUGHVLJQHH
7KHVWXG\GUXJLQYHQWRU\DQGGLVSHQVLQJORJVPXVWEHDYDLODEOHI RULQVSHFWLRQE\WKHVWXG\
PRQLWRU6WXG\PHGLFDWLRQVXSSOLHVLQFOXGLQJSDUWLDOO\XVHGRU HPSW\ERWWOHVPXVWEHDFFRXQWHG
IRUE\WKHVWXG\PRQLWRUSULRUWRGHVWUXFWLRQRUUHWXUQ6WXG\GUXJDFFRXQWDELOLW\UHFRUGVZLOOEHSURYLGHGWRHDFKVWXG\ VLWHWR
ï‚·5HFRUGWKHGDWHUHFHLYHGDQGTXDQWLW\RI VWXG\GUXJ
ï‚·5HFRUGWKHGDWHVXEMHFWQXPEHUVXEMHFWLQLWLDOVWKHVWXG\GU XJVWXG\GUXJERWWOHQXPEHU
GLVSHQVHG
ï‚·5HFRUGWKHGDWHTXDQWLW\RIXVHGDQGXQXVHGVWXG\ GUXJUHWXUQHG DORQJZLWKWKHLQLWLDOVRI
WKHSHUVRQUHFRUGLQJWKHLQIRUPDWLRQ
5.5.1. Study Drug Return or Disposal
7KHVWXG\PRQLWRUZLOOSURYLGHLQVWUXFWLRQVIRUUHWXUQ,IUHWX UQLVQRWSRVVLEOHWKHVWXG\PRQLWRU
ZLOOHYDOXDWHHDFKVWXG\FHQWHUÂ¶VVWXG\GUXJGLVSRVDOSURFHGXUHV DQGSURYLGHDSSURSULDWH
LQVWUXFWLRQIRUGHVWUXFWLRQRIXQXVHGVWXG\GUXJVXSSOLHV,IWKHVLWHKDVDQDSSURSULDWHVWDQGDUG
RSHUDWLQJSURFHGXUH623IRUGUXJGHVWUXFWLRQDVGHWHUPLQHGE\*LOHDG4XDOLW\$VVXUDQFHWKHVLWHPD\GHVWUR\XVHGHPSW\RUSDUWLDOO\HPSW\DQGXQXVHGVWX G\GUXJVXSSOLHVLQDFFRUGDQFH
ZLWKWKDWVLWHÂ¶VDSSURYHG623$FRS\RIWKHVLWHÂ¶VDSSURYHG623 ZLOOEHREWDLQHGIRUFHQWUDO
ILOHV
,IWKHVWXG\GUXJLVGHVWUR\HGRQVLWHWKH,QYHVWLJDWRUPXVWPD LQWDLQDFFXUDWHUHFRUGVIRUDOO
VWXG\GUXJGHVWUR\HG5HFRUGVPXVWVKRZWKHLGHQWLILFDWLRQDQGT XDQWLW\RIHDFKXQLWGHVWUR\HG
WKHPHWKRGRIGHVWUXFWLRQDQGWKHSHUVRQZKRGLVSRVHGRIWKHV WXG\GUXJ8SRQVWXG\
FRPSOHWLRQFRSLHVRIWKHVWXG\GUXJDFFRXQWDELOLW\UHFRUGVPXVW EHILOHGDWWKHVLWH$QRWKHU
FRS\ZLOOEHUHWXUQHGWR*LOHDG7KHVWXG\PRQLWRUZLOOUHYLHZV WXG\GUXJVXSSOLHVDQG
DVVRFLDWHGUHFRUGVDWSHULRGLFLQWHUYDOV
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\6. STUDY PROCEDURES
7KHVWXG\SURFHGXUHVWREHFRQGXFWHGIRUHDFKVXEMHFWHQUROOHGLQWKHVWXG\DUHSUHVHQWHGLQ
WDEXODUIRUPLQ $SSHQGL[ DQGGHVFULEHGLQWKHWH[WWKDWIROORZV
$Q\GHYLDWLRQIURPSURWRFROSURFHGXUHVVKRXOGEHQRWHGLQWKHV XEMHFWÂ¶VFOLQLFDOFKDUWDQG
DSSURSULDWHHOHFWURQLF&DVH5HSRUW)RUPVH&5)V,QDGGLWLRQ WKHVSRQVRURU
&RQWUDFW5HVHDUFK2UJDQL]DWLRQ&52VKRXOGEHSURPSWO\QRWLILHGRIDQ\SURWRFROGHYLDWLRQV
6.1. Subject Enrollment and Treatment Assignment
,WLVWKHUHVSRQVLELOLW\RIWKH,QYHVWLJDWRUWRHQVXUHWKDWVXE MHFWVDUHHOLJLEOHIRUVWXG\SULRUWR
HQUROOPHQW3OHDVHUHIHUWR6HFWLRQ IRUGHWDLOVDERXWUDQGRPL]DWLRQDQGWUHDWPHQWDVVLJQPHQW
6.2. Pretreatment Assessments
6.2.1. Screening Visit
6XEMHFWVZLOOEHVFUHHQHGZLWKLQGD\VEHIRUH'D\WRGHWHUPLQH HOLJLELOLW\IRUSDUWLFLSDWLRQLQ
WKHVWXG\7KHIROORZLQJZLOOEHSHUIRUPHGDQGGRFXPHQWHGDWVF UHHQLQJ
ï‚·2EWDLQZULWWHQLQIRUPHGFRQVHQW
ï‚·2EWDLQPHGLFDOKLVWRU\LQFOXGLQJKLVWRU\RI+,9GLVHDVHUHODWHGHYHQWVDQGSULRU
PHGLFDWLRQVZLWKLQGD\VRIWKH6FUHHQLQJYLVLW
ï‚·&RPSOHWHSK\VLFDOH[DPLQDWLRQXURJHQLWDODQRUHFWDOH[DPVZLOO EHSHUIRUPHGDWWKH
GLVFUHWLRQRIWKH,QYHVWLJDWRU
ï‚·9LWDOVLJQVPHDVXUHPHQWEORRGSUHVVXUHSXOVHUHVSLUDWLRQUDW HDQGWHPSHUDWXUH
ERG\ZHLJKWDQGKHLJKW
ï‚·OHDG(&*SHUIRUPHGVXSLQH
ï‚·8ULQHFROOHFWLRQIRUWKHIROORZLQJODERUDWRU\DQDO\VHV
ï‚¾8ULQDO\VLVDQGXULQHFKHPLVWU\
ï‚·%ORRGVDPSOHFROOHFWLRQIRUWKHIROORZLQJODERUDWRU\DQDO\VHV
ï‚¾6HUXPSUHJQDQF\WHVWIHPDOHVRIFKLOGEHDULQJSRWHQWLDORQO\ ,IWKHWHVWLVSRVLWLYHWKH
VXEMHFWZLOOQRWEHHQUROOHG
ï‚¾&KHPLVWU\SURILOHDONDOLQHSKRVSKDWDVH$67$/7WRWDOELOLUX ELQGLUHFWDQGLQGLUHFW
ELOLUXELQWRWDOSURWHLQDOEXPLQELFDUERQDWH%81FDOFLXPFK ORULGHFUHDWLQLQH
JOXFRVHSRWDVVLXPDQGVRGLXP
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\ï‚¾+HPDWRORJ\SURILOHFRPSOHWHEORRGFRXQW&%&ZLWKGLIIHUHQWLD ODQGSODWHOHWFRXQW
ï‚¾&'FHOOFRXQW
ï‚¾3ODVPD+,951$7DTPDQY
ï‚¾:KROHEORRGVDPSOHIRUSURYLUDOJHQRW\SHDQDO\VLVRIDUFKLYHGU HVLVWDQFHLIDKLVWRULFDO
JHQRW\SHLVQRWDYDLODEOH
ï‚¾+HSDWLWLV%YLUXVVXUIDFHDQWLJHQVHURORJ\+%V$JDQG+HSDWLWLV %FRUH$QWLERG\+%F$E
ï‚¾+HSDWLWLV&YLUXV+&9$EVHURORJ\UHIOH[+&951$LVSHUIRUPHGLQVXEMHFWVZLWK
SRVLWLYH+&9$EVHURORJ\
ï‚¾(VWLPDWHG*)5DFFRUGLQJWRWKH&RFNFURIW*DXOWIRUPXODIRUFUHD WLQLQHFOHDUDQFHH*)5 &*
0DOH Â±DJHLQ\HDUVÃ®ZWLQNJ ï€½&/FUP/PLQ
Ã®VHUXPFUHDWLQLQHLQPJG/
)HPDOH Â±DJHLQ\HDUVÃ®ZWLQNJï‚´ ï€½&/FUP/PLQ
Ã®VHUXPFUHDWLQLQHLQPJG/
ï‚·5HYLHZRI&RQFRPLWDQW0HGLFDWLRQV
5HFRUGDQ\VHULRXVDGYHUVHHYHQWVDQGDOODGYHUVHHYHQWVUHODWHGWRSURWRFROPDQGDWHG
SURFHGXUHVRFFXUULQJDIWHUVLJQLQJRIWKHFRQVHQWIRUP6XEMHFWVPHHWLQJDOORIWKHLQFOXVLRQFULWHULDDQGQRQHRIWKHH[FOXVLRQFULWHULDZLOOUHWXUQWRWKH FOLQLFZLWKLQGD\VDIWHUVFUHHQLQJ
IRUUDQGRPL]DWLRQLQWRWKHVWXG\
)URPWKHWLPHRIREWDLQLQJLQIRUPHGFRQVHQWWKURXJKWKHILUVWDGPLQLVWUDWLRQRIVWXG\GUXJ
UHFRUGDOOVHULRXVDGYHUVHHYHQWV6$(VDVZHOODVDQ\DGYHUVHHYHQWVUHODWHGWRSURWRFROPDQGDWHGSURFHGXUHVRQWKHDGYHUVHHYHQWVFDVHUHSRUW IRUPH&5)$OORWKHU
XQWRZDUGPHGLFDORFFXUUHQFHVREVHUYHGGXULQJWKHVFUHHQLQJSHUL RGLQFOXGLQJH[DFHUEDWLRQRU
FKDQJHVLQPHGLFDOKLVWRU\DUHWREHFDSWXUHGRQWKHPHGLFDOKLVWRU\H&5)6HH6HFWLRQ 
$GYHUVH(YHQWVDQG7R[LFLW\0DQDJHPHQWIRUDGGLWLRQDOGHWDLOV
6.2.2. Day 1 Visit
7KHIROORZLQJHYDOXDWLRQVDUHWREHFRPSOHWHGDWWKH'D\9LVLW 7KHVXEMHFWPXVWFRPSOHWHDOO
HYDOXDWLRQVEHIRUHEHLQJGLVSHQVHGWKHVWXG\ GUXJ,QLWLDWLRQRI WUHDWPHQWZLWKWKHVWXG\GUXJ
PXVWWDNHSODFHZLWKLQKRXUVDIWHUWKLVYLVLW
ï‚·5HYLHZRI$(VDQGFKDQJHVLQFRQFRPLWDQWPHGLFDWLRQV
ï‚·&RPSOHWHSK\VLFDOH[DPLQDWLRQXURJHQLWDODQRUHFWDOH[DPVZLOO EHSHUIRUPHGDWWKH
GLVFUHWLRQRIWKH,QYHVWLJDWRU
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\ï‚·9LWDOVLJQVLQFOXGLQJZHLJKW
ï‚·8ULQHFROOHFWLRQIRUWKHIROORZLQJODERUDWRU\DQDO\VHV
ï‚¾8ULQDO\VLVDQGXULQHFKHPLVWU\
ï‚¾5HQDOVDIHW\HYDOXDWLRQV)DVWLQJQRIRRGRUGULQNH[FHSWZDWH UDWOHDVWKRXUVSULRUWR
EORRGFROOHFWLRQUHWLQROELQGLQJSURWHLQDQGEHWDPLFURJOREX OLQ
o,IWKHVXEMHFWKDVQRWIDVWHGSULRUWRWKHYLVLWWKHYLVLWPD\ SURFHHGEXWWKHVXEMHFW
PXVWUHWXUQZLWKLQKRXUVLQDIDVWHGVWDWH
ï‚¾8ULQHSUHJQDQF\WHVWIHPDOHVRIFKLOGEHDULQJSRWHQWLDORQO\,IWKHXULQHSUHJQDQF\WHVW
LVSRVLWLYHDW'D\YLVLWVWXG\GUXJZLOOQRWEHGLVSHQVHG7 KHSRVLWLYHUHVXOWZLOOEH
FRQILUPHGZLWKDVHUXPSUHJQDQF\WHVW,IWKHVHUXPSUHJQDQF\W HVWLVSRVLWLYHWKH
VXEMHFWZLOOQRWEHDEOHWRSDUWLFLSDWH
ï‚¾8ULQHVDPSOHVWRUDJHIRUSRVVLEOHDGGLWLRQDOFOLQLFDOWHVWLQJ
ï‚·%ORRGVDPSOHFROOHFWLRQIRUWKHIROORZLQJODERUDWRU\DQDO\VHV
ï‚¾&KHPLVWU\SURILOHJOXFRVHZLOOEHGRQHDVSDUWRIWKHIDVWLQJP HWDEROLFDVVHVVPHQWV
ï‚¾+HPDWRORJ\SURILOH
ï‚¾&'FHOOFRXQW
ï‚¾3ODVPD+,951$
ï‚¾&\VWDWLQ&
ï‚¾H*)5&*
ï‚¾0HWDEROLFDVVHVVPHQWV)DVWLQJQRIRRGRUGULQNVH[FHSWZDWHUDWOHDVWKRXUVSULRUWR
EORRGFROOHFWLRQJOXFRVHDQGOLSLGSDQHOWRWDOFKROHVWHURO+ '/GLUHFW/'/
DQGWULJO\FHULGHV
o,IWKHVXEMHFWKDVQRWIDVWHGSULRUWRWKHYLVLWWKHYLVLWPD\ SURFHHGEXWWKHVXEMHFW
PXVWUHWXUQZLWKLQKRXUVLQDIDVWHGVWDWH
ï‚¾6HUXPERQHVDIHW\HYDOXDWLRQV)DVWLQJQRIRRGRUGULQNH[FHSW ZDWHUDWOHDVWKRXUV
SULRUWREORRGFROOHFWLRQSDUDWK\URLGKRUPRQH37+DQGVHUXP 2+9LWDPLQ'
o,IWKHVXEMHFWKDVQRWIDVWHGSULRUWRWKHYLVLWWKHYLVLWPD\ SURFHHGEXWWKHVXEMHFW
PXVWUHWXUQZLWKLQKRXUVLQDIDVWHGVWDWHWRGUDZEORRGIRUWKHVHHYDOXDWLRQV
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\6.4. Treatment Assessments
6.4.1. Treatment Visits (Weeks 4, 8, and 12)
7KHIROORZLQJHYDOXDWLRQVDUHWREHFRPSOHWHGDWWKHHQGRI:HH NVDQGXQOHVVRWKHUZLVH
VSHFLILHG
$OOVWXG\YLVLWVDUHWREHVFKHGXOHGUHODWLYHWRWKH'D\YLVLW GDWH6WXG\YLVLWVDUHWREH
FRPSOHWHGZLWKLQÂ“GD\VRIWKHSURWRFROVSHFLILHGYLVLWGDWHEDVHGRQWKH'D\YLVLW5HJXODUO\VFKHGXOHGHYDOXDWLRQVZLOOEHPDGHRQDOOVXEMHFWVZK HWKHURUQRWWKH\FRQWLQXHWR
UHFHLYHVWXG\GUXJ
ï‚·5HYLHZRI$(VDQGFKDQJHVLQFRQFRPLWDQWPHGLFDWLRQV
ï‚·6\PSWRPGLUHFWHGSK\VLFDOH[DPLQDWLRQDVQHHGHG
ï‚·9LWDOVLJQVPHDVXUHPHQWLQFOXGLQJZHLJKW
ï‚·8ULQHFROOHFWLRQIRUWKHIROORZLQJODERUDWRU\DQDO\VHV
ï‚¾8ULQDO\VLVDQGXULQHFKHPLVWU\
ï‚¾8ULQHSUHJQDQF\WHVWIHPDOHVRIFKLOGEHDULQJSRWHQWLDORQO\S RVLWLYHXULQHSUHJQDQF\
WHVWVZLOOEHFRQILUPHGZLWKDVHUXPWHVW,IWKHWHVWLVSRVLWLYHWKHVXEMHFWZLOOEH
GLVFRQWLQXHG
ï‚¾5HQDOVDIHW\HYDOXDWLRQV)DVWLQJQRIRRGRUGULQNH[FHSWZDW HUDWOHDVWKRXUVSULRUWR
EORRGFROOHFWLRQUHWLQROELQGLQJSURWHLQDQGEHWDPLFURJOREX OLQWeeks 4 and 12
o,IWKHVXEMHFWKDVQRWIDVWHGSULRUWRWKHYLVLWWKHYLVLWPD\ SURFHHGEXWWKHVXEMHFW
PXVWUHWXUQZLWKLQKRXUVLQDIDVWHGVWDWH
ï‚¾8ULQHVDPSOHVWRUDJHIRUSRVVLEOHDGGLWLRQDOFOLQLFDOWHVWLQJ
ï‚·%ORRGVDPSOHFROOHFWLRQIRUWKHIROORZLQJODERUDWRU\DQDO\VHV
ï‚¾&KHPLVWU\SURILOHJOXFRVHZLOOEHGRQHDVSDUWRIWKHIDVWLQJ PHWDEROLFDVVHVVPHQWVDW
:HHN
ï‚¾+HPDWRORJ\SURILOH
ï‚¾&'FHOOFRXQW
ï‚¾3ODVPD+,951$
ï‚¾H*)5
&*
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\6.4.2. Treatment Assessments (Week 24)
7KHIROORZLQJHYDOXDWLRQVDUHWREHFRPSOHWHGDWWKHHQGRI:HH N
$OOVWXG\YLVLWVDUHWREHVFKHGXOHGUHODWLYHWRWKH'D\YLVL WGDWH6WXG\YLVLWVDUHWREH
FRPSOHWHGZLWKLQÂ“GD\VRIWKHSURWRFROVSHFLILHGYLVLWGDWHED VHGRQWKH'D\YLVLW
5HJXODUO\VFKHGXOHGHYDOXDWLRQVZLOOEHPDGHRQDOOVXEMHFWVZKH WKHURUQRWWKH\FRQWLQXHWR
UHFHLYHVWXG\GUXJ
6XEMHFWVUDQGRPL]HGWR7UHDWPHQW*URXSZLOOEHLQVWUXFWHGWRGLVFRQWLQXHWKHLUSUHYLRXV$59
SOXVWKLUGDJHQWUHJLPHQDQGZLOOVZLWFKWRWKH(&)7$))'&WD EOHWDQGPXVWLQLWLDWHGRVLQJRI
VWXG\GUXJZLWKLQKRXUVDIWHUWKH:HHNYLVLW
ï‚·5HYLHZRI$(VDQGFKDQJHVLQFRQFRPLWDQWPHGLFDWLRQV
ï‚·&RPSOHWHSK\VLFDOH[DPLQDWLRQXURJHQLWDODQRUHFWDOH[DPVZLOO EHSHUIRUPHGDWWKH
GLVFUHWLRQRIWKH,QYHVWLJDWRU
ï‚·9LWDOVLJQVLQFOXGLQJZHLJKW
ï‚·8ULQHFROOHFWLRQIRUWKHIROORZLQJODERUDWRU\DQDO\VHV
ï‚¾8ULQDO\VLVDQGXULQHFKHPLVWU\
ï‚¾5HQDOVDIHW\HYDOXDWLRQV)DVWLQJQRIRRGRUGULQNH[FHSWZDWHUDWOHDVWKRXUVSULRUWR
EORRGFROOHFWLRQUHWLQROELQGLQJSURWHLQDQGEHWDPLFURJOREX OLQ
o,IWKHVXEMHFWKDVQRWIDVWHGSULRUWRWKHYLVLWWKHYLVLWPD\ SURFHHGEXWWKHVXEMHFW
PXVWUHWXUQZLWKLQKRXUVLQDIDVWHGVWDWH
ï‚¾8ULQHSUHJQDQF\WHVWIHPDOHVRIFKLOGEHDULQJSRWHQWLDORQO\S RVLWLYHXULQHSUHJQDQF\
WHVWVZLOOEHFRQILUPHGZLWKDVHUXPWHVW,IWKHWHVWLVSRVLWLYHWKHVXEMHFWZLOOEH
GLVFRQWLQXHG
ï‚¾8ULQHVDPSOHVWRUDJHIRUSRVVLEOHDGGLWLRQDOFOLQLFDOWHVWLQJ
ï‚·%ORRGVDPSOHFROOHFWLRQIRUWKHIROORZLQJODERUDWRU\DQDO\VHV
ï‚¾&KHPLVWU\SURILOHJOXFRVHZLOOEHGRQHDVSDUWRIWKHIDVWLQJP HWDEROLFDVVHVVPHQWV
ï‚¾+HPDWRORJ\SURILOH
ï‚¾&'FHOOFRXQW
ï‚¾3ODVPD+,951$
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\6.4.3. Treatment Assessments (Week 28 and 32) âˆ’Treatment Group 2 ONLY
7KHIROORZLQJHYDOXDWLRQVDUHWREHFRPSOHWHGDWWKHHQGRI:HHNDQGIRUVXEMHFWV
UDQGRPL]HGWR7UHDWPHQW*URXSDQGZKRZLOOEHVZLWFKHGIURPWKHLUH[LVWLQJUHJLPHQWRWKH(&)7$))'&DWZHHN
6WXG\YLVLWVDUHWREHFRPSOHWHGZLWKLQÂ“GD\VRIWKHSURWRFR OVSHFLILHGYLVLWGDWHXQOHVV
RWKHUZLVHVSHFLILHG5HJXODUO\VFKHGXOHGHYDOXDWLRQVZLOOEHPDGHRQDOOVXEMHFWVZK HWKHURUQRWWKH\FRQWLQXHWR
UHFHLYHVWXG\GUXJ
ï‚·5HYLHZRI$(VDQGFKDQJHVLQFRQFRPLWDQWPHGLFDWLRQV
ï‚·6\PSWRPGLUHFWHGSK\VLFDOH[DPLQDWLRQDVQHHGHG
ï‚·9LWDOVLJQVLQFOXGLQJZHLJKW
ï‚·8ULQHFROOHFWLRQIRUWKHIROORZLQJODERUDWRU\DQDO\VHV
ï‚¾8ULQDO\VLVDQGXULQHFKHPLVWU\
ï‚¾5HQDOVDIHW\HYDOXDWLRQV)DVWLQJQRIRRGRUGULQNH[FHSWZDWHUDWOHDVWKRXUVSULRUWR
EORRGFROOHFWLRQUHWLQROELQGLQJSURWHLQDQGEHWDPLFURJOREXOLQ Week 28
o,IWKHVXEMHFWKDVQRWIDVWHGSULRUWRWKHYLVLWWKHYLVLWPD\ SURFHHGEXWWKHVXEMHFW
PXVWUHWXUQZLWKLQKRXUVLQDIDVWHGVWDWH
ï‚¾8ULQHSUHJQDQF\WHVWIHPDOHVRIFKLOGEHDULQJSRWHQWLDORQO\S RVLWLYHXULQHSUHJQDQF\
WHVWVZLOOEHFRQILUPHGZLWKDVHUXPWHVW,IWKHWHVWLVSRVLWLYHWKHVXEMHFWZLOOEH
GLVFRQWLQXHG
ï‚¾8ULQHVDPSOHVWRUDJHIRUSRVVLEOHDGGLWLRQDOFOLQLFDOWHVWLQJ
ï‚·%ORRGVDPSOHFROOHFWLRQIRUWKHIROORZLQJODERUDWRU\DQDO\VHV
ï‚¾&KHPLVWU\SURILOH
ï‚¾+HPDWRORJ\SURILOH
ï‚¾&'FHOOFRXQW
ï‚¾3ODVPD+,951$
ï‚¾H*)5
&*
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\5HJXODUO\VFKHGXOHGHYDOXDWLRQVZLOOEHPDGHRQDOOVXEMHFWVZK HWKHURUQRWWKH\FRQWLQXHWR
UHFHLYHVWXG\GUXJ
ï‚·5HYLHZRI$(VDQGFKDQJHVLQFRQFRPLWDQWPHGLFDWLRQV
ï‚·&RPSOHWHSK\VLFDOH[DPLQDWLRQ Week 48XURJHQLWDODQRUHFWDOH[DPVZLOOEHSHUIRUPHGDW
WKHGLVFUHWLRQRIWKH,QYHVWLJDWRU
ï‚·6\PSWRPGLUHFWHGSK\VLFDOH[DPLQDWLRQDVQHHGHG Week 36
ï‚·9LWDOVLJQVLQFOXGLQJZHLJKW
ï‚·OHDG(&*SHUIRUPHGVXSLQH Week 48
ï‚·8ULQHFROOHFWLRQIRUWKHIROORZLQJODERUDWRU\DQDO\VHV
ï‚¾8ULQDO\VLVDQGXULQHFKHPLVWU\
ï‚¾5HQDOVDIHW\HYDOXDWLRQV)DVWLQJQRIRRGRUGULQNH[FHSWZDW HUDWOHDVWKRXUVSULRUWR
EORRGFROOHFWLRQUHWLQROELQGLQJSURWHLQDQGEHWDPLFURJOREX OLQ
Week 36 [Treatment Group 2 subjects only] and Week 48 [all subjects])
o,IWKHVXEMHFWKDVQRWIDVWHGSULRUWRWKHYLVLWWKHYLVLWPD\ SURFHHGEXWWKHVXEMHFW
PXVWUHWXUQZLWKLQKRXUVLQDIDVWHGVWDWH
ï‚¾8ULQHSUHJQDQF\WHVWIHPDOHVRIFKLOGEHDULQJSRWHQWLDORQO\S RVLWLYHXULQHSUHJQDQF\
WHVWVZLOOEHFRQILUPHGZLWKDVHUXPWHVW
ï‚¾8ULQHVDPSOHVWRUDJHIRUSRVVLEOHDGGLWLRQDOFOLQLFDOWHVWLQJ
ï‚·%ORRGVDPSOHFROOHFWLRQIRUWKHIROORZLQJODERUDWRU\DQDO\VHVï‚¾&KHPLVWU\SURILOHJOXFRVHZLOOEHGRQHDVSDUWRIWKHIDVWLQJP HWDEROLFDVVHVVPHQWVDW
Week 36 [Treatment Group 2 subjects only] and Week 48 [all subjects] 
ï‚¾+HPDWRORJ\SURILOH
ï‚¾&'FHOOFRXQW
ï‚¾3ODVPD+,951$
ï‚¾H*)5
&*
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\6.5. Post-treatment Assessments
6.5.1. Early Study Drug Discontinuation (ESDD) Visit
,IWKHVXEMHFWGLVFRQWLQXHVVWXG\GUXJSULRUWRWKH:HHNYLVL W7UHDWPHQW*URXSDQG
7UHDWPHQW*URXS DIWHUGHOD\HGVZLWFKDW:HHNRUWKHLUFXUUHQWUHJLPHQSULRUWRWKH
:HHNYLVLW7UHDWPHQW*URXSWKHVXEMHFWZLOOEHDVNHGWRU HWXUQWRWKHFOLQLFZLWKLQ
KRXUVRIVWRSSLQJVWXG\GUXJVIRUWKH(6''YLVLW7KHVXEMHFW ZLOOEHDVNHGWRFRQWLQXH
DWWHQGLQJWKHVFKHGXOHGVWXG\YLVLWVWKURXJK:HHN
$WWKH(6''9LVLWDQ\HYDOXDWLRQVVKRZLQJDEQRUPDOUHVXOWVLQGL FDWLQJWKDWWKHUHLVDSRVVLEOH
RUSUREDEOHFDXVDOUHODWLRQVKLSZLWKWKHVWXG\GUXJZLOOEHUHSH DWHGZHHNO\RUDVRIWHQDV
GHHPHGSUXGHQWE\WKH,QYHVWLJDWRUXQWLOWKHDEQRUPDOLW\LVUH VROYHGUHWXUQVWREDVHOLQHRULV
RWKHUZLVHH[SODLQHG7KHIROORZLQJHYDOXDWLRQVDUHWREHFRPSOHWHGDW WKLVYLVLW
ï‚·5HYLHZRI$(VDQGFKDQJHVLQFRQFRPLWDQWPHGLFDWLRQV
ï‚·&RPSOHWHSK\VLFDOH[DPLQDWLRQXURJHQLWDODQRUHFWDOH[DPVZLOOEHSHUIRUPHGDWWKH
GLVFUHWLRQRIWKH,QYHVWLJDWRU
ï‚·9LWDOVLJQVLQFOXGLQJZHLJKW
ï‚·OHDG(&*
ï‚·8ULQHFROOHFWLRQIRUWKHIROORZLQJODERUDWRU\DQDO\VHV
ï‚¾8ULQDO\VLVDQGXULQHFKHPLVWU\
ï‚¾8ULQHSUHJQDQF\WHVWIHPDOHVRIFKLOGEHDULQJSRWHQWLDORQO\SR VLWLYHXULQHSUHJQDQF\
WHVWVZLOOEHFRQILUPHGZLWKDVHUXPWHVW
ï‚¾8ULQHVDPSOHVWRUDJHIRUSRVVLEOHDGGLWLRQDOFOLQLFDOWHVWLQJ
ï‚·%ORRGVDPSOHFROOHFWLRQIRUWKHIROORZLQJODERUDWRU\DQDO\VHV
ï‚¾&KHPLVWU\SURILOH
ï‚¾+HPDWRORJ\SURILOH
ï‚¾&'FHOOFRXQW
ï‚¾3ODVPD+,951$
ï‚¾H*)5
&*
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\ï‚·%ORRGVDPSOHFROOHFWLRQIRUWKHIROORZLQJODERUDWRU\DQDO\VHV
ï‚¾&KHPLVWU\SURILOH
ï‚¾+HPDWRORJ\SURILOH
ï‚¾3ODVPD+,951$
ï‚¾&'FHOOFRXQW
$WWKH'D\)ROORZ8S9LVLWDQ\HYDOXDWLRQVVKRZLQJDEQRUPDO UHVXOWVLQGLFDWLQJWKDWWKHUHLV
DUHDVRQDEOHSRVVLELOLW\RIDFDXVDOUHODWLRQVKLSZLWKWKHVWXG\GUXJZLOOEHUHSHDWHGZHHNO\
RUDVRIWHQDVGHHPHGSUXGHQWE\WKH,QYHVWLJDWRUXQWLOWKHDE QRUPDOLW\LVUHVROYHGUHWXUQVWR
EDVHOLQHRULVRWKHUZLVHH[SODLQHG
6.6. Assessments for Premature Discontinuation from Study
,IDVXEMHFWGLVFRQWLQXHVVWXG\GRVLQJIRUH[DPSOHDVDUHVXOWRIDQ$(HYHU\DWWHPSWVKRXOG
EHPDGHWRNHHSWKHVXEMHFWLQWKHVWXG\VHH6HFWLRQ &ULWHULDIRU'LVFRQWLQXDWLRQRI
6WXG\7UHDWPHQWDQGFRQWLQXHWRSHUIRUPWKHUHTXLUHGVWXG\UHOD WHGIROORZXSDQGSURFHGXUHV
,IWKLVLVQRWSRVVLEOHRUDFFHSWDEOHWRWKHVXEMHFWRU,QYHVWLJDWRUWKHVXEMHFWPD\EHZLWKGUDZQIURPWKHVWXG\
6.7. Criteria for Discontinuation of Study Treatment
6WXG\GUXJ PD\EHGLVFRQWLQXHGLQWKHIROORZLQJLQVWDQFHV
ï‚·,QWHUFXUUHQWLOOQHVVWKDWZRXOGLQWKHMXGJPHQWRIWKHLQYHVWLJDWRUDIIHFWDVVHVVPHQWVRI
FOLQLFDOVWDWXVWRDVLJQLILFDQWGHJUHH)ROORZLQJUHVROXWLRQRI LQWHUFXUUHQWLOOQHVVWKHVXEMHFW
PD\UHVXPHVWXG\ GRVLQJDWWKHGLVFUHWLRQRIWKHLQYHVWLJDWRU
ï‚·8QDFFHSWDEOHWR[LFLW\RU WR[LFLW\WKDWLQWKHMXGJPHQWRIWKHLQYHVWLJDWRUFRPSURPLVHVWKH
DELOLW\WRFRQWLQXHVWXG\VSHFLILFSURFHGXUHVRULVFRQVLGHUHG WRQRWEHLQWKHVXEMHFWÂ¶VEHVW
LQWHUHVW
ï‚·/DFNRIHIILFDF\YLURORJLFIDLOXUH
ï‚·6XEMHFWUHTXHVWWRGLVFRQWLQXHIRUDQ\UHDVRQ
ï‚·6XEMHFWQRQFRPSOLDQFH
ï‚·3UHJQDQF\GXULQJWKHVWXG\UHIHUWR $SSHQGL[
ï‚·'LVFRQWLQXDWLRQRIWKHVWXG\DWWKHUHTXHVWRI*LOHDGDUHJXOD WRU\DJHQF\RUDQLQVWLWXWLRQDO
UHYLHZERDUGRULQGHSHQGHQWHWKLFVFRPPLWWHH,5%,(&
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\6.8. Other Evaluations
6.8.1. Blood and Urine Storage
)URPVXEMHFWVZKRSURYLGHDGGLWLRQDOFRQVHQWDSRUWLRQRIWKHEORRGGUDZQDWDOOYLVLWV
H[FHSWVFUHHQLQJXQVFKHGXOHGRU'D\)ROORZ8SZLOOEHIUR] HQDQGVWRUHG$SRUWLRQRIWKH
XULQHFROOHFWHGIURPDOOVXEMHFWVDWDOOYLVLWVH[FHSWVFUHHQLQJXQVFKHGXOHGRU'D\)ROORZ8S7KHVHVWRUHGVDPSOHVPD\EHXVHGE\*LOHDGRURXUUHVHDUFKSDUWQHUVWRKHOSDQVZHUTXHVWLRQVDERXWWKHVWXG\GUXJ+,9LQIHFWLRQDQGLWVDVVRFLD WHGFRQGLWLRQVRUFOLQLFDO
ODERUDWRU\WHVWLQJWRSURYLGHDGGLWLRQDOVDIHW\GDWD1RKXPDQ JHQHWLFWHVWLQJZLOOEHSHUIRUPHG
ZLWKRXWH[SUHVVFRQVHQWRIWKHVWXG\VXEMHFWV$WWKHFRQFOXVLRQRIWKLVVWXG\WKHVHVDPSOHVPD\EHUHWDLQHGLQVWRUDJHIRU*LOHDGIRUDSHULRGRIXSWR\HDUV 
6.8.2. Bone Safety and Inflammation
)RUDOOVXEMHFWVEORRGZLOOEHFROOHFWHGIRUVHOHFWHGHYDOXDWLR QVRIERQHVDIHW\LQFOXGLQJVHUXP
2+9LWDPLQ'DQGSDUDWK\URLGKRUPRQH37+(YDOXDWLRQVIRUL QIOD[COMPANY_003]WLRQPD\LQFOXGH
F\VWDWLQ&,/KV&53V&'V&'V71)5DQG/S3/$& ROOHFWLRQVZLOOEHPDGHDW
'D\:HHNVDQG)RU7UHDWPHQW$UPVXEMHFWVFROOHF WLRQVZLOODOVREHPDGHDW
:HHNVDQG
6.8.3. Markers of Platelet Function and Coagulation
)RUDOOVXEMHFWVEORRGZLOOEHFROOHFWHGIRUVHOHFWHGHYDOXDWL RQVRISODWHOHWIXQFWLRQDQG
FRDJXODWLRQPD\LQFOXGHVROXEOHJO\FRSURWHLQ9,V*39,3VHOHF WLQVROXEOH&'OLJDQGDQG
'GLPHU&ROOHFWLRQVZLOOEHPDGHDW'D\:HHNVDQG)RU7UHDWPHQW$UP
VXEMHFWVFROOHFWLRQVZLOODOVREHPDGHDW:HHNVDQG
6.8.4. Markers of Renal Tubular Function
)RUDOOVXEMHFWVXULQHZLOOEHFROOHFWHGIRUVHOHFWHGHYDOXDWL RQVRIUHQDOWXEXODUIXQFWLRQPD\
LQFOXGHUHWLQROELQGLQJSURWHLQDQGEHWDPLFURJOREXOLQ&ROOHFWLRQVZLOOEHPDGHDW'D\
:HHNVDQG)RU7UHDWPHQW$UPVXEMHFWVFROOHFWLRQVZLOODOVREHPDGHDW:HHNVDQG
6.9. End of Study
(QGRIVWXG\LVGHILQHGDVFRPSOHWLRQRIWKHZHHNVRIWUHDWP HQWDQGWKH'D\)ROORZ8S
YLVLW
6.10. Post Study Care
$IWHUDVXEMHFWKDVFRPSOHWHGWHUPLQDWHGWKHLUSDUWLFLSDWLRQLQ WKHVWXG\ORQJWHUPFDUHIRUWKH
VXEMHFWZLOOUHPDLQWKHUHVSRQVLELOLW\RIWKHLUSULPDU\WUHDWLQ JSK\VLFLDQ
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\6.11. Virologic Failure
6XEMHFWVZKRH[SHULHQFHYLURORJLFUHERXQG95DVGHILQHGEHORZZLOOEHFRQVLGHUHGWRKDYH
YLURORJLFIDLOXUH
6XEMHFWVZLOOEHFRQVLGHUHGWRKDYHYLURORJLFUHERXQGLIWKH\K DYHWZRFRQVHFXWLYHFRQILUPHG
+,951$WHVWUHVXOWVRIÂ•FRSLHVP/DWDVFKHGXOHGRUXQVFKHGXOHGYLVLW
6.11.1. Management of Virologic Failure
ï‚·,IWKHYLUDOORDGLVÂ•FRSLHVP/+,9 51$VKRXOGEHUHSHDW HGDWDVFKHGXOHGRU
XQVFKHGXOHGYLVLWWRZHHNVDIWHUWKHGDWHRIWKHRULJLQDOWHV WZLWK+,951$
Â•FRSLHVP/
ï‚·8SRQFRQILUPDWLRQRIWZRFRQVHFXWLYHUHVXOWVRI+,951$Â• FRSLHVP/
SRWHQWLDOFDXVHVRIYLURORJLFIDLOXUHVKRXOGEHGRFXPHQWHG$VVHVVPHQWVVKRXOGLQFOXGH
ï‚¾$GKHUHQFH
ï‚¾&RQFRPLWDQWPHGLFDWLRQ
ï‚¾&RPRUELGLWLHVIRUH[DPSOHDFWLYHVXEVWDQFHDEXVHGHSUHVVLRQ RWKHU
LQWHUFXUUHQWLOOQHVVHV
ï‚·,QYHVWLJDWRUVVKRXOGGLVFXVVWKHPDQDJHPHQWRIDOOVXEMHFWVZLWKFRQILUPHGYLURORJLFIDLOXUH
ZLWKWKH0HGLFDO0RQLWRU
ï‚·,IYLURORJLFIDLOXUHLVFRQILUPHGDWWKHVFKHGXOHGRUXQVFKHGXOHGYLVLWDQG+,951$YDOXHLVÂ•FRSLHVP/WKHEORRGVDPSOHVIURPWKHFRQILUPDWLRQYLVL WZLOOEHXVHGIRU+,9
JHQRW\SHSKHQRW\SHWHVWLQJ
ï‚·,IJHQRW\SHSKHQRW\S HUHVLVWDQFHWRVWXG\GUXJRUFXUUHQWUHJLPHQLVGRFXPHQWHGVWXG\GUXJ
RUFXUUHQWUHJLPHQVKRXOGEHGLVFRQWLQXHG
ï‚·,IQRUHVLVWDQFHLVGHWHFWHGIURPJHQRW \SHSKHQRW\SHWHVWLQJV XEMHFWPD\UHPDLQRQVWXG\
GUXJRUFXUUHQWUHJLPHQDQG+,951$VKRXOGEHUHSHDWHGWR ZHHNVIURPWKHGDWHRI
FRQILUPHGWHVWZLWK+,951$Â•FRSLHVP/,QYHVWLJDWRUVVKR XOGFDUHIXOO\HYDOXDWHWKH
EHQHILWVDQGULVNVRIUHPDLQLQJRQVWXG\GUXJRUF XUUHQWUHJLPHQIRUHDFKLQGLYLGXDOVXEMHFW
DQGGRFXPHQWWKLVDVVHVVPHQWLQWKHRQVLWHPHGLFDOUHFRUG
3OHDVHUHIHUWR )LJXUH IRUWKHPDQDJHPHQWRIVXEMHFWVZKRPHHWWKHFULWHULDIRU
YLURORJLFIDLOXUH
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\7. ADVERSE EVEN TS AND TOXICITY MANAGEMENT
7.1. Definitions of Adverse Events, Adverse Reactions, and Serious Adverse Events
7.1.1. Adverse Events
$QDGYHUVHHYHQW$(LVDQ\XQWRZDUGPHGLFDORFFXUUHQFHLQDFOLQLFDOVWXG\ VXEMHFW
DGPLQLVWHUHGDPHGLFLQDOSURGXFWZKLFKGRHVQRWQHFHVVDULO\KDY HDFDXVDOUHODWLRQVKLSZLWKWKH
WUHDWPHQW$Q$(FDQWKHUHIRUHEHDQ\XQIDYRUDEOHDQGRUXQLQWHQ GHGVLJQV\PSWRPRUGLVHDVH
WHPSRUDOO\DVVRFLDWHGZLWKWKHXVHRIDPHGLFLQDOSURGXFWZKHW KHURUQRWFRQVLGHUHGUHODWHGWR
WKHPHGLFLQDOSURGXFW$(VPD\DOVRLQFOXGHSUHRUSRVWWUHDWPHQ WFRPSOLFDWLRQVWKDWRFFXUDVD
UHVXOWRISURWRFROVSHFLILHGSURFHGXUHVODFNRIHIILFDF\RYHUG RVHGUXJDEXVHPLVXVHUHSRUWVRU
RFFXSDWLRQDOH[SRVXUH3UHH[LVWLQJHYHQWVWKDWLQFUHDVHLQVHYHU LW\RUFKDQJHLQQDWXUHGXULQJRU
DVDFRQVHTXHQFHRISDUWLFLSDWLRQLQWKHFOLQLFDOVWXG\ZLOODO VREHFRQVLGHUHG$(V
$Q$(GRHVQRWLQFOXGHWKHIROORZLQJ
ï‚·0HGLFDORUVXUJLFDOSURFHGXUHVVXFKDV VXUJHU\HQGRVFRS\WRRWK H[WUDFWLRQDQGWUDQVIXVLRQ
7KHFRQGLWLRQWKDWOHGWRWKHSURFHGXUHPD\EHDQDGYHUVHHYHQWDQGPXVWEHUHSRUWHG
ï‚·3UHH[LVWLQJGLVHDVHVFRQGLWLRQVRUODERUDWRU\DEQRUPDOLWLHVSUH VHQWRUGHWHFWHGEHIRUHWKH
VFUHHQLQJYLVLWWKDWGRQRWZRUVHQ
ï‚·6LWXDWLRQVZKHUHDQXQWRZDUGPHGLFDORFFXUUHQFHKDVQRWRFFXUUHGHJKRVSLWDOL]DWLRQIRU
HOHFWLYHVXUJHU\VRFLDODQGRUFRQYHQLHQFHDGPLVVLRQV
ï‚·2YHUGRVHZLWKRXWFOLQLFDOVHTXHODHVHH6HFWLRQ 
ï‚·$Q\PHGLFDOFRQGLWLRQRUFOLQLFDOO\VLJQLILFDQWODERUDWRU\DEQR UPDOLW\ZLWKDQRQVHWGDWH
EHIRUHWKHFRQVHQWIRUPLVVLJQHGDQGQRWUHODWHGWRDSURWRFRO DVVRFLDWHGSURFHGXUHLVQRWDQ
$(,WLVFRQVLGHUHGWREHSUHH[LVWLQJDQGVKRXOGEHGRFXPHQWH GRQWKHPHGLFDOKLVWRU\&5)
7.1.2. Serious Adverse Events
$serious adverse event 6$(LVGHILQHGDVDQHYHQWWKDWDWDQ\GRVHUHVXOWVLQWKHI ROORZLQJ
ï‚·'HDWK
ï‚·/LIHWKUHDWHQLQJ1RWH7KHWHUPÂ³OLIHWKUHDWHQLQJÂ´LQWKHGHILQ LWLRQRIÂ³VHULRXVÂ´UHIHUVWRDQ
HYHQWLQZKLFKWKHVXEMHFWZDVDWULVNRIGHDWKDWWKHWLPHRIWKHHYHQWLWGRHVQRWUHIHUWRDQ
HYHQWWKDWK\SRWKHWLFDOO\PLJKWKDYHFDXVHGGHDWKLILWZHUHPR UHVHYHUH
ï‚·,QSDWLHQWKRVSLWDOL]DWLRQRUSURORQJDWLRQRIH[LVWLQJKRVSLWDO L]DWLRQ
ï‚·3HUVLVWHQWRUVLJQLILFDQWGLVDELOLW\LQFDSDFLW\
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\ï‚·$FRQJHQLWDODQRPDO\ELUWKGHIHFW
ï‚·$PHGLFDOO\LPSRUWDQWHYHQWRUUHDFWLRQVXFKHYHQWVPD\QRWEHL PPHGLDWHO\
OLIHWKUHDWHQLQJRUUHVXOWLQGHDWKRUKRVSLWDOL]DWLRQEXWPD\ MHRSDUGL]HWKHVXEMHFWRUPD\
UHTXLUHLQWHUYHQWLRQWRSUHYHQWRQHRIWKHRWKHURXWFRPHVFRQVWLWXWLQJ6$(V0HGLFDODQG
VFLHQWLILFMXGJPHQWPXVWEHH[HUFLVHGWRGHWHUPLQHZKHWKHUVXFKDQHYHQWLVDUHSRUWDEOHXQGHUH[SHGLWHGUHSRUWLQJUXOHV([DPSOHVRIPHGLFDOO\LPSRUWDQWHYHQWVLQFOXGHLQWHQVLYHWUHDWPHQWLQDQHPHUJHQF\URRPRUDWKRPHIRUDOOHUJLFEURQFKRVSDVPEORRGG\VFUDVLDVRUFRQYXOVLRQVWKDWGRQRWUHVXOWLQKRVSLWDOL]DWLRQDQGGHYHORSPHQWRIGUXJGHSHQGHQF\RUGUXJDEXVH)RUWKHDYRLGDQFHRIGRXEWLQIHFWLRQVUHVXOWLQJIUR PFRQWDPLQDWHGPHGLFLQDO
SURGXFWZLOOEHFRQVLGHUHGDPHGLFDOO\LPSRUWDQWHYHQWDQGVXEMHFWWRH[SHGLWHGUHSRUWLQJUHTXLUHPHQWV
7.1.3. Clinical Laboratory Abnormalities and Other Abnormal Assessments as 
Adverse Events or Serious Adverse Events
/DERUDWRU\DEQRUPDOLWLHVZLWKRXWFOLQLFDOVLJQLILFDQFHDUHQRW UHFRUGHGDV$(VRU6$(V
+RZHYHUODERUDWRU\DEQRUPDOLWLHVHJFOLQLFDOFKHPLVWU\KHPD WRORJ\DQGXULQDO\VLVWKDW
UHTXLUHPHGLFDORUVXUJLFDOLQWHUYHQWLRQRUOHDGWRVWXG\GUXJ LQWHUUXSWLRQPRGLILFDWLRQRU
GLVFRQWLQXDWLRQPXVWEHUHFRUGHGDVDQ$(DVZHOODVDQ6$(L IDSSOLFDEOH,QDGGLWLRQ
ODERUDWRU\RURWKHUDEQRUPDODVVHVVPHQWVHJHOHFWURFDUGLRJUDP [UD\VYLWDOVLJQVWKDWDUH
DVVRFLDWHGZLWKVLJQVDQGRUV\PSWRPVPXVWEHUHFRUGHGDVDQ$(RU6$(LIWKH\PHHWWKHGHILQLWLRQRIDQ$(RU6$(DVGHVFULEHGLQ6HFWLRQV DQG,IWKHODERUDWRU\
DEQRUPDOLW\LVSDUWRIDV\QGURPHUHFRUGWKHV\QGURPHRUGLDJQRVLVHJDQHPLDQRWWKHODERUDWRU\UHVXOWLHGHFUHDVHGKHPRJORELQ
)RUVSHFLILFLQIRUPDWLRQRQKDQGOLQJRIFOLQLFDOODERUDWRU\DEQ RUPDOLWLHVLQWKLVVWXG\SOHDVH
UHIHUWR$SSHQGL[
7.2. Assessment of Adverse Events and Serious Adverse Events
7KHLQYHVWLJDWRURUTXDOLILHGVXELQYHVWLJDWRULVUHVSRQVLEOHIRU DVVHVVLQJ$(VDQG6$(VIRU
FDXVDOLW\DQGVHYHULW\ DQGIRUILQDOUHYLHZDQGFRQILUPDWLRQR IDFFXUDF\RIHYHQWLQIRUPDWLRQ
DQGDVVHVVPHQWV
7.2.1. Assessment of Causality for Study Drugs and Procedures
7KHLQYHVWLJDWRURUTXDOLILHGVXELQYHVWLJDWRULVUHVSRQVLEOHIRUDVVHVVLQJWKHUHODWLRQVKLSWRVWXG\
GUXJWKHUDS\ XVLQJFOLQLFDOMXGJPHQWDQGWKHIROORZLQJFRQVLGHUDWLRQV
ï‚·No: (YLGHQFHH[LVWVWKDWWKHDGYHUVHHYHQWKDVDQHWLRORJ\RWKHUWK DQWKHVWXG\GUXJ)RU
6$(VDQDOWHUQDWLYHFDXVDOLW\PXVWEHSURYLGHGHJSUHH[LVWLQJFRQGLWLRQXQGHUO\LQJGLVHDVHLQWHUFXUUHQWLOOQHVVRUFRQFRPLWDQWPHGLFDWLRQ
ï‚·Yes:7KHUHLVUHDVRQDEOHSRVVLELOLW\WKDWWKHHYHQWPD\KDYHEHHQFD XVHGE\WKH,03
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\,WVKRXOGEHHPSKDVL]HGWKDWLQHIIHFWLYHWUHDWPHQWVKRXOGQRWE HFRQVLGHUHGDVFDXVDOO\UHODWHGLQ
WKHFRQWH[WRIDGYHUVHHYHQWUHSRUWLQJ
7KHUHODWLRQVKLSWRVWXG\SURFHGXUHVHJLQYDVLYHSURFHGXUHVV XFKDVYHQLSXQFWXUHRUELRSV\
VKRXOGEHDVVHVVHGXVLQJWKHIROORZLQJFRQVLGHUDWLRQV
ï‚·No: (YLGHQFHH[LVWVWKDWWKHDGYHUVHHYHQWKDVDQHWLRORJ\RWKHUWK DQWKHVWXG\SURFHGXUH
ï‚·Yes:7KHDGYHUVHHYHQWRFFXUUHGDVDUHVXOWRISURWRFROSURFHGXUHV HJYHQLSXQFWXUH
7.2.2. Assessment of Severity
6HYHULW\VKRXOGEHUHFRUGHGDQGJUDGHGDFFRUGLQJWRWKH*6,*UDGLQJ6FDOHIRU6HYHULW \RI
$GYHUVH(YHQWVDQG/DERUDWRU\$EQRUPDOLWLHV $SSHQGL[)RUDGYHUVHHYHQWVDVVRFLDWHGZLWK
ODERUDWRU\DEQRUPDOLWLHVWKHHYHQWVKRXOGEHJUDGHGRQWKHEDVL VRIWKHFOLQLFDOVHYHULW\LQWKH
FRQWH[WRIWKHXQGHUO\LQJFRQGLWLRQVWKLVPD\RUPD\QRWEHLQ DJUHHPHQWZLWKWKHJUDGLQJRI
WKHODERUDWRU\DEQRUPDOLW\
7.3. Investigator Requirements and Instructions for Reporting Adverse Events
and Serious Adverse Events to [COMPANY_009]
5HTXLUHPHQWVIRU&ROOHFWLRQ3ULRUWR6WXG\'UXJ,QLWLDWLRQ
$IWHULQIRUPHGFRQVHQWEXWSULRUWRLQLWLDWLRQRIVWXG\PHGLFD WLRQWKHIROORZLQJW\SHVRIHYHQWV
VKRXOGEHUHSRUWHGRQWKHFDVHUHSRUWIRUPH&5)DOO6$(VDQG DGYHUVHHYHQWVUHODWHGWR
SURWRFROPDQGDWHGSURFHGXUHV
7.3.1. Adverse Events
)ROORZLQJLQLWLDWLRQRIVWXG\GUXJFROOHFWDOO$(VUHJDUGOHVV RIFDXVHRUUHODWLRQVKLSXQWLO
ZHHNVDIWHUODVWDGPLQLVWUDWLRQRIVWXG\GUXJPXVWEHUHSRUWHG WRWKHH&5)GDWDEDVHDV
LQVWUXFWHG
$OO$(VVKRXOGEHIROORZHGXSXQWLOUHVROXWLRQRUXQWLOWKHDGYHUVHHYHQWLVVWDEOHLISRVVLEOH
*LOHDG6FLHQFHVPD\UHTXHVWWKDWFHUWDLQ$(VEHIROORZHGEH\RQG WKHSURWRFROGHILQHGIROORZXS
SHULRG
7.3.2. Serious Adverse Events
$OO6$(VUHJDUGOHVVRIFDXVHRUUHODWLRQVKLSWKDWRFFXUVDIWHU WKHVXEMHFWILUVWFRQVHQWVWR
SDUWLFLSDWHLQWKHVWXG\LHVLJQLQJWKHLQIRUPHGFRQVHQWDQGWKURXJKRXWWKHGXUDWLRQRIWKH
VWXG\LQFOXGLQJWKHSURWRFROUHTXLUHGSRVWWUHDWPHQWIROORZXS SHULRGPXVWEHUHSRUWHGWRWKH
H&5)GDWDEDVHDQG*LOHDG'UXJ6DIHW\DQG3XEOLF+HDOWK'63+DVLQVWUXFWHG7KLVDOVRLQFOXGHVDQ\6$(VUHVXOWLQJIURPSURWRFRODVVRFLDWHGSURFHGXUHVSHUIRUPHGDIWHULQIRUPHGFRQVHQWLVVLJQHG
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\$Q\6$(VDQGGHDWKVWKDWRFFXUZLWKLQGD\VRIWKHODVWGRVHR IVWXG\GUXJUHJDUGOHVVRI
FDXVDOLW\VKRXOGDOVREHUHSRUWHG
,QYHVWLJDWRUVDUHQRWREOLJDWHGWRDFWLYHO\VHHN6$(VDIWHUWKHSURWRFROGHILQHGIROORZXSSHULRG
+RZHYHULIWKHLQYHVWLJDWRUOHDUQVRIDQ\6$(VWKDWRFFXUDIWH UVWXG\SDUWLFLSDWLRQKDV
FRQFOXGHGDQGWKHHYHQWLVGHHPHGUHOHYDQWWRWKHXVHRIVWXG\ GUXJKHVKHVKRXOGSURPSWO\
GRFXPHQWDQGUHSRUWWKHHYHQWWR*LOHDG'63+
$OO6$(VVKRXOGEHIROORZHGXSXQWLOUHVROXWLRQLISRVVLEOH,I E\WKHODVWGD\RQVWXG\
LQFOXGLQJWKHRIIVWXG\ PHGLFDWLRQIROORZXSSHULRGWKH6$(KDV QRWUHVROYHGWKHQWKH6$(
ZLOOEHIROORZHGXSXQWLOWKHLQYHVWLJDWRUDQGRU*LOHDG6FLHQFHVGHWHUPLQHWKDWWKHVXEMHFW
V
FRQGLWLRQLVVWDEOH+RZHYHU*LOHDG6FLHQFHVPD\UHTXHVWWKDWFHUWDLQ6$(VEHIROORZHGXQWLOUHVROXWLRQ
ï‚·$OO$(VDQG6$(VZLOOEHUHFRUGHGLQWKHH&5)GDWDEDVHZLWKLQWKHWLPHOLQHVRXWOLQHGLQWKH
H&5)FRPSOHWLRQJXLGHOLQH
7.3.3. Electronic Serious Adverse Event (eSAE) Reporting Process
ï‚·6LWHSHUVRQQHOUHFRUGDOO6$(GDWDLQWKHH&5)GDWDEDVHDQGIUR PWKHUHWUDQVPLWWKH6$(
LQIRUPDWLRQWR*LOHDG'63+ZLWKLQKRXUVRIWKHLQYHVWLJDWRUÂ¶VNQRZOHGJHRIWKHHYHQW
'HWDLOHGLQVWUXFWLRQVFDQEHIRXQGLQWKHH&5)FRPSOHWLRQJXLGHOLQHV
ï‚·,IIRUDQ\UHDVRQLWLVQRWSRVVLEOHWRUHFRUGWKH6$(LQIRUPDW LRQHOHFWURQLFDOO\LHWKHH&5)
GDWDEDVHLVQRWIXQFWLRQLQJUHFRUGWKH6$(RQWKHSDSHUVHULRX VDGYHUVHHYHQWUHSRUWLQJ
IRUPDQGVXEPLWZLWKLQKRXUVWR
[COMPANY_009] Sciences DSPH:)D[(PDLOVDIHW\BIF#JLOHDGFRP
ï‚·$VVRRQDVLWLVSRVVLEOHWRGRVRDQ\6$(UHSRUWHGYLDSDSHUPXVWEHWUDQVFULEHGLQWRWKH
H&5)'DWDEDVHDFFRUGLQJWRLQVWUXFWLRQVLQWKHH&5)FRPSOHWLRQJXLGHOLQHV
ï‚·,IDQ6$(KDVEHHQUHSRUWHGYLDDSDSHUIRUPEHFDXVHWKHH&5)GDWDEDVHKDVEHHQORFNHGQR
IXUWKHUDFWLRQLVQHFHVVDU\
ï‚·)RUIDWDORUOLIHWKUHDWHQLQJHYHQWVFRSLHVRIKRVSLWDOFDVHU HSRUWVDXWRSV\UHSRUWVDQGRWKHU
GRFXPHQWVDUHDOVR WREHVXEPLWWHGE\HPDLORUID[ZKHQUHTXHVWH GDQGDSSOLFDEOH
7UDQVPLVVLRQRIVXFKGRFXPHQWVVKRXOGRFFXUZLWKRXWSHUVRQDOVXEMHFWLGHQWLILFDWLRQPDLQWDLQLQJWKHWUDFHDELOLW\RIDGRFXPHQWWRWKHVXEMHFWLGHQWL ILHUV
ï‚·$GGLWLRQDOLQIRUPDWLRQPD\EHUHTXHVWHGWRHQVXUHWKHWLPHO\FR PSOHWLRQRIDFFXUDWHVDIHW\
UHSRUWV
ï‚·$Q\PHGLFDWLRQVQHFHVVDU\IRUWUHDWPHQWRIWKH6$(PXVWEHUHFR UGHGRQWRWKHFRQFRPLWDQW
PHGLFDWLRQVHFWLRQRIWKHVXEMHFWÂ¶VH&5)DQGWKHHYHQWGHVFULSWLRQVHFWLRQRIWKH6$(IRUP
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\7.4. [COMPANY_009] Reporting Requirements
'HSHQGLQJRQUHOHYDQWORFDOOHJLVODWLRQRUUHJXODWLRQVLQFOXGL QJWKHDSSOLFDEOH86)'$
&RGHRI)HGHUDO5HJXODWLRQVWKH(8&OLQLFDO7ULDOV'LUHFWLYH (&DQGUHOHYDQW
XSGDWHVDQGRWKHUFRXQWU\VSHFLILFOHJLVODWLRQRUUHJXODWLRQV *LOHDGPD\EHUHTXLUHGWRH[SHGLWH
WRZRUOGZLGHUHJXODWRU\DJHQFLHVUHSRUWVRI6$(VVHULRXVDGYHUVHGUXJUHDFWLRQV6$'5VRU
VXVSHFWHGXQH[SHFWHGVHULRXVDGYHUVHUHDFWLRQV686$5V,QDFFR UGDQFHZLWKWKH
(8&OLQLFDO7ULDOV'LUHFWLYH(&*LOHDGRUDVSHFLILHG GHVLJQHHZLOOQRWLI\ZRUOGZLGH
UHJXODWRU\DJHQFLHVDQGWKHUHOHYDQW,(&LQFRQFHUQHG0HPEHU6WDWHVRIDSSOLFDEOH686$5VDVRXWOLQHGLQFXUUHQWUHJXODWLRQV
$VVHVVPHQWRIH[SHFWHGQHVVIRU6$(VZLOOEHGHWHUPLQHGE\*LOHDG XVLQJUHIHUHQFHVDIHW\
LQIRUPDWLRQVSHFLILHGLQWKHLQYHVWLJDWRUÂ¶VEURFKXUHRUUHOHYDQW ORFDOODEHODVDSSOLFDEOH
$OOLQYHVWLJDWRUVZLOOUHFHLYHDVDIHW\OHWWHUQRWLI\LQJWKHPR IUHOHYDQW686$5UHSRUWVDVVRFLDWHG
ZLWKDQ\VWXG\GUXJ 7KHLQYHVWLJDWRUVKRXOGQRWLI\WKH,5%RU, (&RI686$5UHSRUWVDVVRRQDV
LVSUDFWLFDOZKHUHWKLVLVUHTXLUHGE\ORFDOUHJXODWRU\DJHQFL HVDQGLQDFFRUGDQFHZLWKWKHORFDO
LQVWLWXWLRQDOSROLF\
7.5. Special Situations Reports
7.5.1. Definitions of Special Situations
6SHFLDOVLWXDWLRQUHSRUWVLQFOXGHDOOUHSRUWVRIPHGLFDWLRQHUU RUDEXVHPLVXVHRYHUGRVHUHSRUWV
RIDGYHUVHHYHQWVDVVRFLDWHGZLWKSURGXFWFRPSODLQWVDQGSUHJQDQ F\UHSRUWVUHJDUGOHVVRIDQ
DVVRFLDWHG$(
0HGLFDWLRQHUURULVDQ\XQLQWHQWLRQDOHUURULQWKHSUHVFULELQJGLVSHQVLQJRUDGPLQLVWUDWLRQRID
PHGLFLQDOSURGXFWZKLOHLQWKHFRQWURORIWKHKHDOWKFDUHSURYL GHUVXEMHFWRUFRQVXPHU
$EXVHLVGHILQHGDVSHUVLVWHQWRUVSRUDGLFLQWHQWLRQDOH[FHVVLYHXVHRIDPHGLFLQDOSURGXFWE\DVXEMHFW
0LVXVHLVGHILQHGDVDQ\LQWHQWLRQDODQGLQDSSURSULDWHXVHRIDP HGLFLQDOSURGXFWWKDWLVQRWLQ
DFFRUGDQFHZLWKWKHSURWRFROLQVWUXFWLRQVRUWKHORFDOSUHVFULELQJLQIRUPDWLRQ$QRYHUGRVHLVGHILQHGDVDQDFFLGHQWDORULQWHQWLRQDODGPLQLVWUD WLRQRIDTXDQWLW\RIDVWXG\
GUXJJLYHQSHUDGPLQLVWUDWLRQRUFXPXODWLYHO\ZKLFKLVDERYHWKHPD[LPXPUHFRPPHQGHGGRVH
DVSHUSURWRFRORULQWKHSURGXFWODEHOOLQJDVLWDSSOLHVWRW KHGDLO\GRVHRIWKHVXEMHFWLQ
TXHVWLRQ,QFDVHVRIDGLVFUHSDQF\LQGUXJDFFRXQWDELOLW\RYHUGRVHZLOOEHHVWDEOLVKHGRQO\ZKHQLWLVFOHDUWKDWWKHVXEMHFWKDVWDNHQWKHH[FHVVGRVHV2YHUGRVHFDQQRWEHHVWDEOLVKHGZKHQWKHVXEMHFWFDQQRWDFFRXQWIRUWKHGLVFUHSDQF\H[FHSWLQF DVHVLQZKLFKWKHLQYHVWLJDWRUKDV
UHDVRQWRVXVSHFWWKDWWKHVXEMHFWKDVWDNHQWKHDGGLWLRQDOGRVHV
3URGXFWFRPSODLQWLVGHILQHGDVFRPSODLQWVDULVLQJIURPSRWHQWLD OGHYLDWLRQVLQWKHPDQXIDFWXUH
SDFNDJLQJRUGLVWULEXWLRQRIWKHVWXG\ GUXJ
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\7.5.2. Instructions for Reporting Special Situations
 ,QVWUXFWLRQVIRU5HSRUWLQJ3UHJQDQFLHV
7KHLQYHVWLJDWRUVKRXOGUHSRUWSUHJQDQFLHVLQIHPDOHVWXG\VXEM HFWVWKDWDUHLGHQWLILHGDIWHU
LQLWLDWLRQRIVWXG\GUXJDQGWKURXJKRXWWKHVWXG\LQFOXGLQJWKH SRVWVWXG\GUXJIROORZXSSHULRG
WR*LOHDG'63+XVLQJWKHSUHJQDQF\UHSRUWIRUPZLWKLQKRXUV RIEHFRPLQJDZDUHRIWKH
SUHJQDQF\
5HIHUWR6HFWLRQ DQGWKHH&5)FRPSOHWLRQJXLGHOLQHVIRUIXOOLQVWUXFWLRQVRQWKHPHFKDQLVP
RISUHJQDQF\UHSRUWLQJ
7KHSUHJQDQF\LWVHOILVQRWFRQVLGHUHGDQ$(QRULVDQLQGXFHG HOHFWLYHDERUWLRQWRWHUPLQDWHD
SUHJQDQF\ZLWKRXWPHGLFDOUHDVRQV
$Q\SUHPDWXUHWHUPLQDWLRQRISUHJQDQF\HJDVSRQWDQHRXVDERUW LRQDQLQGXFHGWKHUDSHXWLF
DERUWLRQGXHWRFRPSOLFDWLRQVRURWKHUPHGLFDOUHDVRQVPXVWEH UHSRUWHGZLWKLQKRXUVDVDQ
6$(7KHXQGHUO\LQJPHGLFDOUHDVRQIRUWKLVSURFHGXUHVKRXOGEH UHFRUGHGDVWKH$(WHUP
$VSRQWDQHRXVDERUWLRQLVDOZD\VFRQVLGHUHGWREHDQ6$(DQGZL OOEHUHSRUWHGDVGHVFULEHGLQ
6HFWLRQ)XUWKHUPRUHDQ\6$(RFFXUULQJDVDQDGYHUVHSUHJQDQF\RXWFRP HSRVWVWXG\PXVW
EHUHSRUWHGWR*LOHDG'63+7KHVXEMHFWVKRXOGUHFHLYHDSSURSULDWHPRQLWRULQJDQGFDUHXQWLO WKHFRQFOXVLRQRIWKH
SUHJQDQF\7KHRXWFRPHVKRXOGEHUHSRUWHGWR*LOHDG'63+XVLQJ WKHSUHJQDQF\RXWFRPHUHSRUW
IRUP,IWKHHQGRIWKHSUHJQDQF\RFFXUVDIWHUWKHVWXG\KDVEH HQFRPSOHWHGWKHRXWFRPHVKRXOG
EHUHSRUWHGGLUHFWO\WR*LOHDG'63+
*LOHDG'63+FRQWDFWLQIRUPDWLRQLVDVIROORZV
[COMPANY_009] Sciences DSPH:)D[
(PDLOVDIHW\BIF#JLOHDGFRP
3UHJQDQFLHVRIIHPDOHSDUWQHUVRIPDOHVWXG\VXEMHFWVDUHQRWFROOHFWHGIRU(&)7$)SURWRFROV
5HIHUWR$SSHQGL[ IRU3UHJQDQF\3UHFDXWLRQV'HILQLWLRQIRU)HPDOHRI&KLOGEHDULQ J3RWHQWLDO
DQG&RQWUDFHSWLYH5HTXLUHPHQWV
 5HSRUWLQJ2WKHU6SHFLDO6LWXDWLRQV
$OORWKHUVSHFLDOVLWXDWLRQUHSRUWVPXVWEHUHSRUWHGRQWKHVSHFLDOVLWXDWLRQVUHSRUWIRUPDQG
IRUZDUGHGWR*LOHDG'63+ZLWKLQKRXUVRIWKHLQYHVWLJDWRUEHFRPLQJDZDUHRIWKHVLWXDWLRQ7KHVHUHSRUWVPXVWFRQVLVWRIVLWXDWLRQVWKDWLQYROYHVWXG\GUX JDQGRU*LOHDGFRQFRPLWDQW
PHGLFDWLRQVEXWGRQRWDSSO\WRQRQ*LOHDGFRQFRPLWDQWPHGLFDW LRQV
6SHFLDOVLWXDWLRQVLQYROYLQJQRQ*LOHDGFRQFRPLWDQWPHGLFDWLRQV GRHVQRWQHHGWREHUHSRUWHGRQ
WKHVSHFLDOVLWXDWLRQVUHSRUWIRUPKRZHYHUIRUVSHFLDOVLWXDW LRQVWKDWUHVXOWLQ$(VGXHWRD
QRQ*LOHDGFRQFRPLWDQWPHGLFDWLRQWKH$(VKRXOGEHUHSRUWHGRQ WKH$(IRUP
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\$Q\LQDSSURSULDWHXVHRIFRQFRPLWDQWPHGLFDWLRQVSURKLELWHGE\WKLVSURWRFROVKRXOGQRWEH
UHSRUWHGDVÂ³PLVXVHÂ´EXWPD\EHPRUHDSSURSULDWHO\GRFXPHQWHG DVDSURWRFROGHYLDWLRQ
5HIHUWR6HFWLRQ DQGWKHH&5)FRPSOHWLRQJXLGHOLQHVIRUIXOOLQVWUXFWLRQVRQWKH PHFKDQLVP
RIVSHFLDOVLWXDWLRQVUHSRUWLQJ
$OOFOLQLFDOVHTXHODHLQUHODWLRQWRWKHVHVSHFLDOVLWXDWLRQUHSRUWVZLOOEHUHSRUWHGDV$(VRU6$(V
DWWKHVDPHWLPHXVLQJWKH$(H&5)DQGRUWKH6$(UHSRUWIRUP'HWDLOVRIWKHV\PSWRPVDQGVLJQVFOLQLFDOPDQDJHPHQWDQGRXWFRPHZLOOEHUHSRUWHGZKHQDYDLODEOH
7.6. Toxicity Management
$OOFOLQLFDODQGFOLQLFDOO\VLJQLILFDQWODERUDWRU\WR[LFLWLHVZLOOEHPDQDJHGDFFRUGLQJWRXQLIRUP
JXLGHOLQHVGHWDLOHGLQ $SSHQGL[DVRXWOLQHVEHORZ
ï‚·&OLQLFDOHYHQWVDQGFOLQLFDOO\VLJQLILFDQWODERUDWRU\DEQRUPDOL WLHVZLOOEHJUDGHGDFFRUGLQJWR
WKH*6,*UDGLQJ6FDOHIRU6HYHULW\RI$GYHUVH(YHQWVDQG/DERUD WRU\$EQRUPDOLWLHV
$SSHQGL[
ï‚·*UDGHDQGFOLQLFDOO\VLJQLILFDQWODERUDWRU\DEQRUPDOLWLHVV KRXOGEHFRQILUPHGE\UHSHDW
WHVWLQJZLWKLQFDOHQGDUGD\VRIUHFHLSWRIUHVXOWVDQGEHIRUHLQYHVWLJDWLRQDOPHGLFLQDOSURGXFWGLVFRQWLQXDWLRQXQOHVVVXFKDGHOD\LVQRWFRQVLVWHQWZLWKJRRGPHGLFDOSUDFWLFH
ï‚·$Q\TXHVWLRQVUHJDUGLQJWR[LFLW\PDQDJHPHQWVKRXOGEHGLUHFWHG WRWKH*LOHDG6FLHQFHV
0HGLFDO0RQLWRU
7.6.1. Grades 1 and 2 Laboratory Abnormality or Clinical Event
ï‚·&RQWLQXHVWXG\GUXJDWWKHGLVFUHWLRQRIWKH,QYHVWLJDWRU
7.6.2. Grade 3 Laboratory Abnormality or Clinical Eventï‚·)RU*UDGHFOLQLFDOO\VLJQLILFDQWODERUDWRU\DEQRUPDOLW\RUFOLQLFDOHYHQW VWXG\GUXJPD\EH
FRQWLQXHGLIWKHHYHQWLVFRQVLGHUHGWREHXQUHODWHGWRVWXG\G UXJ
ï‚·)RUD*UDGHFOLQLFDOHYHQWRUFOLQLFDOO\VLJQLILFDQWODERUDWRU\DEQRUPDOLW\FRQILUPHGE\
UHSHDWWHVWLQJWKDWLVFRQVLGHUHGWREHUHODW HGWRVWXG\GUXJ VWXG\GUXJVKRXOGEHZLWKKHOG
XQWLOWKHWR[LFLW\UHWXUQVWRÂ”*UDGH:KHQUHVWDUWLQJVWXG\ GUXJIROORZLQJUHVROXWLRQRIWKH
DGYHUVHHYHQWWKHVWXG\GUXJVKRXOGEHUHVWDUWHGDWIXOOGRVHXSRQGLVFXVVLRQZLWKWKH0HGLFDO0RQLWRU
ï‚·,IDODERUDWRU\DEQRUPDOLW\UHFXUVWRÂ•*UDGHIROORZLQJUHFKD OOHQJHZLWKVWXG\GUXJDQGLV
FRQVLGHUHGUHODWHGWRVWXG\GUXJWKHQVWXG\GUXJVKRXOGEHSHU PDQHQWO\GLVFRQWLQXHGDQGWKH
VXEMHFWPDQDJHGDFFRUGLQJWRORFDOSUDFWLFH5HFXUUHQFHRIODER UDWRU\DEQRUPDOLWLHV
FRQVLGHUHGXQUHODWHGWR VWXG\GUXJPD\ QRWUHTXLUHSHUPDQHQWGLVFRQWLQXDWLRQEXWUHTXLUHV
GLVFXVVLRQZLWKWKH0HGLFDO0RQLWRU
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\7.6.3. Grade 4 Laboratory Abnormality or Clinical Event
ï‚·)RUD*UDGHFOLQLFDOHYHQWRUFOLQLFDOO\VLJQLILFDQW*UDGHODERUDWRU\DEQRUPDOLW\
FRQILUPHGE\UHSHDWWHVWLQJWKDWLVFRQVLGHUHGUHODWHGWRVWXG\ GUXJVWXG\ GUXJVKRXOGEH
SHUPDQHQWO\GLVFRQWLQXHGDQGWKHVXEMHFWPDQDJHGDFFRUGLQJWRO RFDOSUDFWLFH7KHVXEMHFW
VKRXOGEHIROORZHGDVFOLQLFDOO\LQGLFDWHGXQWLOWKHODERUDWRU\DEQRUPDOLW\UHWXUQVWREDVHOLQH
RULVRWKHUZLVHH[SODLQHGZKLFKHYHURFFXUVILUVW$FOLQLFDOO\ VLJQLILFDQW*UDGHODERUDWRU\
DEQRUPDOLW\WKDWLVQRWFRQILUPHGE\UHSHDWWHVWLQJVKRXOGEHP DQDJHGDFFRUGLQJWRWKH
DOJRULWKPIRUWKHQHZWR[LFLW\JUDGH
ï‚·6WXG\GUXJPD\EHFRQWLQXHGZLWKRXWGRVHLQWHUUXSWLRQIRUDFOLQLFDOO\QRQVLJQLILFDQW
*UDGHODERUDWRU\DEQRUPDOLW\ HJ*UDGH&.DIWHUVWUHQXRXVH[HUFLVHRUWULJO\FHULGH
HOHYDWLRQWKDWLVQRQIDVWLQJRUWKDWFDQEHPHGLFDOO\PDQDJHG RUDFOLQLFDOHYHQWFRQVLGHUHG
XQUHODWHGWRVWXG\GUXJUHTXLUHVGLVFXVVLRQZLWKWKH0HGLFDO0RQLWRU
7.6.4. Management of Hyperbilirubinemia in Patients Receiving Atazanavir
0RVWSDWLHQWVWDNLQJDWD]DQDYLUVXOIDWHH[SHULHQFHDV\PSWRPDWLF HOHYDWLRQVLQLQGLUHFW
XQFRQMXJDWHGELOLUXELQUHODWHGWRLQKLELWLRQRI8'3JOXFXURQ\ OWUDQVIHUDVH8*7
$VVXEMHFWVRQ$79FRQWDLQLQJUHJLPHQDUHH[SHFWHGWRKDYHDWD] DQDYLUDVVRFLDWHG
K\SHUELOLUXELQHPLDRFFDVLRQDOO\XSWR*UDGH!Ã®8/1WKH PDQDJHPHQWRIJUDGHG
ODERUDWRU\DEQRUPDOLW\GHVFULEHGDERYHLQ6HFWLRQ LVQRWDSSOLFDEOHIRUWKHPDQDJHPHQWRI
JUDGHGK\SHUELOLUXELQHPLDLQWKHVHVXEMHFWV
+RZHYHUUHSHDWWHVWLQJVKRXOGEHGRQHDQGDOWHUQDWLYHHWLRORJL HVHJDFXWHKHSDWLWLV%RU&EH
VRXJKWLQWKHIROORZLQJVXEMHFWV ,QWKRVHZLWKHOHYDWLRQLQFRQMXJDWHGGLUHFWELOLUXELQ! Ã®8/1LHGLUHFW
K\SHUELOLUXELQHPLDUHJDUGOHVVRIWKHK\SHUELOLUXELQHPLDJUDGH OLYHUODEVWRWDOELOLUXELQ
GLUHFWELOLUXELQ$67$/7VKRXOGEHUHSHDWHGZLWKLQGD\VRI WKH,QYHVWLJDWRUEHLQJ
QRWLILHGRIWKHHOHYDWHGELOLUXELQOHYHODQGEHGLVFXVVHGZLWKWKH0HGLFDO0RQLWRU
7KHUHDIWHUWKHPDQDJHPHQWRIDVXEMHFWZKRFRQWLQXHVWRKDYHGLUHFWELOLUXELQ!Ã®8/1ZKLFKLVGHHPHGDVFOLQLFDOO\QRWVLJQLILFDQWVKRXOGEHIROORZHGDFFRUGLQJWRWKHFOLQLFDOMXGJPHQWRIWKH,QYHVWLJDWRU
 ,QWKRVHZLWKKHSDWLFWUDQVDPLQDVHHOHYDWLRQWKHJUDGHG$67RU$/7DEQRUPDOLWLHVVKRXOG
EHPDQDJHGDFFRUGLQJWR6HFWLRQ 
'RVHPRGLILFDWLRQRIDWD]DQDYLUVXOIDWHLVQRWSHUPLWWHG6XEMH FWVZKRH[SHULHQFHXQDFFHSWDEOH
MDXQGLFHVFOHUDOLFWHUXVGXHWRDWD]DQDYLUDVVRFLDWHGK\SHUELOL UXELQHPLDFDQEHGLVFRQWLQXHG
IURPVWXG\DWWKHGLVFUHWLRQRIWKH,QYHVWLJDWRU
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\7.6.5. Management of Possible Abacavir Hypersensitivity Reaction
$EDFDYLUVKRXOGQRWEHXVHGLQSDWLHQWVNQRZQWRFDUU\WKH+/$ %
DOOHOHGXHWRLQFUHDVHG
ULVNRIK\SHUVHQVLWLYLW\UHDFWLRQXQOHVVQRRWKHUWKHUDSHXWLFRSWLRQLVDYDLODEOHEDVHGRQWKH
WUHDWPHQWKLVWRU\DQGUHVLVWDQFHWHVWLQJ
,QDFOLQLFDOVWXG\RIVXEMHFWVZLWKDQHJDWLYH+/$%
 VWDWXVUHFHLYLQJDEDFDYLU
GHYHORSHGDK\SHUVHQVLWLYLW\UHDFWLRQ7KHUHIRUHHYHQLQWKHD EVHQFHRI+/$%
DOOHOHLWLV
LPSRUWDQWWRSHUPDQHQWO\GLVFRQWLQXHDEDFDYLUDQGQRWUHFKDOOHQ JHZLWKDEDFDYLULID
K\SHUVHQVLWLYLW\UHDFWLRQFDQQRWEHUXOHGRXWRQFOLQLFDOJURXQ GVGXHWRWKHSRWHQWLDOIRUDVHYHUH
RUHYHQIDWDOUHDFWLRQ+\SHUVHQVLWLYLW\UHDFWLRQVDUHFKDUDFWHUL]HGE\WKHDSSHDUDQFHRIV\PSWRPVLQGLFDWLQJPXOWL
RUJDQV\VWHPLQYROYHPHQW$OPRVWDOO K\SHUVHQVLWLYLW\UHDFWLRQV ZLOOKDYHIHYHUDQGRUUDVKDV
SDUWRIWKHV\QGURPH2WKHUVLJQVDQGV\P SWRPVPD\LQFOXGHUHVS LUDWRU\VLJQVDQGV\PSWRPV
VXFKDVG\VSQRHDVRUHWKURDWFRXJKDQGDEQRUPDOFKHVW[UD\ ILQGLQJVSUHGRPLQDQWO\
LQILOWUDWHVZKLFKFDQEHORFDOL]HGJDVWURLQWHVWLQDOV\PSWRPV VXFKDVQDXVHDYRPLWLQJ
GLDU[LOCATION_006]HDRUDEGRPLQDOSDLQDQGPD\OHDGWRPLVGLDJQRVLVRIK\ SHUVHQVLWLYLW\DVUHVSLUDWRU\
GLVHDVHSQHXPRQLDEURQFKLWLVSKDU\QJLWLVRUJDVWURHQWHULWLV2WKHUIUHTXHQWO\REVHUYHGVLJQVRUV\PSWRPVRIWKHK\SHUVHQVLWLYLW\UHDFWLRQPD\LQFOXGHOHWKDU J\RUPDODLVHDQG
PXVFXORVNHOHWDOV\PSWRPVP\DOJLDUDUHO\P\RO\VLVDUWKUDOJLD 7KHV\PSWRPVUHODWHGWRWKLV
K\SHUVHQVLWLYLW\UHDFWLRQZRUVHQZLWKFRQWLQXHGWKHUDS\DQGFDQ EHOLIHWKUHDWHQLQJ
7KHVHV\PSWRPVXVXDOO\UHVROYHXSRQGLVFRQWLQXDWLRQRIDEDFDYLU
+\SHUVHQVLWLYLW\UHDFWLRQV\PSWRPVXVXDOO\DSSHDUZLWKLQWKHIL UVWVL[ZHHNVRILQLWLDWLRQRI
WUHDWPHQWZLWKDEDFDYLUDOWKRXJKWKHVHUHDFWLRQVPD\RFFXUDWDQ\WLPHGXULQJWKHUDS\3DWLHQWV
VKRXOGEHPRQLWRUHGFORVHO\HVSHFLDOO\GXULQJWKHILUVWWZRPR QWKVRIWUHDWPHQWZLWKDEDFDYLU
5HJDUGOHVVRIWKHLU+/$%
VWDWXVSDWLHQWVZKRDUHGLDJQRVHGZLWKDK\SHUVHQVLWLYLW\UHDFWLRQZKLOVWRQWKHUDS\0867GLVFRQWLQXHDEDFDYLULPPHGLDWHO\ DQG08671(9(5EH
UHVWDUWHG5HVWDUWLQJDEDFDYLUIROORZLQJDK\SHUVHQVLWLYLW\UHDF WLRQZLOOUHVXOWLQDSURPSWUHWXUQ
RIV\PSWRPVZLWKLQKRXUV7KLVUHFXUUHQFHLVXVXDOO\PRUHVHYHU HWKDQRQLQLWLDOSUHVHQWDWLRQ
DQGPD\LQFOXGHOLIHWKUHDWHQLQJK\SRWHQVLRQDQGGHDWK7RDYRLGDGHOD\LQGLDJQRVLVDQGPLQLPL]HWKHULVNRIDOLIHWKUHDWHQLQJK\SHUVHQVLWLYLW\UHDFWL RQDEDFDYLUPXVWEHSHUPDQHQWO\
GLVFRQWLQXHGLIK\SHUVHQVLWLYLW\ FDQQRWEHUXOHGRXWHYHQZKHQRWKHUGLDJQRVHVDUHSRVVLEOH
UHVSLUDWRU\GLVHDVHVIOXOLNHLOOQHVVJDVWURHQWHULWLVRUUHD FWLRQVWRRWKHUPHGLFLQDOSURGXFWV
^`
7.6.6. Management of Potential Nephrotoxicity
(VWLPDWHGJORPHUXODUILOWUDWLRQUDWHDFFRUGLQJWRWKH&RFNFURI W*DXOWH*)5 &*IRUPXODIRU
FUHDWLQLQHFOHDUDQFHZLOOEHIROORZHGSRVWEDVHOLQHGXULQJWKH VWXG\$OOVXEMHFWVZLWKHVWLPDWHG
H*)5&*P/PLQPXVWKDYHVHUXPFUHDWLQLQHPHDVXUHGDJDLQZLWKLQFDOHQGDUGD\VRI
UHFHLSWRIUHVXOWV$WWKHWLPHRIWKLVUHSHDWVHUXPFUHDWLQLQH DVVHVVPHQW&\VWDWLQ&ZLOODOVREH
PHDVXUHGDQGWKHH*)5E\&.'(3,F\ VWDWLQ&ZLOOEHFDOFXODWHGDQGFRPSDUHGZLWKWKH
EDVHOLQHPHDVXUHPHQW$Q\VXEMHFWVZKRKDYHDQHVWLPDWHGH*)5 &*P/PLQWKDWDOVR
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\H[SHULHQFH!UHGXFWLRQLQH*)5E\&.' (3,F\VWDWLQ&IURP EDVHOLQHRUZKRKDYHRWKHU
FOLQLFDODQGRUODERUDWRU\HYLGHQFHRIDFXWHUHQDOIDLOXUHZLOOEHGLVFXVVHGZLWKWKH
0HGLFDO0RQLWRUDQGPD\GLVFRQWLQXHIURPVWXG\GUXJV)RUVXEMHFW VZLWKH*)5 &*P/PLQ
ZKRDUHQRWGLVFRQWLQXHGEDVHGRQWR[LFLW\PDQDJHPHQWSURFHGXUHVDERYHDQGFRQVLGHUHGWRKDYHVWDEOHUHQDOIXQFWLRQSHU3ULQFLSDO,QYHVWLJDWRUDQG0HGLFDO0RQLWRULWLVQRWPDQGDWRU\WRUHSHDWH*)5DVVHVVPHQWVZLWKLQGD\V
&.'(3,F\VWDWLQ&IRUPXODDGMXVWHGIRUDJHDQGVH[
H*)5P/PLQP
 Ã®PLQ6F\Vâˆ’Ã®PD[6F\VÃ®$JH
>Ã®LIIHPDOH@
ZKHUH6F\VLVVHUXPF\VWDWLQ&PJ/PLQ6F\VLQGLFDWHVWKHPLQLPXPRI6F\VÈ›RU
DQGPD[6F\VLQGLFDWHVWKHPD[LPXPRI6F\VÈ›RU$OOVX EMHFWVZLWKDFKDQJHIURP
EDVHOLQHVHUXPFUHDWLQLQHRIÂ•PJG/PXVWKDYHVHUXPFUHDWLQLQHUHSHDWHGZLWKDFRQFXUUHQWXULQDO\VLVDQGXULQHFKHPLVWU\ZLWKLQWZRZHHNVRIUHFHLSWRIUHVXOWV,IDVXEMHFWKDVDFRQILUPHGFKDQJHIURPEDVHOLQHVHUXPFUHDWLQLQHRIÂ•PJG/W KH0HGLFDO0RQLWRUVKRXOGEH
QRWLILHGDQGDFRQVXOWDWLRQZLWKDQHSKURORJLVWVKRXOGEHREWDLQHG
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\8. STATISTICAL CONSIDERATIONS
8.1. Analysis Objectives and Endpoints
8.1.1. Analysis Objectives
7KHSULPDU\REMHFWLYHRIWKLVVWXG\LV
ï‚·7RHYDOXDWHWKHHIILFDF\RIVZLWFKLQJWR(&)7$))'&UHODWLYH WRFRQWLQXLQJRQDEDVHOLQH
UHJLPHQFRQVLVWLQJRI$%&7&SOXVDWKLUGDQWLUHWURYLUDODJHQW LQPDLQWDLQLQJ+,951$
FRSLHVP/DW:HHNXVLQJ)'$VQDSVKRWDOJRULWKPLQYLURORJLFDOO\VXSSUHVVHG
+,9LQIHFWHGDGXOWVXEMHFWV
7KHVHFRQGDU\REMHFWLYHVRIWKLVVWXG\DUH
ï‚·7RHYDOXDWHWKHSURSRUWLRQRIVXEMHFWVPDLQWDLQLQJYLURORJLFDOUHVSRQVHGHILQHGDV
+,951$FRSLHVP/)'$VQDSVKRWDQDO \VLVDW:HHNVDQG
ï‚·7RHYDOXDWHFKDQJHVIURPEDVHOLQHLQ&'FHOOFRXQWVDW:HHNV DQG
ï‚·7RHYDOXDWHWKHVDIHW\DQGWROHUDELOLW\RIWKHWZRWUHDWPHQWJU RXSVRYHUDQGZHHNV
8.1.2. Primary Endpoint
7KHSULPDU\HQGSRLQWLVWKHSURSRUWLRQRIVXEMHFWVZLWK+,95 1$FRSLHVP/DW:HHN
DVGHILQHGE\WKH)'$VQDSVKRWDOJRULWKP
8.1.3. Secondary Endpoint
6HFRQGDU\HIILFDF\HQGSRLQWVDUH
ï‚·3URSRUWLRQRIVXEMHFWVZLWK+,951$FRSLHVP/ DW:HHNVDQGDVGHILQHGE\
WKH)'$VQDSVKRWDOJRULWKP
ï‚·7KHFKDQJHIURPEDVHOLQHLQ&'FHOOFRXQWVDW:HHNVDQG
8.2. Analysis Conventions
8.2.1. Analysis Sets
 (IILFDF\
)XOO$QDO\VLV6HW)$6
7KH)XOO$QDO\VLV6HWZLOOLQFOXGHDOOWKHVXEMHFWVZKRZHUHUD QGRPL]HGDQGUHFHLYHGDWOHDVW
RQHGRVHRIVWXG\GUXJ7KH)$6ZLOOH[FOXGHVXEMHFWVZLWKPDMR USURWRFROYLRODWLRQV
HJQRWRQWKHFRUUHFWEDVHOLQHUHJLPHQUHJLPHQ6XEMHFWVZLOO EHJURXSHGDFFRUGLQJWRWKH
WUHDWPHQWWRZKLFKWKH\ZHUHUDQGRPL]HG7KH)$6DQDO\VLVVHWLVWKHSULPDU\DQDO\VLVVHWIRU
WKHHIILFDF\EDVHGDQDO\VHV
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\ 6DIHW\
7KHSULPDU\DQDO\VLVVHWIRUVDIHW\DQDO\VHVLVGHILQHGDVDOOVXEMHFWVWKDWDUHUDQGRPL]HGWRWKH
VWXG\DQGUHFHLYHGDWOHDVWRQHGRVHRIVWXG\PHGLFDWLRQ6XEMHF WVZLOOEHJURXSHGDFFRUGLQJWR
WKHWUHDWPHQWWKH\DFWXDOO\UHFHLYHG
$OOGDWDFROOHFWHGGXULQJWUHDWPHQWZLOOEHLQFOXGHGLQWKHVDI HW\VX[COMPANY_003]ULHV .
8.3. Demographic Data and Baseline Characteristics
'HPRJUDSKLFDQGEDVHOLQHPHDVXUHPHQWVZLOOEHVX[COMPANY_003]UL]HGXVLQJVWDQGDUGGHVFULSWLYHPHWKRGV
'HPRJUDSKLFVX[COMPANY_003]ULHVZLOOLQFOXGHVH[UDFHHWKQLFLW\DQGDJH%DVHOLQHGDWDZLOOLQFOXGHDVX[COMPANY_003]U\RI ERG\ZHLJKWKHLJKWER G\PDVVLQGH[ULVNIDFWRUVIRU
+,9LQIHFWLRQDQGHQUROOPHQWGLVWULEXWLRQ)RUFDWHJRULFDOGHPRJUDSKLFDQGEDVHOLQHFKDUDFWHULVWLFVD&RF KUDQ0DQWHO+DHQV]HO&0+
WHVWZLOOEHXVHGWRFRPSDUHWUHDWPHQWJURXSV)RUFRQWLQXRXVGHPRJUDSKLFDQGEDVHOLQH
FKDUDFWHULVWLFVD:LOFR[RQUDQNVXPWHVWZLOOEHXVHGWRFRPSDUHWUHDWPHQWJURXSV
8.4. Efficacy Analysis
8.4.1. Primary Analysis
7KHQXOOK\SRWKHVLVLVWKDWWKHSURSRUWLRQRIVXEMHFWVPDLQWDLQ LQJ+,951$FRSLHVP/
DVGHILQHGE\WKH)'$VQDSVKRWDQDO\VLVDW:HHNLQWKH7UHD WPHQW*URXS,PPHGLDWH
6ZLWFKLVDWOHDVWZRUVHWKDQWKHUHVSRQVHUDWHLQWKH7UHD WPHQW*URXS'HOD\HG6ZLWFK
WKHDOWHUQDWLYHK\SRWKHVLVLVWKDWWKHUHVSRQVHUDWHLQ7UHDWPHQW*URXSLVOHVVWKDQZRUVH
WKDQWKDWLQ7UHDWPHQW*URXS
7KHSULPDU\HYDOXDWLRQRIQRQLQIHULRULW\DW:HHNZLOOEHGR QHE\FRQVWUXFWLQJDWZRVLGHG
H[DFWFRQILGHQFHLQWHUYDOIRUWKHGLIIHUHQFHLQWUHDWPHQWJURXSUHVSRQVHUDWHV
7UHDWPHQW*URXS(&)7$))'&PLQXV7UHDWPHQW*URXS&RQWL QXLQJ%DVHOLQH
WUHDWPHQWUHJLPHQXVLQJLQYHUWHGWZRRQHVLGHGWHVWVZLWKWKHV WDQGDUGL]HGVWDWLVWLF
2QFHQRQLQIHULRULW \RI7UHDWPHQW*URXS(&)7$))'&WUHDWPHQ WUHJLPHQWR7UHDWPHQW
*URXS&RQWLQXLQJ%DVHOLQHWUHDWPHQWUHJLPHQLVHVWDEOLVKHGWKHORZHUERXQGRIWKH&,
ZLOOEHFRPSDUHGWRLIWKHORZHUERXQGRIWKH&,LVJUHDWHUWKDQWKHQVXSHULRULW \RI
7UHDWPHQW*URXS(&)7$))'&RYHU7UHDWPHQW*URXSFRQWLQXLQJ%DVHOLQHWUHDWPHQWUHJLPHQZLOOEHHVWDEOLVKHG
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\8.4.2. Secondary Analyses
7KHPHWKRGVWRDVVHVVSURSRUWLRQRI+,951$FRSLHVP/DW:HHNVDQGXVLQJ
)'$VQDSVKRWDQDO\VLVZLOOEHYHU\VLPLODUWRWKHSULPDU\HQGSR LQWDQDO\VLVH[FHSWWKHDQDO\VLV
ZLQGRZZLOOGLIIHUDQGWKHVHDQDO\VLVZLQGRZVZLOOEHGHILQHGL QWKH6WDWLVWLFDO$QDO\VLV3ODQ
7KHFKDQJHVIURPEDVHOLQHLQ&'FRXQWDW:HHNVDQGZLOO EHVX[COMPANY_003]UL]HGXVLQJ
GHVFULSWLYHVWDWLVWLFV7KHGLIIHUHQFHVLQFKDQJHVIURPEDVHOLQ HEHWZHHQWKHWZRWUHDWPHQWJURXSV
DQGWKHDVVRFLDWHGFRQILGHQFHLQWHUYDOVZLOOEHFRQVWUXFWHGXVLQJ$QDO\VLVRI9DULDQFH
$129$PRGHOLQFOXGLQJWUHDWPHQWJURXSDVIL[HGHIIHFW
8.5. Safety Analysis
$OOVDIHW\DQDO\V HVZLOOEHSHUIRUPHGXVLQJWKHVDIHW\DQDO\VLVVHW
$OOVDIHW\GDWDFROOHFWHGRQRUDIWHUWKHGDWH VWXG\GUXJZDVIL UVWGLVSHQVHGXSWRWKHGDWHRIODVW
GRVHRIVWXG\GUXJSOXVGD\VZLOOEHVX[COMPANY_003]UL]HGE\WUHDWPHQW JURXSDFFRUGLQJ WRWKHVWXG\
GUXJUHFHLYHG'DWDIRUWKHSUHWUHDWPHQWDQGSRVWWKHGDWHRIO DVWGRVHSOXVGD\VZLOOEH
LQFOXGHGLQGDWDOLVWLQJV
8.5.1. Extent of Exposure
$VXEMHFWÂ¶VH[WHQWRIH[SRVXUHWRVWXG\GUXJZLOOEHJHQHUDWHGIU RPWKHVWXG\GUXJ
DGPLQLVWUDWLRQGDWD([SRVXUHGDWDZLOOEHVX[COMPANY_003]UL]HGE\WUHDWP HQWJURXS
'XUDWLRQRIH[SRVXUHWRVWXG\GUXJZLOOEHH[SUHVVHGDVWKHQXP EHURIZHHNVEHWZHHQWKHILUVW
DQGODVWGRVHRIWKHVWXG\GUXJLQFOXVLYHUHJDUGOHVVRIWHPSR UDU\LQWHUUXSWLRQVLQVWXG\GUXJ
DGPLQLVWUDWLRQDQGVX[COMPANY_003]UL]HGE\WUHDWPHQW'RVLQJLQIRUPDWLRQI RULQGLYLGXDOVXEMHFWVZLOOEH
OLVWHG
8.5.2. Adverse Events
&OLQLFDODQGODERUDWRU\DGYHUVHHYHQWVZLOOEHFRGHGXVLQJWKH0HGLFDO'LFWLRQDU\IRU
5HJXODWRU\$FWLYLWLHV0HG'5$6\VWHP2UJDQ&ODVV62&+LJK /HYHO*URXS7HUP
+/*7+LJK/HYHO7HUP+/73UHIHUUHG7HUP37DQG/RZHU/HYHO7HUP//7ZLOOEH
DWWDFKHGWRWKHFOLQLFDOGDWDEDVH
7UHDWPHQWHPHUJHQWDGYHUVHHYHQWVDUHHYHQWVWKDWPHHWRQHRIWKHIROORZLQJFULWHULDXSWR
GD\VDIWHUWKHSHUPDQHQWGLVFRQWLQXDWLRQRIWKHVWXG\GUXJ
ï‚·$GYHUVHHYHQWVZLWKRQVHWGDWHVRQRUDIWHUWKHILUVWGRVHGDWHRIVWXG\GUXJDQGQRODWHUWKDQ
GD\VDIWHUSHUPDQHQWGLVFRQWLQXDWLRQRIVWXG\GUXJRU
ï‚·$GYHUVHHYHQWVWKDWUHVXOWLQSHUPDQHQWVWXG\GUXJGLVFRQWLQXDW LRQ
6X[COMPANY_003]ULHVQXPEHUDQGSHUFHQWDJHRIVXEMHFWVRIWUHDWPHQWHPHU JHQWDGYHUVHHYHQWV
E\62&DQG37ZLOOEHSURYLGHGE\WUHDWPHQWJURXS$GGLWLRQDOV X[COMPANY_003]ULHVZLOOLQFOXGH
VX[COMPANY_003]ULHVIRUDGYHUVHHYHQWVE\JUDGH,QYHVWLJDWRUÂ¶VDVVHVVPHQWRIUHODWLRQVKLSWRVWXG\GUXJDQGHIIHFWRQVWXG\GUXJGRVLQJ
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\8.5.3. Laboratory Evaluations
6HOHFWHGODERUDWRU\GDWDZLOOEHVX[COMPANY_003]UL]HGXVLQJRQO\REVHUYHGGDWD$EVROXWHYDOXHVDQG
FKDQJHVIURPEDVHOLQHDWDOOVFKHGXOHGWLPHSRLQWVZLOOEHVX[COMPANY_003] UL]HG
*UDGHGODERUDWRU\DEQRUPDOLWLHVZLOOEHGHILQHGXVLQJWKH*6,*UDGLQJ6FDOHIRUVHYHULW\RI$GYHUVH(YHQWVDQG/DERUDWRU\$EQRUPDOLWLHV $SSHQGL[
,QFLGHQFHRIWUHDWPHQWHPHUJHQWODERUDWRU\DEQRUPDOLWLHVGHILQ HGDVYDOXHVWKDWLQFUHDVHDWOHDVW
RQHWR[LFLW\JUDGHIURPEDVHOLQHDWDQ\WLPHSRVWEDVHOLQHXSW RWKHGDWHRIODVWGRVHRIVWXG\
GUXJSOXVGD\VZLOOEHVX[COMPANY_003]UL]HGE\WUHDWPHQWJURXS,IED VHOLQHGDWDDUHPLVVLQJ WKHQDQ\
JUDGHGDEQRUPDOLW\LHDWOHDVWD*UDGHZLOOEHFRQVLGHUH GWUHDWPHQWHPHUJHQW
7KHPD[LPXPWR[LFLW\JUDGHZLOOEHVX[COMPANY_003]UL]HGE\ODERUDWRU\SDUD PHWHU
/DERUDWRU\DEQRUPDOLWLHVWKDWRFFXUEHIRUHWKHILUVWGRVHRIVW XG\GUXJRUDIWHUWKHVXEMHFWKDV
EHHQGLVFRQWLQXHGIURPWUHDWPHQWSOXVGD\VZLOOEHLQFOXGHGLQDGDWDOLVWLQJ
8.5.4. Other Safety Evaluations
:HLJKWZLOOEHVX[COMPANY_003]UL]HGE\YLVLW
6DIHW\(&*VZLOOEHOLVWHGDQGVX[COMPANY_003]UL]HGIRUVXEMHFWVLQWKH6 DIHW\$QDO\VLV6HW7KHQXPEHU
DQGSHUFHQWRIVXEMHFWVZLWKDEQRUPDOVDIHW\(&*ZLOOEHVX[COMPANY_003]U L]HGE\YLVLW
8.6. Biomarker Analysis
7KHUHQDOYDVFXODUDQGLQIOD[COMPANY_003]WRU\PDUNHUVZLOOEHVX[COMPANY_003]UL]HGE\WUHDWPHQWJURXSDQGYLVLW
XVLQJGHVFULSWLYHVWDWLVWLFV7KHGLIIHUHQFHLQFKDQJHIURPEDVH OLQHLQWKHVHELRPDUNHUVEHWZHHQ
WZRWUHDWPHQWJURXSVZLOOEHWHVWHGXVLQJ:LOFR[RQUDQNVXPWHVW
8.7. Sample Size
:LWKVXEMHFWVUDQGRPL]HGWRVZLWFKWRWKH(&)7$))'&DW' D\DQGVXEMHFWV
UDQGRPL]HGWRWKHGHOD\HGVZLWFKJURXSDW:HHNWKHORZHUOLPLWRIWKHREVHUYHGRQHVLGHG
FRQILGHQFHLQWHUYDOZLOOEHH[SHFWHGWREHJUHDWHUWKDQLHQRQLQIHULRULW\PDUJLQRIZLWK!SRZHUZKHQWKHSHUFHQWDJHRIUHVSRQGHUVLQERWKWUHDWPHQWJURXSVIRUWKHSULPDU\HQGSRLQWLVDWOHDVWDW:HHN
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\9. RESPONSIBILITIES
9.1. Investigator Responsibilities
9.1.1. Good Clinical Practice
7KHLQYHVWLJDWRUZLOOHQVXUHWKDWWKLVVWXG\LVFRQGXFWHGLQDF FRUGDQFHZLWKWKHSULQFLSOHVRIWKH
'HFODUDWLRQRI+HOVLQNLDVDPHQGHGLQ(GLQEXUJK7RN\R9HQLFH +RQJ.RQJ:DVKLQJWRQ
6HRXODQG6RXWK$IULFD,QWHUQDWLRQDO&RQIHUHQFHRQ+DUPRQLVDWLRQ,&+JXLGHOLQHVRUZLWK
WKHODZVDQGUHJXODWLRQVRIWKHFRXQWU\LQZKLFKWKHUHVHDUFKLVFRQGXFWHGZKLFKHYHUDIIRUGVWKHJUHDWHUSURWHFWLRQWRWKHVWXG\VXEMHFW7KHVHVWDQGDUGVDUHFR QVLVWHQWZLWKWKH(XURSHDQ8QLRQ
&OLQLFDO7ULDOV'LUHFWLYH(&DQG*RRG&OLQLFDO3UDFWLFH'LUHFWLYH(&
7KHLQYHVWLJDWRUZLOOHQVXUHDGKHUHQFHWRWKHEDVLFSULQFLSOHVRI*RRG&OLQLFDO3UDFWLFHDV
RXWOLQHGLQ&)5VXESDUW'Â³5HVSRQVLELOLWLHVRI6SRQVRUVD QG,QYHVWLJDWRUVÂ´
&)5SDUWDQG&)5SDUW
7KHLQYHVWLJDWRUDQGDOODSSOLFDEOHVXELQYHVWLJDWRUVZLOOFRPSO \ZLWK&)53DUW
SURYLGLQJGRFXPHQWDWLRQRIWKHLUILQDQFLDOLQWHUHVWRUDUUDQJHPHQWVZLWK*LOHDGRUSURSULHWDU\
LQWHUHVWVLQWKHLQYHVWLJDWLRQDOGUXJXQGHUVWXG\7KLVGRFXPHQ WDWLRQPXVWEHSURYLGHGSULRUWR
WKHLQYHVWLJDWRUÂ¶VDQGDQ\VXELQYHVWLJDWRUÂ¶VSDUWLFLSDWLRQLQ WKHVWXG\7KHLQYHVWLJDWRUDQG
VXELQYHVWLJDWRUDJUHHWRQRWLI\*LOHDGRIDQ\FKDQJHLQUHSRUWDE OHLQWHUHVWVGXULQJWKHVWXG\DQG
IRU\HDUIROORZLQJFRPSOHWLRQRIWKHVWXG\6WXG\FRPSOHWLRQ LVGHILQHGDVWKHGDWHZKHQWKH
ODVWVXEMHFWFRPSOHWHVWKHSURWRFROGHILQHGDFWLYLWLHV
9.1.2. Institutional Review Board (IRB) / Independent Ethics Committee (IEC) 
Review and Approval
7KHLQYHVWLJDWRURUVSRQVRUDVDSSURSULDWHDFFRUGLQJWRORFDOUHJXODWLRQVZLOOVXEPLWWKLV
SURWRFROLQIRUPHGFRQVHQWIRUPDQGDQ\DFFRPSDQ\LQJPDWHULDO WREHSURYLGHGWRWKHVXEMHFW
VXFKDVDGYHUWLVHPHQWVVXEMHFWLQIRUPDWLRQVKHHWVRUGHVFULSWLRQVRIWKHVWXG\XVHGWRREWDLQLQIRUPHGFRQVHQWWRDQ,5%,(&7KHLQYHVWLJDWRUZLOOQRWEHJLQDQ\VWXG\VXEMHFWDFWLYLWLHVXQWLODSSURYDOIURPWKH,5%,(&KDVEHHQGRFXPHQWHGDQGSURYLGHGDVDOHWWHUWRWKHLQYHVWLJDWRU
%HIRUHLPSOHPHQWDWLRQWKHLQYHVWLJDWRUZLOOVXEPLWWRDQGUHFHL YHGRFXPHQWHGDSSURYDOIURP
WKH,5%,(&DQ\PRGLILFDWLRQVPDGHWRWKHSURWRFRORUDQ\DFFRPSD Q\LQJPDWHULDOWREH
SURYLGHGWRWKHVXEMHFWDIWHULQLWLDO,5%,(&DSSURYDOZLWKWKH H[FHSWLRQRIWKRVHQHFHVVDU\WR
UHGXFHLPPHGLDWHULVNWRVWXG\VXEMHFWV
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\9.1.3. Informed Consent
7KHLQYHVWLJDWRULVUHVSRQVLEOHIRUREWDLQLQJZULWWHQLQIRUPHGFRQVHQWIURPHDFKLQGLYLGXDO
SDUWLFLSDWLQJLQWKLVVWXG\DIWHUDGHTXDWHH[SODQDWLRQRIWKHDLPVPHWKRGVREMHFWLYHVDQGSRWHQWLDOKD]DUGVRIWKHVWXG\DQGEHIRUHXQGHU WDNLQJDQ\V WXG\UHODWHGSURFHGXUHV
7KHLQYHVWLJDWRUPXVWXVHWKHPRVWFXUUHQW,5%RU,(&DSSURYHGFRQ VHQWIRUPIRUGRFXPHQWLQJ
ZULWWHQLQIRUPHGFRQVHQW(DFKLQIRUPHGFRQVHQWZLOOEHDSSURSU LDWHO\VLJQHGDQGGDWHGE\WKH
VXEMHFWRUWKHVXEMHFWÂ¶VOHJDOO\DXWKRUL]HGUHSUHVHQWDWLYHDQG WKHSHUVRQFRQGXFWLQJWKHFRQVHQW
GLVFXVVLRQDQGDOVRE\DQLPSDUWLDOZLWQHVVLIUHTXLUHGE\,5% RU,(&RUORFDOUHTXLUHPHQWV
9.1.4. Confidentiality
7KHLQYHVWLJDWRUPXVWDVVXUHWKDWVXEMHFWVÂ¶DQRQ\PLW\ZLOOEHVWULFWO\PDLQWDLQHGDQGWKDWWKHLU
LGHQWLWLHVDUHSURWHFWHGIURPXQDXWKRUL]HGSDUWLHV2QO\VXEMHF WLQLWLDOVGDWHRIELUWKDQRWKHU
XQLTXHLGHQWLILHUDVDOORZHGE\ORFDOODZDQGDQLGHQWLILFDWL RQFRGHZLOOEHUHFRUGHGRQDQ\
IRUPRUELRORJLFDOVDPSOHVXEPLWWHGWRWKH6SRQVRU,5%RU,(& ,RUODERUDWRU\/DERUDWRU\
VSHFLPHQVPXVWEHODEHOHGLQVXFKDZD\DVWRSURWHFWVXEMHFWL GHQWLW\ZKLOHDOORZLQJWKHUHVXOWV
WREHUHFRUGHGWRWKHSURSHUVXEMHFW5HIHUWRVSHFLILFODERUDWRU\LQVWUXFWLRQVRULQDFFRUGDQFHZLWKORFDOUHJXODWLRQV127(7KHLQYHVWLJDWRUPXVWNHHSDVFUHHQLQJORJVKRZLQJFRGHVQDPHVDQGDGGUHVVHVIRUDOOVXEMHFWVVFUHHQHGDQGIRUDOOVXEMHFWVHQUROOHGLQWKHWULDO6XEMHFWGDWDZLOOEHSURFHVVHGLQDFFRUGDQFHZLWKDOODSSOLFDEOHUHJXODWLRQV
7KHLQYHVWLJDWRUDJUHHVWKDWDOOLQIRUPDWLRQUHFHLYHGIURP*LOH DGLQFOXGLQJEXWQRWOLPLWHGWRWKH
,QYHVWLJDWRUÂ¶V%URFKXUHWKLVSURWRFROH&5)WKHVWXG\GUXJDQ GDQ\RWKHUVWXG\LQIRUPDWLRQ
UHPDLQWKHVROHDQGH[FOXVLYHSURSHUW\RI*LOHDGGXULQJWKHFRQ GXFWRIWKHVWXG\DQGWKHUHDIWHU
7KLVLQIRUPDWLRQLVQRWWREHGLVFORVHGWRDQ\WKLUGSDUW\H[FHSWHPSOR\HHVRUDJHQWVGLUHFWO\
LQYROYHGLQWKHFRQGXFWRIWKHVWXG\RUDVUHTXLUHGE\ODZZLWK RXWSULRUZULWWHQFRQVHQWIURP
*LOHDG7KHLQYHVWLJDWRUIXUWKHUDJUHHVWRWDNHDOOUHDVRQDEOHSUHFDXWLRQVWRSUHYHQWWKHGLVFORVXUHE \DQ\HPSOR\HHRUDJHQWRIWKHVWXG\VLWHWRDQ\WK LUGSDUW\RURWKHUZLVHLQWRWKH
SXEOLFGRPDLQ
9.1.5. Study Files and Retention of Records
7KHLQYHVWLJDWRUPXVWPDLQWDLQDGHTXDWHDQGDFFXUDWHUHFRUGVWRHQDEOHWKHFRQGXFWRIWKHVWXG\
WREHIXOO\GRFXPHQWHGDQGWKHVWXG\GDWDWREHVXEVHTXHQWO\YH ULILHG7KHVHGRFXPHQWVVKRXOG
EHFODVVLILHGLQWRDWOHDVWWKHIROORZLQJWZRFDWHJRULHVLQY HVWLJDWRUÂ¶VVWXG\ILOHDQG
VXEMHFWFOLQLFDOVRXUFHGRFXPHQWV
7KHLQYHVWLJDWRUÂ¶VVWXG\ILOHZLOOFRQWDLQWKHSURWRFRODPHQGPHQWV&5)DQGTXHU\IRUPV,5%
RU,(&DQGJRYHUQPHQWDODSSURYDOZLWKFRUUHVSRQGHQFHLQIRUPHGFRQVHQWGUXJUHFRUGVVWDIIFXUULFXOXPYLWDHDQGDXWKRUL]DWLRQIRUPVDQGRWKHUDSSURSULDWHGRFXPHQWVDQGFRUUHVSRQGHQFH
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\7KHUHTXLUHGVRXUFHGDWDVKRXOGLQFOXGHVHTXHQWLDOQRWHVFRQWDLQLQJDWOHDVWWKHIROORZLQJ
LQIRUPDWLRQIRUHDFKVXEMHFW
ï‚·6XEMHFWLGHQWLILFDWLRQQDPHGDWHRIELUWKJHQGHU
ï‚·'RFXPHQWDWLRQWKDWVXEMHFWPHHWVHOLJLELOLW\FULWHULDLHKLVW RU\SK\VLFDOH[DPLQDWLRQDQG
FRQILUPDWLRQRIGLDJQRVLVWRVXSSRUWLQFOXVLRQDQGH[FOXVLRQFULWHULD
ï‚·'RFXPHQWDWLRQRIWKHUHDVRQVDFRQVHQWHGVXEMHFWLVQRWHQURO OHG
ï‚·3DUWLFLSDWLRQLQVWXG\LQFOXGLQJ VWXG\QXPEHU
ï‚·6WXG\GLVFXVVHGDQGGDWHRILQIRUPHGFRQVHQW
ï‚·'DWHVRIDOOYLVLWV
ï‚·'RFXPHQWDWLRQWKDWSURWRFROVSHFLILFSURFHGXUHVZHUHSHUIRUPHG
ï‚·5HVXOWVRIHIILFDF\SDUDPHWHUVDVUHTXLUHGE\WKHSURWRFRO
ï‚·6WDUWDQGHQGGDWHLQFOXGLQJGRVHUHJLPHQRI VWXG\GUXJLQFOX GLQJGDWHVRIGLVSHQVLQJDQG
UHWXUQ
ï‚·5HFRUGRIDOODGYHUVHHYHQWVDQGRWKHUVDIHW\SDUDPHWHUVVWDUWDQGHQGGDWHDQGLQFOXGLQJ
FDXVDOLW\DQGVHYHULW\
ï‚·&RQFRPLWDQWPHGLFDWLRQLQFOXGLQJVWDUWDQGHQGGDWHGRVHLIUHOHYDQWGRVHFKDQJHV
ï‚·'DWHRIVWXG\FRPSOHWLRQDQGUHDVRQIRUHDUO\GLVFRQWLQXDWLRQ LILWRFFXUV
$OOFOLQLFDOVWXG\GRFXPHQWVPXVWEHUHWDLQHGE\WKHLQYHVWLJDWRUXQWLODWOHDVW\HDUVRU
DFFRUGLQJWRORFDOODZVZKLFKHYHULVORQJHUDIWHUWKHODVWDS SURYDORIDPDUNHWLQJDSSOLFDWLRQLQ
DQ,&+UHJLRQLH8QLWHG6WDWHV(XURSHRU-DSDQDQGXQWLOW KHUHDUHQRSHQGLQJRUSODQQHG
PDUNHWLQJDSSOLFDWLRQVLQDQ,&+UHJLRQRULIQRDSSOLFDWLRQLVILOHGRULIWKHDSSOLFDWLRQLVQRWDSSURYHGIRUVXFKLQGLFDWLRQXQWLO\HDUVDIWHUWKHLQYHVWLJDWLRQLVGLVFRQWLQXHGDQGUHJXODWRU\DXWKRULWLHVKDYHEHHQQRWLILHG,QYHVWLJDWRUVPD\EHUHTXLUHGW RUHWDLQGRFXPHQWVORQJHULI
VSHFLILHGE\UHJXODWRU\UHTXLUHPHQWVE\ORFDOUHJXODWLRQVRU E\DQDJUHHPHQWZLWK*LOHDG
7KHLQYHVWLJDWRUPXVWQRWLI\*LOHDGEHIRUHGHVWUR\LQJDQ\FOLQLF DOVWXG\UHFRUGV
6KRXOGWKHLQYHVWLJDWRUZLVKWRDVVLJQWKHVWXG\UHFRUGVWRDQR WKHUSDUW\RUPRYHWKHPWRDQRWKHU
ORFDWLRQ*LOHDGPXVWEHQRWLILHGLQDGYDQFH
,IWKHLQYHVWLJDWRUFDQQRWSURYLGHIRUWKLVDUFKLYLQJUHTXLUHPH QWDWWKHVWXG\VLWHIRUDQ\RUDOORI
WKHGRFXPHQWVVSHFLDODUUDQJHPHQWVPXVWEHPDGHEHWZHHQWKHLQYHVWLJDWRUDQG*LOHDGWRVWRUH
WKHVHUHFRUGVVHFXUHO\DZD \IURPWKHVLWHVRWKDWWKH\FDQEHUHWXUQHGVHDOHGWRWKHLQYHVWLJDWRU
LQFDVHRIDQLQVSHFWLRQ:KHQVRXUFHGRFXPHQWVDUHUHTXLUHGIRUWKHFRQWLQXHGFDUHRIWKHVXEMHFWDSSURSULDWHFRSLHVVKRXOGEHPDGHIRUVWRUDJH DZD\IURPWKHVLWH
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\9.1.6. Case Report Forms
)RUHDFKVXEMHFWFRQVHQWHGDQH&5)ZLOOEHFRPSOHWHGE\DQDXW KRUL]HGVWXG\VWDIIPHPEHU
ZKRVHWUDLQLQJIRUWKLVIXQFWLRQLVGRFXPHQWHGDFFRUGLQJWRVWX G\SURFHGXUHV7KHH&5)VKRXOG
EHFRPSOHWHGRQWKHGD\RIWKHVXEMHFWYLVLWWRHQDEOHWKHVSRQ VRUWRSHUIRUPFHQWUDOPRQLWRULQJ
RIVDIHW\GDWD 7KH(OLJLELOLW\ &ULWHULDH&5)VKRXOGEHFRPSOHWH GRQO\DIWHUDOOGDWDUHODWHGWR
HOLJLELOLW\KDYHEHHQUHFHLYHG6XEVHTXHQWWRGDWDHQWU\DVWX G\PRQLWRUZLOOSHUIRUPVRXUFHGDWD
YHULILFDWLRQZLWKLQWKH('&V\VWHP2ULJLQDOHQWULHVDVZHOODV DQ\FKDQJHVWRGDWDILHOGVZLOOEH
VWRUHGLQWKHDXGLWWUDLORIWKHV\VWHP3ULRUWRGDWDEDVHORFNWKHLQYHVWLJDWRUZLOOXVHKLVKHUORJ
LQFUHGHQWLDOVWRFRQILUPWKDWWKHIRUPVKDYHEHHQUHYLHZHGDQGWKDWWKHHQWULHVDFFXUDWHO\UHIOHFWWKHLQIRUPDWLRQLQWKHVRXUFHGRFXPHQWV7KHH&5)FDSWXU HWKHGDWDUHTXLUHGSHUWKH
SURWRFROVFKHGXOHRIHYHQWVDQGSURFHGXUHV6\ VWHPJHQHUDWHGRUPDQXDOTXHULHVZLOOEHLVVXHG
WRWKHLQYHVWLJDWLYHVLWHVWDIIDVGDWDGLVFUHSDQFLHVDUHLGHQWLILHGE\WKHPRQLWRURULQWHUQDO*LOHDGVWDIIZKRURXWLQHO\UHYLHZWKHGDWDIRUFRPSOHWHQHVVFRUUHFWQHVVDQGFRQVLVWHQF\7KHVLWHFRRUGLQDWRULVUHVSRQVLEOHIRUUHVSRQGLQJWRWKHTXHULHVLQDWLPHO\PDQQHUZLWKLQWKHV\VWHPHLWKHUE\FRQILUPLQJWKHGDWDDVFRUUHFWRUXSGDWLQJWKHRULJLQDOHQWU\DQGSURYLGLQJWKHUHDVRQIRUWKHXSGDWHHJGDWDHQWU\HUURU$WWKHFRQFOXVLRQRIWKHWULDO*LOHDGZLOOSURYLGHWKHVLWHZLWKDUHDGRQO\ DUFKLYHFRS\RI WKHGDWDHQWHUHGE\WKDWVLWH7KLVDUFKLYHPXVWEHVWRUHGLQ
DFFRUGDQFHZLWKWKHUHFRUGVUHWHQWLRQUHTXLUHPHQWVRXWOLQHGLQ6HFWLRQ 
9.1.7. Inspections
7KHLQYHVWLJDWRUZLOOPDNHDYDLODEOHDOOVRXUFHGRFXPHQWVDQGRW KHUUHFRUGVIRUWKLVWULDOWR
*LOHDGÂ¶VDSSRLQWHGVWXG\PRQLWRUVWR,5%VRU,(&VRUWRUHJXOD WRU\DXWKRULW\RUKHDOWKDXWKRULW\
LQVSHFWRUV
9.1.8. Protocol Compliance
7KHLQYHVWLJDWRULVUHVSRQVLEOHIRUHQVXULQJWKHVWXG\LVFRQGXFWHGLQDFFRUGDQFHZLWKWKH
SURFHGXUHVDQGHYDOXDWLRQVGHVFULEHGLQWKLVSURWRFRO
9.2. Sponsor Responsibilities
9.2.1. Protocol Modifications
3URWRFROPRGLILFDWLRQVH[FHSWWKRVHLQWHQGHGWRUHGXFHLPPHGLDW HULVNWRVWXG\VXEMHFWVPD\EH
PDGHRQO\E\*LOHDG7KHLQYHVWLJDWRUPXVWVXEPLWDOOSURWRFROPRGLILFDWLRQVWRWKH,5%RU,(&
LQDFFRUGDQFHZLWKORFDOUHTXLUHPHQWVDQGUHFHLYHGRFXPHQWHG,5% RU,(&DSSURYDOEHIRUH
PRGLILFDWLRQVFDQEHLPSOHPHQWHG
9.2.2. Study Report and Publications
$FOLQLFDOVWXG\UHSRUW&65ZLOOEHSUHSDUHGDQGSURYLGHGWR WKHUHJXODWRU\DJHQF\LHV
*LOHDGZLOOHQVXUHWKDWWKHUHSRUWPHHWVWKHVWDQGDUGVVHWRXWL QWKH,&+*XLGHOLQHIRU6WUXFWXUH
DQG&RQWHQWRI&OLQLFDO6WXG\5HSRUWV,&+(1RWHWKDWDQDEE UHYLDWHGUHSRUWPD\EH
SUHSDUHGLQFHUWDLQFDVHV
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\,QYHVWLJDWRUVLQWKLVVWXG\ PD\FRPPXQLFDWHRUDOO\SUHVHQWRU SXEOLVKLQVFLHQWLILFMRXUQDOVRU
RWKHUVFKRODUO\PHGLDRQO\DIWHUWKHIROORZLQJFRQGLWLRQVKDYH EHHQPHW
ï‚·7KHUHVXOWVRIWKHVWXG\LQWKHLUHQWLUHW\KDYHEHHQSXEOLFO\GLVFORVHGE\RUZLWKWKHFRQVHQW
RI*LOHDGLQDQDEVWUDFWPDQXVFULSWRUSUHVHQWDWLRQIRUPRUW KHVWXG\KDVEHHQFRPSOHWHGDW
DOOVWXG\VLWHVIRUDWOHDVW\HDUV
ï‚·7KHLQYHVWLJDWRUZLOOVXEPLWWR*LOHDGDQ\SURSRVHGSXEOLFDWLRQ RUSUHVHQWDWLRQDORQJZLWK
WKHUHVSHFWLYHVFLHQWLILFMRXUQDORUSUHVHQWDWLRQIRUXPDWOHDV WGD\VEHIRUHVXEPLVVLRQRI
WKHSXEOLFDWLRQRUSUHVHQWDWLRQ
ï‚·1RVXFKFRPPXQLFDWLRQSUHVHQWDWLRQRUSXEOLFDWLRQZLOOLQFOXG H*LOHDGÂ¶VFRQILGHQWLDO
LQIRUPDWLRQVHH6HFWLRQ 
ï‚·7KHLQYHVWLJDWRUZLOOFRPSO\ZLWK*LOHDGÂ¶VUHTXHVWWRGHOHWHUH IHUHQFHVWRLWVFRQILGHQWLDO
LQIRUPDWLRQRWKHUWKDQWKHVWXG\UHVXOWVLQDQ\SDSHURUSUHV HQWDWLRQDQGDJUHHVWRZLWKKROG
SXEOLFDWLRQRUSUHVHQWDWLRQIRUDQDGGLWLRQDOGD\VLQRUGHUWRREWDLQSDWHQWSURWHFWLRQLI
GHHPHGQHFHVVDU\
9.3. Joint Investigator/Sponsor Responsibilities
9.3.1. Payment Reporting
,QYHVWLJDWRUVDQGWKHLUVWXG\VWDIIPD\EHDVNHGWRSURYLGHVHU YLFHVSHUIRUPHGXQGHUWKLV
SURWRFROHJDWWHQGDQFHDW, QYHVWLJDWRU
V0HHWLQJV ,IUHTXLUHGXQGHUWKHDSSOLFDEOHVWDWXWRU\DQG
UHJXODWRU\UHTXLUHPHQWV*LOHDGZLOOFDSWXUHDQGGLVFORVHWR)H GHUDODQG6WDWHDJHQFLHVDQ\
H[SHQVHVSDLGRUUHLPEXUVHGIRUVXFKVHUYLFHVLQFOXGLQJDQ\FO LQLFDOWULDOSD\PHQWVPHDOWUDYHO
H[SHQVHVRUUHLPEXUVHPHQWVFRQVXOWLQJIHHVDQGDQ\RWKHUWUDQ VIHURIYDOXH
9.3.2. Access to Information for Monitoring
,QDFFRUGDQFHZLWKUHJXODWLRQVDQGJXLGHOLQHVWKHVWXG\PRQLWRU PXVWKDYHGLUHFWDFFHVVWRWKH
LQYHVWLJDWRUÂ¶VVRXUFHGRFXPHQWDWLRQLQRUGHUWRYHULI\WKHDFFX UDF\RIWKHGDWDUHFRUGHGLQWKH
H&5)
7KHPRQLWRULVUHVSRQVLEOHIRUURXWLQHUHYLHZRIWKHH&5)DWUHJ XODULQWHUYDOVWKURXJKRXWWKH
VWXG\WRYHULI\DGKHUHQFHWRWKHSURWRFRODQGWKHFRPSOHWHQHVV FRQVLVWHQF\DQGDFFXUDF\RIWKH
GDWDEHLQJHQWHUHGRQWKHP7KHPRQLWRUVKRXOGKDYHDFFHVVWRD Q\VXEMHFWUHFRUGVQHHGHGWR
YHULI\WKHHQWULHVRQWKHH&5)7KHLQYHVWLJDWRUDJUHHVWRFRRS HUDWHZLWKWKHPRQLWRUWRHQVXUH
WKDWDQ\SUREOHPVGHWHFWHGWKURXJKDQ\W \SHRIPRQLWRULQJFHQW UDORQVLWHDUHUHVROYHG
9.3.3. Access to Information for Auditing or Inspections
5HSUHVHQWDWLYHVRIUHJXODWRU\DXWKRULWLHVRURI*LOHDGPD\FRQG XFWLQVSHFWLRQVRUDXGLWVRIWKH
FOLQLFDOVWXG\,IWKHLQYHVWLJDWRULVQRWLILHGRIDQLQVSHFWLR QE\DUHJXODWRU\DXWKRULW\WKH
LQYHVWLJDWRUDJUHHVWRQRWLI\WKH*LOHDGPHGLFDOPRQLWRULPPHGL DWHO\7KHLQYHVWLJDWRUDJUHHVWR
SURYLGHWRUHSUHVHQWDWLYHVRIDUHJXODWRU\DJHQF\RU*LOHDGDFF HVVWRUHFRUGVIDFLOLWLHVDQG
SHUVRQQHOIRUWKHHIIHFWLYHFRQGXFWRIDQ\LQVSHFWLRQRUDXGLW
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\9.3.4. Study Discontinuation
%RWKWKHVSRQVRUDQGWKHLQYHVWLJDWRUUHVHUYHWKHULJKWWRWHUP LQDWHWKHVWXG\DWDQ\WLPH6KRXOG
WKLVEHQHFHVVDU\ERWKSDUWLHVZLOODUUDQJHGLVFRQWLQXDWLRQSURFHGXUHVDQGQRWLI\WKHDSSURSULDWH
UHJXODWRU\DXWKRULW\LHV,5%VDQG,(&V,QWHUPLQDWLQJWKHVWXG\*LOHDGDQGWKHLQYHVWLJDWRUZLOODVVXUHWKDWDGHTXDWHFRQVLGHUDWLRQLVJLYHQWRWKHSURWHFWLRQRIWKHVXEMHFWVÂ¶LQWHUHVWV
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\10. REFERENCES
13 5REELQV%/*UHHQKDZ--&RQQHOO\0&)ULGODQG$0HWDEROLFSDW KZD\VIRU
DFWLYDWLRQRIWKHDQWLYLUDODJHQW SKRVSKRQ\OPHWKR[\HWK\ODGHQLQHLQKXPDQ
O\PSKRLGFHOOV$QWLPLFURE$JHQWV&KHPRWKHU 
1238 &HQWHUVIRU'LVHDVH&RQWURODQG3UHYHQWLRQUHYLVHGFODVVL ILFDWLRQV\VWHP
IRU+,9LQIHFWLRQDQGH[SDQGHGVXUYHLOODQFHFDVHGHILQLWLRQIRU $,'6DPRQJ
DGROHVFHQWVDQGDGXOWV00:555
2202 &RFNFURIW':*DXOW0+3UHGLFWLRQRIFUHDWLQLQHFOHDUDQFHIURPVHUXP
FUHDWLQLQH1HSKURQ
4256 &KHVQH\0)DFWRUVDIIHFWLQJDGKHUHQFHWRDQWLUHWURYLUDOWKHUDS \&OLQ,QIHFW'LV
6XSSO66
4266 6WRQH9(--7ROVRQ-3LORQ73RWHQWLDOLPSDFWRIRQFHGDLO\UHJLPHQVRQDGKHUHQFHWR+$$57>DEVWUDFW@WK$QQXDO0HHWLQJRIWKH,QIHFWLRXV'LVHDVH6RFLHW\RI$PHULFD2FW&KLFDJRSSS$EVWUDF W
7896 &HQWHUVIRU'LVHDVH&RQWURODQG3UHYHQWLRQ5HYLVHG&ODVVL ILFDWLRQ6\VWHP
IRU+XPDQ,PPXQRGHILFLHQF\9LUXV,QIHFWLRQLQ&KLOGUHQ/HVV7KDQ<HDUVRI$JH00:555
8284 6WHUQH-+HUQiQ0/HGHUJHUEHU%7LOOLQJ.:HEHU56HQGL3HWDO/RQJWHUPHIIHFWLYHQHVVRISRWHQWDQWLUHWURYLUDOWKHUDS\LQSUHYHQWLQJ$,'6DQGGHDWKDSURVSHFWLYHFRKRUWVWXG\/DQFHW
[ZIP_CODE] &DPSVPLWK0/5KRGHV3++DOO+,*UHHQ7$8QGLDJQRVHG+,9SUH YDOHQFH
DPRQJDGXOWVDQGDGROHVFHQWVLQWKH8QLWHG6WDWHVDWWKHHQGRI-$FTXLU,PPXQH'HILF6\QGU
[ZIP_CODE] :RUOG+HDOWK2UJDQL]DWLRQ81$,'681,&()*OREDO+,9$,'65HVSRQVH(SLGHPLFXSGDWHDQGKHDOWKVHFWRUSURJUHVVWRZDUGVXQLYHUVDODFFHVV3URJUHVV5HSRUW
[ZIP_CODE] 3DQHORQ$QWLUHWURYLUDO*XLGHOLQHVIRU$GXOWVDQG$GROHVFHQWV*XLGHOLQHVIRUWKHXVHRIDQWLUHWURYLUDODJHQWVLQ+,9LQIHFWHGDGXOWVDQGDGROHVFHQWV'HSDUWPHQWRI+HDOWKDQG+XPDQ6HUYLFHVÂ±$YDLODEOHDWKWWSZZZDLGVLQIRQLKJRY&RQWHQW)LOHV$GXOWDQG$GROHVFHQW*/SGI$FFHVVHG$XJXVW
[ZIP_CODE] 0RFURIW$9HOOD6%HQILHOG7/&KLHVL$0LOOHU9*DUJDOLDQRV3HWDO&KDQJLQJSDWWHUQVRIPRUWDOLW\DFURVV(XURSHLQSDWLHQWVLQIHFW HGZLWK+,9
(XUR6,'$6WXG\*URXS/DQFHW
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\[ZIP_CODE] (]]DWL0/RSH]$'(VWLPDWHVRIJOREDOPRUWDOLW\DWWULEXWDEOH WRVPRNLQJLQ
/DQFHW
[ZIP_CODE] 3DOHOOD)-'HODQH\.00RRUPDQ$&/RYHOHVV02)XKUHU-6DWWHQ*$HWDO
'HFOLQLQJ0RUELGLW\DQG0RUWDOLW\$PRQJ3DWLHQWV:LWK$GYDQFHG +XPDQ
,PPXQRGHILFLHQF\9LUXV, QIHFWLRQ1(QJ-0HG
[ZIP_CODE] 6D[3(:RKO'<LQ073RVW)'H-HVXV(6DDJ0HWDO7HQRIRYLUDODIHQDPLGHYHUVXVWHQRIRYLUGLVRSUR[LOIXPDUDWHFRIRUPXODWHGZLWKHOYLWHJUDYLUFRELFLVWDWDQGHPWULFLWDELQHIRULQLWLDOWUHDWPHQWRI+,9LQIHFWLRQWZRUDQGRPLVHGGRXEOHEOLQGSKDVHQRQLQIHULRULW\WULDOV/DQF HW
[ZIP_CODE] 'HSDUWPHQWIRU+HDOWKDQG+XPDQ6HUYLFHV'++6*XLGHOLQHVIRUWKH8VHRI$QWLUHWURYLUDO$JHQWVLQ+,9,QIHFWHG$GXOWVDQG$GROHVFHQWV 'HYHORSHGE\
WKH'++63DQHORQ$QWLUHWURYLUDO*XLGHOLQHVIRU$GXOWVDQG$GROH VFHQWVÂ±$
:RUNLQJ*URXSRIWKH2IILFHRI$,'65HVHDUFK$GYLVRU\&RXQFLO2$5$&'RZQORDGHGIURPKWWSDLGVLQIRQLKJRYJXLGHOLQHVRQ /DVW8SGDWHG
$SULO
[ADDRESS_1050269]500RNRWRII('%UDQVRQ%2ZHQ60:KLWPRUH6+DOO+, 0RUELGLW\
DQG0RUWDOLW\:HHNO\5HSRUW00:55HYLVHG6XUYHLOODQFH&DVH'HILQLWLRQIRU+,9,QIHFWLRQ8QLWHG6WDWHV&HQWHUVIRU'LVHDVH&RQW URODQG
3UHYHQWLRQ
[ZIP_CODE] 7KH-RLQW8QLWHG1DWLRQV3URJUDPPHRQ+,9$,'681$,'65HJLRQDO)DFW6KHHW1RUWK$PHULFD:HVWHUQDQG&HQWUDO(XURSH
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\11. APPENDICES
$SSHQGL[ ,QYHVWLJDWRU6LJQDWXUH3DJH$SSHQGL[ 6WXG\3URFHGXUHV7DEOH
$SSHQGL[ 0DQDJHPHQWRI&OLQLFDODQG/DERUDWRU\$GYHUVH(YHQWV$SSHQGL[ *6,*UDGLQJ6FDOHIRU6HYHULW\RI$GYHUVH(YHQWVDQG /DERUDWRU\$EQRUPDOLWLHV
$SSHQGL[ 3UHJQDQF\3UHFDXWLRQV'HILQLWLRQIRU)HPDOHRI&KLOG EHDULQJ3RWHQWLDODQG
&RQWUDFHSWLYH5HTXLUHPHQWV
$SSHQGL[ 'HILQLWLRQVRI+,95HODWHG'LVHDVH&'&*XLGHOLQHV^`
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\Appendix 2. Study Procedures Table
Study Procedure ScreeningaDay 1bEnd of Weekc
30 Day 
Follow-upeESDDf4 8 12 24w28d32d36 48
,QIRUPHG&RQVHQW ;
0HGLFDO+LVWRU\ ;
&RQFRPLWDQW0HGLFDWLRQV ; ; ; ; ; ;;;;; ; ;
$GYHUVH(YHQWV ; ; ; ; ; ;;;;; ; ;
&RPSOHWH3K\VLFDO([DPJ;; ; ; ;
6\PSWRP'LUHFWHG3K\VLFDO([DPK;;; ;;; ;
/HDG(&*3HUIRUPHG6XSLQH ; ; ;
9LWDO6LJQVDQG:HLJKW ; ; ; ; ; ;;;;; ; ;
+HLJKW ;
8ULQDO\VLVDQG8ULQH&KHPLVWU\ ; ; ; ; ; ;;;;; ;X;
8ULQH6WRUDJH6DPSOH ; ; ; ; ;;;;; ;
8ULQH3UHJQDQF\7HVWL; ;;;;;;;; ; ;
6HUXP3UHJQDQF\7HVWL;
&KHPLVWU\3URILOHM; ; ;;;;;;;; ; ;
+HPDWRORJ\3URILOHN; ; ;;;;;;;; ; ;
3ODVPD+,951$O; ; ;;;;;;;; ; ;
&'&HOO&RXQW ; ; ; ; ; ;;;;; ; ;
:KROH%ORRG6DPSOHP;
+%9DQG+&96HURORJLHVQ;
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\Study Procedure ScreeningaDay 1bEnd of Weekc
30 Day 
Follow-upeESDDf4 8 12 24w28d32d36 48
0HWDEROLF$VVHVVPHQWVR;; ; ;G;
&\VWDWLQ& ;
(VWLPDWHG*)5 &*S; ; ;;;;;;;; ;
3ODVPD6WRUDJH6DPSOHT; ;;;;;;;; ;
;; ; ; ; ;G;;
+,9*HQRW\SH3KHQRW\SHU;;
(YDOXDWLRQVRI%RQH	5HQDO6DIHW\,QIOD[COMPANY_003]WLRQDQG3ODWHOHWDQG&RDJXODWLRQ)XQFWLRQ
V;; ; ; ; ;G;
4XHVWLRQQDLUHV9$6+,9764V+,9764F(4'6)DQG)$&,7)
W ; ;;;;;;;; ;
5DQGRPL]DWLRQ ;
6WXG\'UXJ'LVSHQVDWLRQDQG$FFRXQWDELOLW\ ; ; ; ; ;;;;;Y;
D (YDOXDWLRQVWREHFRPSOHWHGZLWKLQGD\VSULRUWR WKH'D\YL VLW
E 6XEMHFWVZLOOEHGLVSHQVHGVWXG\GUXJRQWKH 'D\YLVLWLQLWLDWLRQRIWUHDWPHQWZLWKWKHVWXG\GUXJPXVWWDNHSODFHZLWKLQ KRXUVDIWHUWKH'D\YLVLW(&)7$))'&ZLOO
EHSURYLGHGWRVXEMHFWVUDQGRPL]HGWR7UHDWPHQW*URXS
F $OOVWXG\YLVLWVDUHWREHVFKHGXOHGUHODWLYHWRWKH 'D\YLVLWGDWH9LVLWZLQGRZVDUHÂ“GD\VRIWKHSURWRFROVSHFLILHGGDWHWKURXJK:HHNÂ“GD\VRIWKHSURWRFRO
VSHFLILHGGDWHWKURXJK:HHN 7KH:HHNYLVLWZLQGRZLVÂ“ZHHN VRIWKHSURWRFROVSHFLILHGGDWH8QOHVVQRWLILHGE\*LOHDGWKH :HHNYLVLWVKRXOGEHFRPSOHWHG
ZLWKLQÂ“GD\VRIWKHYLVLWGDWH)RU7UHDWPHQW*URXSVXEMHFWV WKH:HHNVDQGYLVLWZLQGRZVDUHÂ“GD\VRIWKHSURWRFROVSHFLILHGGDWH
G 7UHDWPHQW*URXSVXEMHFWVRQO\
H 2QO\UHTXLUHGIRUWKRVHVXEMHFWVZKRSHUPDQHQWO\GLVFRQWLQXHVWXG\GUXJRUWKHLUFXUUHQWUHJLPHQDQGUHIXVHFRQWLQXHVWXG\YLVLWVWKURXJK:HHN)RUWKHSXUSRVHRI
VFKHGXOLQJD'D\)ROORZ8S9LVLWDÂ“GD\VZLQGRZPD\EHXVH G
I (DUO\6WXG\'UXJ'LVFRQWLQXDWLRQYLVLWWRRFFXUZLWKLQKRXUVRIODVWGRVHRIVWXG\GUXJ6XEMHFWVZLOOEHDVNHGWRFRQWLQXHDWWHQGLQJWKHVFKHGXOHGVWXG\YLVLWVWKURXJK
:HHNYLVLWHYHQLIWKHVXEMHFWGLVFRQWLQXHVVWXG\GUXJ
J &RPSOHWHSK\VLFDOH[DPLQDWLRQXURJHQLWDODQRUHFWDOH[DPVZLOOEHSHUIRUPHGDWWKHGLVFUHWLRQRIWKH,QYHVWLJDWRUK 6\PSWRPGLUHFWH[COMPANY_004]\VLFDOH[DPLQDWLRQDVQHHGHG
L )HPDOHVRIFKLOGEHDULQJSRWHQWLDORQO\3RVLWLYHXULQHSUHJQDQF\WHVWVZLOOEHFRQILUPHGZLWKDVHUXPWHVW[COMPANY_003]
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\Appendix 4. GSI Grading Scale for Severity of Adverse Events and Laboratory Abnormalities
$QWLYLUDO7R[LFLW\*UDGLQJ6FDOH9HUVLRQ$SULO
HEMATOLOGY
Grade 1 Grade 2 Grade 3 Grade 4
+HPRJORELQ
+,9326,7,9(
Adult and Pediatric ï‚³ï‚³57 DaysWRJG/
WRJ/WRï€¼JG/
WRï€¼J/WRï€¼JG/
WRï€¼J/ï€¼JG/
ï€¼J/
+,91(*$7,9(
Adult and Pediatric ï‚³57 Days WRJG/
WRJ/
25$Q\GHFUHDVHIURP%DVHOLQH
WRï€¼JG/
WRï€¼J/WRï€¼JG/
WRï€¼J/
25
$Q\GHFUHDVHIURP%DVHOLQH
WRï€¼JG/
WRï€¼J/WRï€¼JG/
WRï€¼J/
25
$Q\GHFUHDVHIURP%DVHOLQH
ï‚³JG/
ï‚³J/ï€¼JG/
ï€¼J/
Infant, 36â€“56 Days
+,9326,7,9(25
1(*$7,9(WRJG/
WRJ/WRï€¼JG/
WRï€¼J/WRï€¼JG/
WRJ/ï€¼JG/
J/
Infant, 22â€“35 Days
+,9326,7,9(25
1(*$7,9(WRJG/
WRJ/WRï€¼JG/
WRï€¼J/WRï€¼JG/
WRï€¼J/ï€¼JG/
ï€¼J/
Infant, 1â€“21 Days
+,9SRVLWLYHRUQHJDWLYHWRJG/
WRJ/WRï€¼JG/
WRï€¼J/WRï€¼JG/
WRï€¼J/ï€¼JG/
ï€¼J/
$EVROXWH1HXWURSKLO&RXQW
$1&
Adult and Pediatric, 
â‰¥ 7 Months#WRPPWRï€¼PPWRï€¼PPï€¼PP
WR*,/ WRï€¼*,/ WR ï€¼*,/ ï€¼*,/
$EVROXWH&'&RXQW
+,91(*$7,9(21/<
Adult and Pediatric 
> 13 YearsWRPP
WRÈ/WRï€¼PP
WRï€¼È/WRï€¼PP
WRï€¼È/ï€¼PP
ï€¼È/
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\HEMATOLOGY
Grade 1 Grade 2 Grade 3 Grade 4
$EVROXWH/\PSKRF\WH&RXQW
+,91(*$7,9(21/<
Adult and Pediatric 
ï€¾ï€¾13 YearsWRPP
WR*,/WRï€¼PP
WRï€¼*,/WRï€¼PP
WRï€¼*,/ï€¼PP
ï€¼*,/
3ODWHOHWV WRPP
WRï€¼*,/WRï€¼PP
WRï€¼*,/WRï€¼PP
WRï€¼*,/ï€¼PP
ï€¼*,/
:%&V PPWRPPWRï€¼ PPWRï€¼PPï€¼PP
*,/WR*,/ WRï€¼*,/ WR ï€¼*,/ ï€¼*,/
+\SRILEULQRJHQHPLD WRPJG/ WRï€¼PJG/ WRï€¼PJG/ ï€¼PJG/
WRJ/ WRï€¼J/ WR ï€¼J/ ï€¼J/
+\SHUILEULQRJHQHPLD ï€¾8/1WRPJG/ ï€¾PJG/ Â²Â²
ï€¾8/1WRJ/ ï€¾J/ Â²Â²
)LEULQ6SOLW3URGXFW WRÈJP/ ï€¾WRÈJP/ ï€¾WRÈJP/ ï€¾ÈJP/
WRPJ/ ï€¾WRPJ/ ï€¾WRPJ/ ï€¾PJ/
3URWKURPELQ7LPH37 ï€¾WR ï‚´8/1 ï€¾WR ï‚´8/1 ï€¾WR ï‚´8/1 ï€¾ï‚´8/1
,QWHUQDWLRQDO1RUPDOL]HG5DWLR
RISURWKURPELQWLPH,15WR[8/1 !WR[8/1 !WR[8/1 ![8/1
$FWLYDWHG3DUWLDO
7KURPERSODVWLQ7LPH$377 ï€¾WR ï‚´8/1 ï€¾WR ï‚´8/1 ï€¾WR ï‚´8/1 ï€¾ï‚´8/1
0HWKHPRJORELQ WR ï€¾WR ï€¾WR ï€¾
 $QRYHUODSEHWZHHQWKH*UDGHVFDOHDQGWKH/DEÂ¶VQRUPDOUDQJHIRUDEVROXWHQHXWURSKLOVPD\UHVXOWIRUSHGLDWULFVXEMHFWV3 OHDVHIROORZWKH*LOHDGFRQYHQWLRQRIJUDGLQJ
DQ\UHVXOWZLWKLQWKH//1DQG8/1D
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\CHEMISTRY
Grade 1 Grade 2 Grade 3 Grade 4
+\SRQDWUHPLD WR//1P(T/ WRï€¼P(T/ WR ï€¼P(T/ ï€¼P(T/
WR//1PPRO/ WRï€¼PPRO/ WR ï€¼PPRO/ ï€¼PPRO/
+\SHUQDWUHPLD !8/1WRP(T/ ï€¾WRP(T/ ï€¾WRP(T/ ï€¾P(T/
!8/1WRPPRO/ ï€¾WRPPRO/ ï€¾WRPPRO/ ï€¾PPRO/
+\SRNDOHPLD
Adult and Pediatric
ï‚³ï‚³1 YearWR//1P(T/ WRï€¼P(T/ WR ï€¼P(T/ ï€¼P(T/
WR//1 PPRO/ WRï€¼PPRO/ WR ï€¼PPRO/ ï€¼PPRO/
Infant <1 Year WRP(T/
WRPPRO/WRï€¼P(T/
WRPPRO/WRï€¼P(T/
WRPPRO/ï€¼P(T/
PPRO/
+\SHUNDOHPLD
Adult and Pediatric
ï‚³1 YearWRP(T/
WRPPRO/ï€¾WRP(T/
ï€¾WRPPRO/ï€¾WRP(T/
ï€¾WRPPRO/ï€¾P(T/
ï€¾PPRO/
Infant <1 Year !8/1WRP(T/
!8/1WRPPRO/!WRP(T/
!WRPPRO/ï€¾WRP(T/
ï€¾WRPPRO/ï€¾P(T/
ï€¾PPRO/
+\SRJO\FHPLD
Adult and Pediatric
ï‚³1 MonthWRPJG/
WRPPRO/WRï€¼PJG/
WRï€¼PPRO/WRï€¼PJG/
WRï€¼PPRO/ï€¼PJG/
ï€¼PPRO/
Infant,ï€¼1 Month WRPJG/
WRPPRO/WRï€¼PJG/
WRï€¼PPRO/WRï€¼PJG/
WRï€¼PPRO/ï€¼PJG/
ï€¼PPRO/
+\SHUJO\FHPLD1RQIDVWLQJ WRPJG/ ï€¾WRPJG/ ï€¾WRPJG/ ï€¾PJG/
WRPPRO/ ï€¾WRPPRO/ ï€¾WRPPRO/ ï€¾PPRO/
+\SHUJO\FHPLD)DVWLQJ WRPJG/
WRPPRO/!WRPJG/
!WRPPRO/!WRPJG/!WRPPRO/!PJG/!PPRO/
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\CHEMISTRY
Grade 1 Grade 2 Grade 3 Grade 4
+\SRFDOFHPLD
FRUUHFWHGIRUDOEXPLQLI
DSSURSULDWH

Adult and Pediatric
ï‚³ï‚³2 Years//1PJG/
WR//1PPRO/WRï€¼PJG/
WRï€¼PPRO/WRï€¼PJG/
WRï€¼PPRO/ï€¼PJG/
ï€¼PPRO/
Pediatric â‰¥ 7 days -2 Years WRPJG/
WRPPRO/WRPJG/WRPPRO/WRPJG/WRPPRO/PJG/PPRO/
Infant,ï€¼7 Days WRPJG/
WRPPRO/WRï€¼PJG/
WRPPRO/WRï€¼PJG/
WRPPRO/ï€¼PJG/
PPRO/
+\SHUFDOFHPLDFRUUHFWHGIRU
DOEXPLQLIDSSURSULDWH

Adult and Pediatric ï‚³7 Days!8/1WRPJG/ ï€¾WRPJG/ ï€¾WRPJG/ ï€¾PJG/
!8/1WRPPRO/ ï€¾WRPPRO/ ï€¾WRPPRO/ ï€¾PPRO/
Infant,ï€¼7 Days WRPJG/
WRPPRO/ï€¾WRPJG/
!WRPPRO/ï€¾WRPJG/
!WRPPRO/ï€¾PJG/
!PPRO/
+\SRFDOFHPLDLRQL]HG PJG/WR ï€¼//1 WRPJG/ WRï€¼PJG/ ï€¼PJG/
PPRO/WR ï€¼//1 WR ï€¼PPRO/ WR ï€¼PPRO/ ï€¼PPRO/
+\SHUFDOFHPLDLRQL]HG ï€¾8/1WRPJG/ ï€¾WRPJG/ ï€¾WRPJG/ ï€¾PJG/
ï€¾8/1WRPPRO/ ï€¾WRPPRO/ ï€¾WRPPRO/ ï€¾PPRO/
+\SRPDJQHVHPLD WR//1PJG/
WR//1P(T/WRï€¼PJG/
WRï€¼P(T/WRï€¼PJG/
WRï€¼P(T/ï€¼PJG/
ï€¼P(T/
WR//1PPRO/ WRï€¼PPRO/ WR ï€¼PPRO/ ï€¼PPRO/
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\CHEMISTRY
Grade 1 Grade 2 Grade 3 Grade 4
+\SRSKRVSKDWHPLD
Adult and Pediatric
ï€¾ï€¾14 YearsWR//1PJG/WRï€¼//1PPRO/WRï€¼PJG/
WRï€¼PPRO/WRï€¼PJG/
WRï€¼PPRO/ï€¼PJG/
ï€¼PPRO/
Pediatric 1 Yearâ€“14 Years WR//1PJG/
WR//1PPRO/WRï€¼PJG/
WRPPRO/WRï€¼PJG/
WRPPRO/ï€¼PJG/
PPRO/
Pediatric ï€¼1Y e a r WR//1PJG/WR//1PPRO/WRï€¼PJG/
WRPPRO/WRï€¼PJG/
WRPPRO/ï€¼PJG/
PPRO/
+\SHUELOLUXELQHPLD
Adult and Pediatric > 14 Days ï€¾WRï‚´8/1 ï€¾WRï‚´8/1 ï€¾WRï‚´8/1 ï€¾ï‚´8/1
Infant, ï‚£14 Days
QRQKHPRO\WLF1$ WRPJG/
WRÈPRO/ï€¾WRPJG/
!WRÈPRO/ï€¾PJG/
!ÈPRO/
Infant, ï‚£14 Days
KHPRO\WLF1$ 1$ WRPJG/
WRÈPRO/ï€¾PJG/
!ÈPRO/
%ORRG8UHD1LWURJHQ WR ï‚´8/1 ï€¾WR ï‚´8/1 ï€¾WR ï‚´8/1 ï€¾ï‚´8/1
+\SHUXULFHPLD !8/1WRPJG/ ï€¾WRPJG/ ï€¾WRPJG/ ï€¾PJG/
!8/1WRÈPRO/ ï€¾WRÈPRO/ ï€¾WRÈPRO/ ï€¾ÈPRO/
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\CHEMISTRY
Grade 1 Grade 2 Grade 3 Grade 4
+\SRXULFHPLD
Adult and Pediatric           
â‰¥ 1 year
Infant  < 1 YearPJG/WR ï€¼//1
ÈPRO/WR ï€¼//1WRï€¼PJG/
WRï€¼ÈPRO/WRï€¼PJG/
WRï€¼ÈPRO/ï€¼PJG/
ï€¼ÈPRO/
1$ PJGOWR//1
ÈPROWR//1WRï€¼PJG/
WRï€¼ÈPRO/ï€¼PJG/
ï€¼ÈPRO/
&UHDWLQLQH

 ï€¾WRPJG/
ï€¾WRÈPRO/ï€¾WRPJG/
ï€¾WRÈPRO/ï€¾WRPJG/
ï€¾WRÈPRO/ï€¾PJG/
ï€¾ÈPRO/
%LFDUERQDWH
Adult and Pediatric 
â‰¥ 4 YearsP(T/WR ï€¼//1 WR ï€¼P(T/ WR ï€¼P(T/ ï€¼P(T/
PPRO/WR ï€¼//1 WR ï€¼PPRO/ WR ï€¼PPRO/ ï€¼PPRO/
Pediatric < 4 Years 1$ P(T/WR//1 WRï€¼P(T/ ï€¼P(T/
PPRO/WR//1 WRï€¼PPRO/ ï€¼PPRO/
7ULJO\FHULGHV)DVWLQJ1$ WRPJG/
Â±PPRO/ï€¾WRPJG/
ï€¾Â±PPRO/ï€¾PJG/
ï€¾PPRO/
/'/)DVWLQJ
$GXOWWRPJG/ !WRPJG/ !PJG/ 1$
WRPPRO/ !WRPPRO/ !PPRO/
/'/)DVWLQJ
3HGLDWULF!WR\HDUVWRPJG/ !WRPJG/ !PJG/ 1$
WRPPRO/ !WRPPRO/ !PPRO/
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\CHEMISTRY
Grade 1 Grade 2 Grade 3 Grade 4
+\SHUFKROHVWHUROHPLD
)DVWLQJWRPJG/ ï€¾WRPJG/ ï€¾PJG/ 1$
WRPPRO/ ï€¾WRPPRO/ ï€¾PPRO/
Pediatric ï€¼ ï€¼18 Years WRPJG/WRPPRO/ï€¾WRPJG/
ï€¾WRPPRO/ï€¾PJG/
ï€¾PPRO/1$
&UHDWLQH.LQDVH WRï€¼ï‚´8/1 WR ï€¼ï‚´8/1 WR ï€¼ï‚´8/1 ï‚³ï‚´8/1

 &DOFLXPVKRXOGEHFRUUHFWHGIRUDOEXPLQLIDOEXPLQLVJG/


 $QRYHUODSEHWZHHQWKH*UDGHVFDOHDQGWKH/DEÂ¶VQRUPDOUDQJ HIRUFUHDWLQLQHPD\UHVXOWIRU0DOHVXEMHFWV!\UV3OHDVHIROORZWKH*LOHDGFRQYHQWLRQRIJUDGLQJDQ\
UHVXOWZLWKLQWKH//1DQG8/1D
ENZYMES
Grade 1 Grade 2 Grade 3 Grade 4
$676*27 WR ï‚´8/1 ï€¾WR ï‚´8/1 ï€¾WR ï‚´8/1 ï€¾ï‚´8/1
$/76*37 WR ï‚´8/1 ï€¾WR ï‚´8/1 ï€¾WR ï‚´8/1 ï€¾ï‚´8/1
**7 WR ï‚´8/1 ï€¾WR ï‚´8/1 ï€¾WR ï‚´8/1 ï€¾ï‚´8/1
$ONDOLQH3KRVSKDWDVH WR ï‚´8/1 ï€¾WR ï‚´8/1 ï€¾WR ï‚´8/1 ï€¾ï‚´8/1
7RWDO$P\ODVH ï€¾WRï‚´8/1 ï€¾WRï‚´8/1 ï€¾WRï‚´8/1 ï€¾ï‚´8/1
3DQFUHDWLF$P\ODVH ï€¾WRï‚´8/1 ï€¾WRï‚´8/1 ï€¾WRï‚´8/1 ï€¾ï‚´8/1
/LSDVH ï€¾WRï‚´8/1 ï€¾WRï‚´8/1 ï€¾WRï‚´8/1 ï€¾ï‚´8/1
$OEXPLQ
Pediatrics <16 years
â‰¥ 16 years WRï€¼//1JG/
WRï€¼//1J/ï€¼JG/
ï€¼J/1$
JG/WR ï€¼//1
J/WRï€¼//1WRï€¼JG/
WRï€¼J/ï€¼JG/
ï€¼J/1$
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\URINALYSIS
Grade 1 Grade 2 Grade 3 Grade 4
+HPDWXULD'LSVWLFN ï€« ï€«  1$
+HPDWXULD4XDQWLWDWLYH
6HH1RWHEHORZ)HPDOHV !8/15%&+3) ï€¾5%&+3) !5%&+3) 1$
0DOHV 5%&+3) ï€¾5%&+3) !5%&+3) 1$
3URWHLQXULD'LSVWLFN ï€« Â±ï€« ï€« 1$
3URWHLQXULD+RXU&ROOHFWLRQ
Adult and Pediatric 
ï‚³ï‚³10 YearsWRPJK !WRPJK !WRPJK ï€¾PJK
Pediatric ï€¾3 Mo to 
< 10 YearsWRPJPK !WRPJPK !WRPJPK ï€¾PJPK
*O\FRVXULD'LSVWLFN  ï€« ï€« 1$
1RWHV
ï‚·7R[LFLW\JUDGHVIRU4XDQWLWDWLYHDQG'LSVWLFN+HPDWXULDZLOOEHDVVLJQHGE\&RYDQFH/DERUDWRU\KRZHYHUIRURWKHUODERUDWRULHV WR[LFLW\JUDGHVZLOORQO\EHDVVLJQHGWR
'LSVWLFN+HPDWXULD
ï‚·:LWKWKHH[FHSWLRQRIOLSLGWHVWVDQ\JUDGHGODERUDWRU\WHVWZLWKDUHVXOWWKDWLVEHWZHHQWKH//1DQG8/1VKRXOGEHDVVLJQHG *UDGH
ï‚·,IWKHVHYHULW\RIDFOLQLFDO$(FRXOGIDOOXQGHUHLWKHURQHRIWZRJUDGHVHJWKHVHYHULW\RIDQ$(FRXOGEHHLWKHU*UDGH RU*UDGHVHOHFWWKHKLJKHURIWKHWZRJUDGHVIRU
WKH$(
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\CARDIOVASCULAR
Grade 1 Grade 2 Grade 3 Grade 4
&DUGLDF$U[LOCATION_006]\WKPLDJHQHUDO
%\(&*RUSK\VLFDOH[DP$V\PSWRPDWLF$1'1R
LQWHUYHQWLRQLQGLFDWHG$V\PSWRPDWLF$1'1RQ
XUJHQWPHGLFDOLQWHUYHQWLRQ
LQGLFDWHG6\PSWRPDWLFQRQOLIH
WKUHDWHQLQJ$1'1RQXUJHQW
PHGLFDOLQWHUYHQWLRQ
LQGLFDWHG/LIHWKUHDWHQLQJDU[LOCATION_006]\WKPLD
258UJHQWLQWHUYHQWLRQ
LQGLFDWHG
&DUGLDFLVFKHPLD,QIDUFWLRQ 1$ 1$ 6\PSWRPDWLFLVFKHPLD
VWDEOHDQJLQD257HVWLQJFRQVLVWHQWZLWKLVFKHPLD8QVWDEOHDQJLQD25$FXWH
P\RFDUGLDOLQIDUFWLRQ
+HPRU[LOCATION_006]DJH
VLJQLILFDQWDFXWHEORRGORVV1$ 6\PSWRPDWLF$1'1R
WUDQVIXVLRQLQGLFDWHG6\PSWRPDWLF$1'
7UDQVIXVLRQRI ï‚£XQLWV
SDFNHG5%&VIRUFKLOGUHQ
ï‚£FFNJLQGLFDWHG/LIHWKUHDWHQLQJK\SRWHQVLRQ
257UDQVIXVLRQRI ï€¾XQLWV
SDFNHG5%&VLQGLFDWHGIRU
FKLOGUHQï‚£FFNJ
LQGLFDWHG
+\SHUWHQVLRQZLWKUHSHDW
WHVWLQJDWVDPHYLVLWÂ±PP+JV\VWROLF
25
Â±PP+JGLDVWROLFï€¾Â±PP+JV\VWROLF
25
ï€¾Â±PP+JGLDVWROLFï€¾PP+JV\VWROLF
25ï€¾PP+JGLDVWROLF/LIHWKUHDWHQLQJ
FRQVHTXHQFHV
HJPDOLJQDQWK\SHUWHQVLRQ25+RVSLWDOL]DWLRQRWKHU
WKDQ(5YLVLWLQGLFDWHG
Pediatric ï‚£ ï‚£17 Years 
ZLWKUHSHDWWHVWLQJDWVDPHYLVLW1$ VWÂ±WKSHUFHQWLOHDGMXVWHG
IRUDJHKHLJKWDQGJHQGHUV\VWROLFDQGRUGLDVWROLFÂ•WKSHUFHQWLOHDGMXVWHGIRU
DJHKHLJKWDQGJHQGHU
V\VWROLFDQGRUGLDVWROLF/LIHWKUHDWHQLQJ
FRQVHTXHQFHV
HJPDOLJQDQWK\SHUWHQVLRQ25+RVSLWDOL]DWLRQLQGLFDWHGRWKHUWKDQHPHUJHQF\URRP
YLVLW
+\SRWHQVLRQ 1$ 6\PSWRPDWLFFRUUHFWHGZLWK
RUDOIOXLGUHSODFHPHQW6\PSWRPDWLF,9IOXLGV
LQGLFDWHG6KRFNUHTXLULQJXVHRI
YDVRSUHVVRUVRUPHFKDQLFDO
DVVLVWDQFHWRPDLQWDLQEORRG
SUHVVXUH
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\CARDIOVASCULAR
Grade 1 Grade 2 Grade 3 Grade 4
3HULFDUGLDO(IIXVLRQ $V\PSWRPDWLFVPDOO
HIIXVLRQUHTXLULQJQR
LQWHUYHQWLRQ$V\PSWRPDWLFPRGHUDWHRU
ODUJHUHIIXVLRQUHTXLULQJQR
LQWHUYHQWLRQ(IIXVLRQZLWKQRQOLIH
WKUHDWHQLQJSK\VLRORJLF
FRQVHTXHQFHV25(IIXVLRQZLWKQRQXUJHQWLQWHUYHQWLRQ
LQGLFDWHG/LIHWKUHDWHQLQJ
FRQVHTXHQFHV
HJWDPSRQDGH258UJHQW
LQWHUYHQWLRQLQGLFDWHG
3URORQJHG35,QWHUYDO 35LQWHUYDO
WRVHF35LQWHUYDO
ï€¾VHF7\SH,,QGGHJUHH$9EORFN259HQWULFXODUSDXVH ï€¾
VHF&RPSOHWH$9EORFN
Pediatric ï‚£ ï‚£16 Years VWGHJUHH$9EORFN
35!QRUPDOIRUDJHDQGUDWH7\SH,QGGHJUHH$9EORFN 7\SH,,QGGHJUHH$9EORFN &RPSOHWH $9EORFN
3URORQJHG47F $V\PSWRPDWLF47FLQWHUYDO
WRVHF25,QFUHDVH
LQWHUYDOï€¼VHFDERYH
EDVHOLQH$V\PSWRPDWLF47FLQWHUYDO
WRVHF25,QFUHDVH
LQLQWHUYDOWRVHF
DERYHEDVHOLQH$V\PSWRPDWLF47FLQWHUYDO
ï‚³VHF25,QFUHDVHLQ
LQWHUYDOï‚³VHFDERYH
EDVHOLQH/LIHWKUHDWHQLQJ
FRQVHTXHQFHVHJ 7RUVDGHGH
SRLQWHVRURWKHUDVVRFLDWHG
VHULRXVYHQWULFXODU
G\V[LOCATION_006]\WKPLD
Pediatric ï‚£16 Years $V\PSWRPDWLF47FLQWHUYDO
WRVHF$V\PSWRPDWLF47FLQWHUYDOWRVHF$V\PSWRPDWLF47FLQWHUYDO
ï‚³VHF/LIHWKUHDWHQLQJ
FRQVHTXHQFHVHJ7RUVDGHGH
SRLQWHVRURWKHUDVVRFLDWHGVHULRXVYHQWULFXODU
G\V[LOCATION_006]\WKPLD
7KURPERVLV(PEROLVP 1$ 'HHSYHLQWKURPERVLV$1'
1RLQWHUYHQWLRQLQGLFDWHG
HJDQWLFRDJXODWLRQO\VLV
ILOWHULQYDVLYHSURFHGXUH'HHSYHLQWKURPERVLV$1'
,QWHUYHQWLRQLQGLFDWHGHJ
DQWLFRDJXODWLRQO\VLVILOWHU
LQYDVLYHSURFHGXUH(PEROLFHYHQW
HJSXOPRQDU\HPEROLVP
OLIHWKUHDWHQLQJWKURPEXV
9DVRYDJDO(SLVRGHDVVRFLDWHG
ZLWKDSURFHGXUHRIDQ\NLQG3UHVHQWZLWKRXWORVVRIFRQVFLRXVQHVV3UHVHQWZLWKWUDQVLHQWORVVRIFRQVFLRXVQHVV1$ 1$
9HQWULFXODU'\VIXQFWLRQFRQJHVWLYHKHDUWIDLOXUH&+)1$ $V\PSWRPDWLFGLDJQRVWLF
ILQGLQJ$1'LQWHUYHQWLRQ
LQGLFDWHG1HZRQVHWZLWKV\PSWRPV
25:RUVHQLQJV\PSWRPDWLF
&+)/LIHWKUHDWHQLQJ&+)
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\RESPI[INVESTIGATOR_10806] 1 Grade 2 Grade 3 Grade 4
%URQFKRVSDVPDFXWH )(9RUSHDNIORZUHGXFHG
WRWR)(9RUSHDNIORZWR)(9RUSHDNIORZWR&\DQRVLV25)(9RUSHDN
IORZï€¼25,QWXEDWLRQ
'\VSQHDRU5HVSLUDWRU\'LVWUHVV '\VSQHDRQH[HUWLRQZLWKQR
RUPLQLPDOLQWHUIHUHQFHZLWK
XVXDOVRFLDO	IXQFWLRQDODFWLYLWLHV'\VSQHDRQH[HUWLRQFDXVLQJJUHDWHUWKDQPLQLPDOLQWHUIHUHQFHZLWKXVXDOVRFLDO	IXQFWLRQDODFWLYLWLHV'\VSQHDDWUHVWFDXVLQJLQDELOLW\WRSHUIRUPXVXDOVRFLDO	IXQFWLRQDODFWLYLWLHV5HVSLUDWRU\IDLOXUHZLWKYHQWLODWRU\VXSSRUWLQGLFDWHG
Pediatric ï€¼ ï€¼14 Years :KHH]LQJ25PLQLPDOLQFUHDVHLQUHVSLUDWRU\UDWHIRUDJH1DVDOIODULQJ25,QWHUFRVWDOUHWUDFWLRQV253XOVHR[LPHWU\WR'\VSQHDDWUHVWFDXVLQJLQDELOLW\WRSHUIRUPXVXDOVRFLDO	IXQFWLRQDODFWLYLWLHV
253XOVHR[LPHWU\ ï€¼5HVSLUDWRU\IDLOXUHZLWK
YHQWLODWRU\VXSSRUWLQGLFDWHG
OCULAR/VISUAL
Grade 1 Grade 2 Grade 3 Grade 4
8YHLWLV $V\PSWRPDWLFEXWGHWHFWDEOH
RQH[DP6\PSWRPDWLFDQWHULRUXYHLWLV250HGLFDOLQWHUYHQWLRQLQGLFDWHG3RVWHULRURUSDQXYHLWLV252SHUDWLYHLQWHUYHQWLRQLQGLFDWHG'LVDEOLQJYLVXDOORVVLQDIIHFWHGH\HV
9LVXDO&KDQJHVIURPEDVHOLQH 9LVXDOFKDQJHVFDXVLQJQRRU
PLQLPDOLQWHUIHUHQFHZLWKXVXDOVRFLDO	IXQFWLRQDODFWLYLWLHV9LVXDOFKDQJHVFDXVLQJJUHDWHUWKDQPLQLPDOLQWHUIHUHQFHZLWKXVXDOVRFLDO	IXQFWLRQDODFWLYLWLHV9LVXDOFKDQJHVFDXVLQJLQDELOLW\WRSHUIRUPXVXDOVRFLDO	IXQFWLRQDODFWLYLWLHV'LVDEOLQJYLVXDOORVVLQDIIHFWHGH\HV
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\SKIN
Grade 1 Grade 2 Grade 3 Grade 4
$ORSHFLD 7KLQQLQJGHWHFWDEOHE\VWXG\
SDUWLFLSDQWRUFDUHJLYHUIRUGLVDEOHGDGXOWV7KLQQLQJRUSDWFK\KDLUORVVGHWHFWDEOHE\KHDOWKFDUHSURYLGHU&RPSOHWHKDLUORVV 1$
&XWDQHRXV5HDFWLRQÂ±5DVK /RFDOL]HGPDFXODUUDVK 'LIIXVHPDFXODU 
PDFXORSDSXODURUPRUELOOLIRUPUDVK257DUJHWOHVLRQV'LIIXVHPDFXODU
PDFXORSDSXODURU
PRUELOOLIRUPUDVKZLWKYHVLFOHVRUOLPLWHGQXPEHURIEXOODH256XSHUILFLDOXOFHUDWLRQVRIPXFRXV
PHPEUDQHOLPLWHGWRRQHVLWH([WHQVLYHRUJHQHUDOL]HGEXOORXVOHVLRQV256WHYHQV
-RKQVRQV\QGURPH258OFHUDWLRQRIPXFRXVPHPEUDQHLQYROYLQJWZRRUPRUHGLVWLQFWPXFRVDOVLWHV
257R[LFHSLGHUPDO
QHFURO\VLV7(1
+\SHUSLJPHQWDWLRQ 6OLJKWRUORFDOL]HG 0DUNHGRUJHQHUDOL]HG 1$ 1$
+\SRSLJPHQWDWLRQ 6OLJKWRUORFDOL]HG 0DUNHGRUJHQHUDOL]HG 1$ 1$
3UXULWLVLWFKLQJÂ±QRVNLQOHVLRQV
6HHDOVR,QMHFWLRQ6LWH
5HDFWLRQV3UXULWLVDVVRFLDWHGZLWKLQMHFWLRQ,WFKLQJFDXVLQJQRRUPLQLPDOLQWHUIHUHQFHZLWKXVXDOVRFLDO	IXQFWLRQDODFWLYLWLHV,WFKLQJFDXVLQJJUHDWHUWKDQPLQLPDOLQWHUIHUHQFHZLWKXVXDOVRFLDO	IXQFWLRQDODFWLYLWLHV,WFKLQJFDXVLQJLQDELOLW\WRSHUIRUPXVXDOVRFLDO	IXQFWLRQDODFWLYLWLHV1$
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\GASTROINTESTINAL
Grade 1 Grade 2 Grade 3 Grade 4
$QRUH[LD /RVVRIDSSHWLWHZLWKRXW
GHFUHDVHGRUDOLQWDNH/RVVRIDSSHWLWHDVVRFLDWHGZLWKGHFUHDVHGRUDOLQWDNH
ZLWKRXWVLJQLILFDQWZHLJKW
ORVV/RVVRIDSSHWLWHDVVRFLDWHGZLWKVLJQLILFDQWZHLJKWORVV/LIHWKUHDWHQLQJFRQVHTXHQFHV25
$JJUHVVLYHLQWHUYHQWLRQ
LQGLFDWHG>HJWXEHIHHGLQJRUWRWDOSDUHQWHUDOQXWULWLRQ@
$VFLWHV $V\PSWRPDWLF 6\PSWRPDWLF$1'
,QWHUYHQWLRQLQGLFDWHGHJGLXUHWLFVRUWKHUDSHXWLFSDUDFHQWHVLV6\PSWRPDWLFGHVSLWHLQWHUYHQWLRQ/LIHWKUHDWHQLQJFRQVHTXHQFHV
&KROHF\VWLWLV 1$ 6\PSWRPDWLF$1'0HGLFDO
LQWHUYHQWLRQLQGLFDWHG5DGLRORJLFHQGRVFRSLFRURSHUDWLYHLQWHUYHQWLRQ
LQGLFDWHG/LIHWKUHDWHQLQJ
FRQVHTXHQFHV
HJVHSVLVRUSHUIRUDWLRQ
&RQVWLSDWLRQ 1$ 3HUVLVWHQWFRQVWLSDWLRQ
UHTXLULQJUHJXODUXVHRI
GLHWDU\PRGLILFDWLRQVOD[DWLYHVRUHQHPDV2EVWLSDWLRQZLWKPDQXDOHYDFXDWLRQLQGLFDWHG/LIHWKUHDWHQLQJFRQVHTXHQFHVHJREVWUXFWLRQ
'LDU[LOCATION_006]HD
Adult and Pediatric ï‚³ï‚³1Y e a r 7UDQVLHQWRULQWHUPLWWHQW
HSLVRGHVRIXQIRUPHGVWRROV
25,QFUHDVHRI ï‚£VWRROV
RYHUEDVHOLQHKU3HUVLVWHQWHSLVRGHVRI
XQIRUPHGWRZDWHU\VWRROV
25,QFUHDVHRIÂ±VWRROV
RYHUEDVHOLQHSHUKUV%ORRG\GLDU[LOCATION_006]HD25,QFUHDVH
RIï‚³VWRROVSHUKRXU
SHULRG25,9IOXLG
UHSODFHPHQWLQGLFDWHG/LIHWKUHDWHQLQJFRQVHTXHQFHV
HJK\SRWHQVLYHVKRFN
Pediatric ï€¼1Y e a r /LTXLGVWRROVPRUH
XQIRUPHGWKDQXVXDOEXWXVXDOQXPEHURIVWRROV/LTXLGVWRROVZLWKLQFUHDVHGQXPEHURIVWRROV250LOGGHK\GUDWLRQ/LTXLGVWRROVZLWKPRGHUDWHGHK\GUDWLRQ/LTXLGVWRROVUHVXOWLQJLQVHYHUHGHK\GUDWLRQZLWKDJJUHVVLYHUHK\GUDWLRQLQGLFDWHG25+\SRWHQVLYHVKRFN
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\GASTROINTESTINAL
Grade 1 Grade 2 Grade 3 Grade 4
'\VSKDJLD2G\QRSKDJLD 6\PSWRPDWLFEXWDEOHWRHDW
XVXDOGLHW6\PSWRPVFDXVLQJDOWHUHGGLHWDU\LQWDNHZLWKRXW
PHGLFDOLQWHUYHQWLRQ
LQGLFDWHG6\PSWRPVFDXVLQJVHYHUHO\DOWHUHGGLHWDU\LQWDNHZLWK
PHGLFDOLQWHUYHQWLRQ
LQGLFDWHG/LIHWKUHDWHQLQJUHGXFWLRQLQRUDOLQWDNH
0XFRVLWLV6WRPDWLWLVFOLQLFDOH[DP
6HHDOVR3URFWLWLV
'\VSKDJLD2G\QRSKDJLD(U\WKHPDRIWKHPXFRVD 3DWFK\SVHXGRPHPEUDQHVRU
XOFHUDWLRQV&RQIOXHQWSVHXGRPHPEUDQHVRUXOFHUDWLRQV250XFRVDOEOHHGLQJZLWKPLQRUWUDXPD7LVVXHQHFURVLV25'LIIXVHVSRQWDQHRXVPXFRVDOEOHHGLQJ25/LIHWKUHDWHQLQJFRQVHTXHQFHVHJDVSLUDWLRQFKRNLQJ
1DXVHD 7UDQVLHQW ï€¼KRXUVRU
LQWHUPLWWHQWQDXVHDZLWKQRRUPLQLPDOLQWHUIHUHQFHZLWK
RUDOLQWDNH3HUVLVWHQWQDXVHDUHVXOWLQJLQ
GHFUHDVHGRUDOLQWDNHIRUÂ±
KRXUV3HUVLVWHQWQDXVHDUHVXOWLQJLQ
PLQLPDORUDOLQWDNHIRU ï€¾
KRXUV25$JJUHVVLYH
UHK\GUDWLRQLQGLFDWHG
HJ,9IOXLGV/LIHWKUHDWHQLQJFRQVHTXHQFHV
HJK\SRWHQVLYHVKRFN
3DQFUHDWLWLV 1$ 6\PSWRPDWLF$1'
+RVSLWDOL]DWLRQQRWLQGLFDWHGRWKHUWKDQ(5YLVLW6\PSWRPDWLF$1'+RVSLWDOL]DWLRQLQGLFDWHGRWKHUWKDQ(5YLVLW/LIHWKUHDWHQLQJFRQVHTXHQFHVHJVHSVLVFLUFXODWRU\IDLOXUHKHPRU[LOCATION_006]DJH
3URFWLWLVIXQFWLRQDOV\PSWRPDWLF
$OVRVHH0XFRVLWLV6WRPDWLWLV
IRU&OLQLFDO([DP5HFWDOGLVFRPI[INVESTIGATOR_13318]$1'1R
LQWHUYHQWLRQLQGLFDWHG6\PSWRPVFDXVLQJJUHDWHUWKDQPLQLPDOLQWHUIHUHQFHZLWKXVXDOVRFLDO	
IXQFWLRQDODFWLYLWLHV25
0HGLFDOLQWHUYHQWLRQLQGLFDWHG6\PSWRPVFDXVLQJLQDELOLW\WRSHUIRUPXVXDOVRFLDOIXQFWLRQDODFWLYLWLHV25
2SHUDWLYHLQWHUYHQWLRQ
LQGLFDWHG/LIHWKUHDWHQLQJFRQVHTXHQFHVHJSHUIRUDWLRQ
9RPLWLQJ 7UDQVLHQWRULQWHUPLWWHQW
YRPLWLQJZLWKQRRUPLQLPDOLQWHUIHUHQFHZLWKRUDOLQWDNH)UHTXHQWHSLVRGHVRIYRPLWLQJZLWKQRRUPLOGGHK\GUDWLRQ3HUVLVWHQWYRPLWLQJUHVXOWLQJLQRUWKRVWDWLFK\SRWHQVLRQ25$JJUHVVLYHUHK\GUDWLRQLQGLFDWHG/LIHWKUHDWHQLQJFRQVHTXHQFHVHJK\SRWHQVLYHVKRFN
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\NEUROLOGICAL
Grade 1 Grade 2 Grade 3 Grade 4
$OWHUDWLRQLQ
3HUVRQDOLW\%HKDYLRURULQ
0RRGHJDJLWDWLRQDQ[LHW\
GHSUHVVLRQPDQLDSV\FKRVLV$OWHUDWLRQFDXVLQJQRRU
PLQLPDOLQWHUIHUHQFHZLWK
XVXDOVRFLDO	IXQFWLRQDO
DFWLYLWLHV$OWHUDWLRQFDXVLQJJUHDWHU
WKDQPLQLPDOLQWHUIHUHQFH
ZLWKXVXDOVRFLDO	
IXQFWLRQDODFWLYLWLHV$OWHUDWLRQFDXVLQJLQDELOLW\
WRSHUIRUPXVXDOVRFLDO	
IXQFWLRQDODFWLYLWLHV%HKDYLRUSRWHQWLDOO\KDUPI[INVESTIGATOR_89236]
WRVHOIRURWKHUV
HJVXLFLGDOKRPLFLGDOLGHDWLRQRUDWWHPSWDFXWHSV\FKRVLV25&DXVLQJLQDELOLW\WRSHUIRUPEDVLFVHOIFDUHIXQFWLRQV
$OWHUHG0HQWDO6WDWXV
)RU'HPHQWLDVHH&RJQLWLYH
DQG%HKDYLRUDO$WWHQWLRQDO
'LVWXUEDQFHLQFOXGLQJGHPHQWLDDQG$''&KDQJHVFDXVLQJQRRU
PLQLPDOLQWHUIHUHQFHZLWK
XVXDOVRFLDO	IXQFWLRQDO
DFWLYLWLHV0LOGOHWKDUJ\RUVRPQROHQFH
FDXVLQJJUHDWHUWKDQPLQLPDO
LQWHUIHUHQFHZLWKXVXDOVRFLDO
	IXQFWLRQDODFWLYLWLHV&RQIXVLRQPHPRU\
LPSDLUPHQWOHWKDUJ\RU
VRPQROHQFHFDXVLQJLQDELOLW\WRSHUIRUPXVXDOVRFLDO	
IXQFWLRQDODFWLYLWLHV'HOLULXP25REWXQGDWLRQ
25FRPD
$WD[LD $V\PSWRPDWLFDWD[LD
GHWHFWDEOHRQH[DP250LQLPDODWD[LDFDXVLQJQRRUPLQLPDOLQWHUIHUHQFHZLWKXVXDOVRFLDO	IXQFWLRQDO
DFWLYLWLHV6\PSWRPDWLFDWD[LDFDXVLQJ
JUHDWHUWKDQPLQLPDO
LQWHUIHUHQFHZLWKXVXDOVRFLDO
	IXQFWLRQDODFWLYLWLHV6\PSWRPDWLFDWD[LDFDXVLQJ
LQDELOLW\WRSHUIRUPXVXDO
VRFLDO	IXQFWLRQDODFWLYLWLHV'LVDEOLQJDWD[LDFDXVLQJ
LQDELOLW\WRSHUIRUPEDVLF
VHOIFDUHIXQFWLRQV
&RJQLWLYHDQG
%HKDYLRUDO$WWHQWLRQDO
'LVWXUEDQFH
LQFOXGLQJGHPHQWLDDQG
$WWHQWLRQ'HILFLW'LVRUGHU'LVDELOLW\FDXVLQJQRRU
PLQLPDOLQWHUIHUHQFHZLWK
XVXDOVRFLDO	IXQFWLRQDO
DFWLYLWLHV256SHFLDOL]HG
UHVRXUFHVQRWLQGLFDWHG'LVDELOLW\FDXVLQJJUHDWHU
WKDQPLQLPDOLQWHUIHUHQFH
ZLWKXVXDOVRFLDO	
IXQFWLRQDODFWLYLWLHV256SHFLDOL]HGUHVRXUFHVRQ
SDUWWLPHEDVLVLQGLFDWHG'LVDELOLW\FDXVLQJLQDELOLW\WR
SHUIRUPXVXDOVRFLDO	
IXQFWLRQDODFWLYLWLHV25
6SHFLDOL]HGUHVRXUFHVRQD
IXOOWLPHEDVLVLQGLFDWHG'LVDELOLW\FDXVLQJLQDELOLW\WR
SHUIRUPEDVLFVHOIFDUH
IXQFWLRQV25
,QVWLWXWLRQDOL]DWLRQLQGLFDWHG
&16,VFKHPLDDFXWH1$ 1$ 7UDQVLHQWLVFKHPLFDWWDFN &HUHEUDOYDVFXODUDFFLGHQW
&9$VWURNHZLWKQHXURORJLFDOGHILFLW
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\NEUROLOGICAL
Grade 1 Grade 2 Grade 3 Grade 4
'HYHORSPHQWDOGHOD\Â±
Pediatric ï‚£ ï‚£16 Years0LOGGHYHORSPHQWDOGHOD\
HLWKHUPRWRURUFRJQLWLYHDV
GHWHUPLQHGE\FRPSDULVRQZLWKDGHYHORSPHQWDOVFUHHQLQJWRRODSSURSULDWHIRU
WKHVHWWLQJ0RGHUDWHGHYHORSPHQWDO
GHOD\HLWKHUPRWRURU
FRJQLWLYHDVGHWHUPLQHGE\FRPSDULVRQZLWKDGHYHORSPHQWDOVFUHHQLQJWRRO
DSSURSULDWHIRUWKHVHWWLQJ6HYHUHGHYHORSPHQWDOGHOD\
HLWKHUPRWRURUFRJQLWLYHDV
GHWHUPLQHGE\FRPSDULVRQZLWKDGHYHORSPHQWDOVFUHHQLQJWRRODSSURSULDWHIRU
WKHVHWWLQJ'HYHORSPHQWDOUHJUHVVLRQ
HLWKHUPRWRURUFRJQLWLYHDV
GHWHUPLQHGE\FRPSDULVRQZLWKDGHYHORSPHQWDOVFUHHQLQJWRRODSSURSULDWHIRU
WKHVHWWLQJ
+HDGDFKH 6\PSWRPVFDXVLQJQRRU
PLQLPDOLQWHUIHUHQFHZLWK
XVXDOVRFLDO	IXQFWLRQDO
DFWLYLWLHV6\PSWRPVFDXVLQJJUHDWHU
WKDQPLQLPDOLQWHUIHUHQFH
ZLWKXVXDOVRFLDO	
IXQFWLRQDODFWLYLWLHV6\PSWRPVFDXVLQJLQDELOLW\
WRSHUIRUPXVXDOVRFLDO	
IXQFWLRQDODFWLYLWLHV6\PSWRPVFDXVLQJLQDELOLW\
WRSHUIRUPEDVLFVHOIFDUH
IXQFWLRQV25+RVSLWDOL]DWLRQLQGLFDWHGRWKHUWKDQ(5YLVLW25+HDGDFKHZLWKVLJQLILFDQWLPSDLUPHQWRIDOHUWQHVVRURWKHUQHXURORJLFIXQFWLRQ
,QVRPQLD 1$ 'LIILFXOW\VOHHSLQJFDXVLQJ
JUHDWHUWKDQPLQLPDOLQWHUIHUHQFHZLWKXVXDO
VRFLDOIXQFWLRQDODFWLYLWLHV'LIILFXOW\VOHHSLQJFDXVLQJ
LQDELOLW\WRSHUIRUPXVXDO
VRFLDO	IXQFWLRQDODFWLYLWLHV'LVDEOLQJLQVRPQLDFDXVLQJ
LQDELOLW\WRSHUIRUPEDVLF
VHOIFDUHIXQFWLRQV
1HXURPXVFXODU:HDNQHVV
LQFOXGLQJP\RSDWK\	
QHXURSDWK\$V\PSWRPDWLFZLWK
GHFUHDVHGVWUHQJWKRQH[DP250LQLPDOPXVFOHZHDNQHVVFDXVLQJQRRUPLQLPDO
LQWHUIHUHQFHZLWKXVXDOVRFLDO
	IXQFWLRQDODFWLYLWLHV0XVFOHZHDNQHVVFDXVLQJ
JUHDWHUWKDQPLQLPDOLQWHUIHUHQFHZLWKXVXDOVRFLDO
	IXQFWLRQDODFWLYLWLHV0XVFOHZHDNQHVVFDXVLQJ
LQDELOLW\WRSHUIRUPXVXDO
VRFLDO	IXQFWLRQDODFWLYLWLHV'LVDEOLQJPXVFOHZHDNQHVV
FDXVLQJLQDELOLW\WRSHUIRUPEDVLFVHOIFDUHIXQFWLRQV255HVSLUDWRU\PXVFOHZHDNQHVVLPSDLULQJYHQWLODWLRQ
1HXURVHQVRU\$OWHUDWLRQ
LQFOXGLQJSDUHVWKHVLDDQG
SDLQIXOQHXURSDWK\$V\PSWRPDWLFZLWKVHQVRU\
DOWHUDWLRQRQH[DPRU
PLQLPDOSDUHVWKHVLDFDXVLQJQRRUPLQLPDOLQWHUIHUHQFHZLWKXVXDOVRFLDO	IXQFWLRQDODFWLYLWLHV6HQVRU\DOWHUDWLRQRU
SDUHVWKHVLDFDXVLQJJUHDWHU
WKDQPLQLPDOLQWHUIHUHQFHZLWKXVXDOVRFLDO	
IXQFWLRQDODFWLYLWLHV6HQVRU\DOWHUDWLRQRU
SDUHVWKHVLDFDXVLQJLQDELOLW\
WRSHUIRUPXVXDOVRFLDO	
IXQFWLRQDODFWLYLWLHV'LVDEOLQJVHQVRU\DOWHUDWLRQ
RUSDUHVWKHVLDFDXVLQJ
LQDELOLW\WRSHUIRUPEDVLF
VHOIFDUHIXQFWLRQV
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\NEUROLOGICAL
Grade 1 Grade 2 Grade 3 Grade 4
6HL]XUHQHZRQVHW 1$ VHL]XUH Â±VHL]XUHV 6HL]XUHVRIDQ\NLQGWKDWDUH
SURORQJHGUHSHWLWLYHHJVWDWXVHSLOHSWLFXVRUGLIILFXOWWRFRQWURO
HJUHIUDFWRU\HSLOHSV\
6HL]XUHSUHH[LVWLQJ
)RU:RUVHQLQJRI([LVWLQJ
(SLOHSV\WKH*UDGHV6KRXOG%H
%DVHGRQDQ,QFUHDVHIURP3UHYLRXV/HYHORI&RQWUROWR
$Q\RI7KHVH/HYHOV1$ ,QFUHDVHGIUHTXHQF\RISUH
H[LVWLQJVHL]XUHVQRQ
UHSHWLWLYHZLWKRXWFKDQJHLQ
VHL]XUHFKDUDFWHU25LQIUHTXHQWEUHDNWKURXJKVHL]XUHVZKLOHRQVWDEOHPHGVLQDSUHYLRXVO\
FRQWUROOHGVHL]XUHGLVRUGHU&KDQJHLQVHL]XUHFKDUDFWHU
IURPEDVHOLQHHLWKHULQ
GXUDWLRQRUTXDOLW\
HJVHYHULW\RUIRFDOLW\6HL]XUHVRIDQ\NLQGWKDWDUH
SURORQJHGUHSHWLWLYH
HJVWDWXVHSLOHSWLFXVRU
GLIILFXOWWRFRQWURO
HJUHIUDFWRU\HSLOHSV\
6HL]XUH
Pediatric ï€¼ ï€¼18 Years6HL]XUHJHQHUDOL]HGRQVHW
ZLWKRUZLWKRXWVHFRQGDU\
JHQHUDOL]DWLRQODVWLQJ
PLQXWHVZLWKKRXUV
SRVWLFWDOVWDWH6HL]XUHJHQHUDOL]HGRQVHW
ZLWKRUZLWKRXWVHFRQGDU\
JHQHUDOL]DWLRQODVWLQJÂ±
PLQXWHVZLWK
KRXUVSRVWLFWDOVWDWH6HL]XUHJHQHUDOL]HGRQVHW
ZLWKRUZLWKRXWVHFRQGDU\
JHQHUDOL]DWLRQODVWLQJ
!PLQXWHV6HL]XUHJHQHUDOL]HGRQVHW
ZLWKRUZLWKRXWVHFRQGDU\
JHQHUDOL]DWLRQUHTXLULQJ
LQWXEDWLRQDQGVHGDWLRQ
6\QFRSHQRWDVVRFLDWHGZLWKDSURFHGXUH1$ 3UHVHQW 1$ 1$
9HUWLJR 9HUWLJRFDXVLQJQRRU
PLQLPDOLQWHUIHUHQFHZLWK
XVXDOVRFLDO	IXQFWLRQDODFWLYLWLHV9HUWLJRFDXVLQJJUHDWHUWKDQPLQLPDOLQWHUIHUHQFHZLWKXVXDOVRFLDO	IXQFWLRQDODFWLYLWLHV9HUWLJRFDXVLQJLQDELOLW\WRSHUIRUPXVXDOVRFLDO	
IXQFWLRQDODFWLYLWLHV'LVDEOLQJYHUWLJRFDXVLQJ
LQDELOLW\WRSHUIRUPEDVLF
VHOIFDUHIXQFWLRQV
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\MUSCULOSKELETAL
Grade 1 Grade 2 Grade 3 Grade 4
$UWKUDOJLD
6HHDOVR$UWKULWLV-RLQWSDLQFDXVLQJQRRU
PLQLPDOLQWHUIHUHQFHZLWK
XVXDOVRFLDO	IXQFWLRQDO
DFWLYLWLHV-RLQWSDLQFDXVLQJJUHDWHUWKDQPLQLPDOLQWHUIHUHQFH
ZLWKXVXDOVRFLDO	
IXQFWLRQDODFWLYLWLHV-RLQWSDLQFDXVLQJLQDELOLW\WRSHUIRUPXVXDOVRFLDO	
IXQFWLRQDODFWLYLWLHV'LVDEOLQJMRLQWSDLQFDXVLQJ
LQDELOLW\WRSHUIRUPEDVLF
VHOIFDUHIXQFWLRQV
$UWKULWLV
6HHDOVR$UWKUDOJLD6WLIIQHVVRUMRLQWVZHOOLQJ
FDXVLQJQRRUPLQLPDOLQWHUIHUHQFHZLWKXVXDOVRFLDO	IXQFWLRQDODFWLYLWLHV6WLIIQHVVRUMRLQWVZHOOLQJFDXVLQJJUHDWHUWKDQPLQLPDOLQWHUIHUHQFHZLWKXVXDOVRFLDO	IXQFWLRQDODFWLYLWLHV6WLIIQHVVRUMRLQWVZHOOLQJFDXVLQJLQDELOLW\WRSHUIRUPXVXDOVRFLDO	IXQFWLRQDODFWLYLWLHV'LVDEOLQJMRLQWVWLIIQHVVRUVZHOOLQJFDXVLQJLQDELOLW\WRSHUIRUPEDVLFVHOIFDUHIXQFWLRQV
%RQH0LQHUDO/RVV %0'WVFRUHRU]VFRUH
Â±WRÂ±%0'WVFRUHRU]VFRUH
ï€¼Â±3DWKRORJLFDOIUDFWXUH
LQFOXGLQJORVVRIYHUWHEUDO
KHLJKW3DWKRORJLFIUDFWXUHFDXVLQJ
OLIHWKUHDWHQLQJ
FRQVHTXHQFHV
Pediatric ï€¼ ï€¼21 Years %0']VFRUH
Â±WRÂ±%0']VFRUHÂ± 3DWKRORJLFDOIUDFWXUH
LQFOXGLQJORVVRIYHUWHEUDOKHLJKW3DWKRORJLFIUDFWXUHFDXVLQJOLIHWKUHDWHQLQJFRQVHTXHQFHV
0\DOJLDQRQLQMHFWLRQVLWH0XVFOHSDLQFDXVLQJQRRUPLQLPDOLQWHUIHUHQFHZLWK
XVXDOVRFLDO	IXQFWLRQDO
DFWLYLWLHV0XVFOHSDLQFDXVLQJJUHDWHUWKDQPLQLPDOLQWHUIHUHQFH
ZLWKXVXDOVRFLDO	
IXQFWLRQDODFWLYLWLHV0XVFOHSDLQFDXVLQJLQDELOLW\WRSHUIRUPXVXDOVRFLDO	
IXQFWLRQDODFWLYLWLHV'LVDEOLQJPXVFOHSDLQ
FDXVLQJLQDELOLW\WRSHUIRUP
EDVLFVHOIFDUHIXQFWLRQV
2VWHRQHFURVLV 1$ $V\PSWRPDWLFZLWK
UDGLRJUDSKLFILQGLQJV$1'
1RRSHUDWLYHLQWHUYHQWLRQLQGLFDWHG6\PSWRPDWLFERQHSDLQZLWKUDGLRJUDSKLFILQGLQJV252SHUDWLYHLQWHUYHQWLRQLQGLFDWHG'LVDEOLQJERQHSDLQZLWKUDGLRJUDSKLFILQGLQJVFDXVLQJLQDELOLW\WRSHUIRUPEDVLFVHOIFDUHIXQFWLRQV
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\SYSTEMIC
Grade 1 Grade 2 Grade 3 Grade 4
$FXWH6\VWHPLF$OOHUJLF5HDFWLRQ/RFDOL]HGXUWLFDULDZKHDOVZLWKQRPHGLFDOLQWHUYHQWLRQLQGLFDWHG/RFDOL]HGXUWLFDULDZLWKPHGLFDOLQWHUYHQWLRQLQGLFDWHG250LOG
DQJLRHGHPDZLWKQRPHGLFDO
LQWHUYHQWLRQLQGLFDWHG*HQHUDOL]HGXUWLFDULD25$QJLRHGHPDZLWKPHGLFDOLQWHUYHQWLRQLQGLFDWHG25
6\PSWRPDWLFPLOG
EURQFKRVSDVP$FXWHDQDSK\OD[LV25/LIHWKUHDWHQLQJEURQFKRVSDVP25ODU\QJHDO
HGHPD
&KLOOV 6\PSWRPVFDXVLQJQRRU
PLQLPDOLQWHUIHUHQFHZLWK
XVXDOVRFLDO	IXQFWLRQDODFWLYLWLHV6\PSWRPVFDXVLQJJUHDWHUWKDQPLQLPDOLQWHUIHUHQFHZLWKXVXDOVRFLDO	IXQFWLRQDODFWLYLWLHV6\PSWRPVFDXVLQJLQDELOLW\WRSHUIRUPXVXDOVRFLDO	IXQFWLRQDODFWLYLWLHV1$
)DWLJXH
0DODLVH6\PSWRPVFDXVLQJQRRU
PLQLPDOLQWHUIHUHQFHZLWK
XVXDOVRFLDO	IXQFWLRQDO
DFWLYLWLHV6\PSWRPVFDXVLQJJUHDWHUWKDQPLQLPDOLQWHUIHUHQFH
ZLWKXVXDOVRFLDO	
IXQFWLRQDODFWLYLWLHV6\PSWRPVFDXVLQJLQDELOLW\WRSHUIRUPXVXDOVRFLDO	
IXQFWLRQDODFWLYLWLHV,QFDSDFLWDWLQJ
IDWLJXHPDODLVHV\PSWRPV
FDXVLQJLQDELOLW\WRSHUIRUP
EDVLFVHOIFDUHIXQFWLRQV
)HYHUQRQD[LOODU\ ï‚°&WRï‚°&
ï‚°)WRï‚°)ï‚°&WRï‚°&
ï‚°)WRï‚°)ï‚°&WRï‚°&
ï‚°)WRï‚°)ï€¾ï‚°&
ï€¾ï‚°)
3DLQ,QGLFDWH%RG\6LWH
6HHDOVR,QMHFWLRQ6LWH3DLQ
+HDGDFKH$UWKUDOJLDDQG
0\DOJLD3DLQFDXVLQJQRRUPLQLPDOLQWHUIHUHQFHZLWKXVXDOVRFLDO
	IXQFWLRQDODFWLYLWLHV3DLQFDXVLQJJUHDWHUWKDQ
PLQLPDOLQWHUIHUHQFHZLWK
XVXDOVRFLDO	IXQFWLRQDO
DFWLYLWLHV3DLQFDXVLQJLQDELOLW\WRSHUIRUPXVXDOVRFLDO	
IXQFWLRQDODFWLYLWLHV'LVDEOLQJSDLQFDXVLQJ
LQDELOLW\WRSHUIRUPEDVLF
VHOIFDUHIXQFWLRQV25
+RVSLWDOL]DWLRQRWKHUWKDQ(5YLVLWLQGLFDWHG
8QLQWHQWLRQDO:HLJKW/RVV 1$ WRORVVLQERG\
ZHLJKWIURPEDVHOLQHWRORVVLQERG\ZHLJKWIURPEDVHOLQHï‚³ORVVLQERG\ZHLJKW
IURPEDVHOLQH25$JJUHVVLYHLQWHUYHQWLRQLQGLFDWHG>HJWXEHIHHGLQJRUWRWDOSDUHQWHUDOQXWULWLRQ@
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\INJECTION SITE REACTION
Grade 1 Grade 2 Grade 3 Grade 4
,QMHFWLRQ6LWH3DLQSDLQZLWKRXWWRXFKLQJ
2U7HQGHUQHVVSDLQZKHQDUHD
LVWRXFKHG3DLQWHQGHUQHVVFDXVLQJQRRUPLQLPDOOLPLWDWLRQRIXVH
RIOLPE3DLQWHQGHUQHVVOLPLWLQJXVH
RIOLPE253DLQWHQGHUQHVV
FDXVLQJJUHDWHUWKDQPLQLPDO
LQWHUIHUHQFHZLWKXVXDOVRFLDO	IXQFWLRQDODFWLYLWLHV3DLQWHQGHUQHVVFDXVLQJLQDELOLW\WRSHUIRUPXVXDO
VRFLDO	IXQFWLRQDODFWLYLWLHV3DLQWHQGHUQHVVFDXVLQJ
LQDELOLW\WRSHUIRUPEDVLF
VHOIFDUHIXQFWLRQ25
+RVSLWDOL]DWLRQRWKHUWKDQ(5YLVLWLQGLFDWHGIRUPDQDJHPHQWRISDLQWHQGHUQHVV
,QMHFWLRQ6LWH5HDFWLRQ
/RFDOL]HG ï€¾<HDUV(U\WKHPD25,QGXUDWLRQRIï‚´FPWRï‚´FP
RUï€­ï‚´FP
(U\WKHPD25,QGXUDWLRQ25(GHPDï€¾FPDQ\GLDPHWHU
RUï€¾FP
8OFHUDWLRQ256HFRQGDU\
LQIHFWLRQ253KOHELWLV25
6WHULOHDEVFHVV25'UDLQDJH1HFURVLVLQYROYLQJGHUPLV
DQGGHHSHUWLVVXH
Pediatric ï‚£ ï‚£15 Years (U\WKHPD25,QGXUDWLRQ25
(GHPDSUHVHQWEXW ï‚£FP
GLDPHWHU(U\WKHPD25,QGXUDWLRQ25
(GHPD!FP GLDPHWHUEXW
VXUIDFHDUHDRIWKHH[WUHPLW\VHJPHQWHJXSSHUDUPWKLJK(U\WKHPD25,QGXUDWLRQ25
(GHPDLQYROYLQJ ï‚³
VXUIDFHDUHDRIWKHH[WUHPLW\
VHJPHQWHJXSSHU
DUPWKLJK258OFHUDWLRQ256HFRQGDU\LQIHFWLRQ253KOHELWLV256WHULOHDEVFHVV25'UDLQDJH1HFURVLVLQYROYLQJGHUPLVDQGGHHSHUWLVVXH
3UXULWLV$VVRFLDWHGZLWK,QMHFWLRQ
6HHDOVR6NLQ3UXULWLV
LWFKLQJÂ²QRVNLQOHVLRQV,WFKLQJORFDOL]HGWRLQMHFWLRQVLWH$1'5HOLHYHG
VSRQWDQHRXVO\RUZLWK ï€¼K
WUHDWPHQW,WFKLQJEH\RQGWKHLQMHFWLRQ
VLWHEXWQRWJHQHUDOL]HG25
,WFKLQJORFDOL]HGWRLQMHFWLRQ
VLWHUHTXLULQJ ï‚³K
WUHDWPHQW*HQHUDOL]HGLWFKLQJFDXVLQJ
LQDELOLW\WRSHUIRUPXVXDO
VRFLDO	IXQFWLRQDODFWLYLWLHV1$
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\ENDOCRINE/METABOLIC
Grade 1 Grade 2 Grade 3 Grade 4
/LSRG\VWURSK\HJEDFNRIQHFNEUHDVWVDEGRPHQ'HWHFWDEOHE\VWXG\SDUWLFLSDQWRUFDUHJLYHUIRU\RXQJFKLOGUHQDQG
GLVDEOHGDGXOWV'HWHFWDEOHRQSK\VLFDOH[DP
E\KHDOWKFDUHSURYLGHU'LVILJXULQJ252EYLRXVFKDQJHVRQFDVXDOYLVXDOLQVSHFWLRQ1$
'LDEHWHV0HOOLWXV 1$ 1HZRQVHWZLWKRXWQHHGWR
LQLWLDWHPHGLFDWLRQ250RGLILFDWLRQRIFXUUHQWPHGVWRUHJDLQJOXFRVHFRQWURO1HZRQVHWZLWKLQLWLDWLRQRILQGLFDWHGPHG25'LDEHWHVXQFRQWUROOHGGHVSLWHWUHDWPHQWPRGLILFDWLRQ/LIHWKUHDWHQLQJFRQVHTXHQFHVHJNHWRDFLGRVLVK\SHURVPRODUQRQNHWRWLFFRPD
*\QHFRPDVWLD 'HWHFWDEOHE\VWXG\SDUWLFLSDQWRUFDUHJLYHUIRU\RXQJFKLOGUHQDQGGLVDEOHG
DGXOWV'HWHFWDEOHRQSK\VLFDOH[DP
E\KHDOWKFDUHSURYLGHU'LVILJXULQJ252EYLRXVRQFDVXDOYLVXDOLQVSHFWLRQ1$
+\SHUWK\URLGLVP $V\PSWRPDWLF 6\PSWRPDWLFFDXVLQJJUHDWHU
WKDQPLQLPDOLQWHUIHUHQFHZLWKXVXDOVRFLDO	IXQFWLRQDODFWLYLWLHV257K\URLGVXSSUHVVLRQWKHUDS\LQGLFDWHG6\PSWRPVFDXVLQJLQDELOLW\
WRSHUIRUPXVXDOVRFLDO	
IXQFWLRQDODFWLYLWLHV258QFRQWUROOHGGHVSLWHWUHDWPHQWPRGLILFDWLRQ/LIHWKUHDWHQLQJ
FRQVHTXHQFHV
HJWK\URLGVWRUP
+\SRWK\URLGLVP $V\PSWRPDWLF 6\PSWRPDWLFFDXVLQJJUHDWHU
WKDQPLQLPDOLQWHUIHUHQFH
ZLWKXVXDOVRFLDO	
IXQFWLRQDODFWLYLWLHV257K\URLGUHSODFHPHQWWKHUDS\LQGLFDWHG6\PSWRPVFDXVLQJLQDELOLW\WRSHUIRUPXVXDOVRFLDO	
IXQFWLRQDODFWLYLWLHV25
8QFRQWUROOHGGHVSLWHWUHDWPHQWPRGLILFDWLRQ/LIHWKUHDWHQLQJFRQVHTXHQFHV
HJP\[HGHPDFRPD
/LSRDWURSK\HJIDWORVVIURP
WKHIDFHH[WUHPLWLHVEXWWRFNV'HWHFWDEOHE\VWXG\SDUWLFLSDQWRUFDUHJLYHUIRU\RXQJFKLOGUHQDQGGLVDEOHG
DGXOWV'HWHFWDEOHRQSK\VLFDOH[DP
E\KHDOWKFDUHSURYLGHU'LVILJXULQJ252EYLRXVRQFDVXDOYLVXDOLQVSHFWLRQ1$
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\GENITOURINARY
Grade 1 Grade 2 Grade 3 Grade 4
,QWHUPHQVWUXDO%OHHGLQJ,0% 6SRWWLQJREVHUYHGE\
SDUWLFLSDQW250LQLPDOEORRGREVHUYHGGXULQJ
FOLQLFDORUFROSRVFRSLFH[DP,QWHUPHQVWUXDOEOHHGLQJQRW
JUHDWHULQGXUDWLRQRUDPRXQWWKDQXVXDOPHQVWUXDOF\FOH,QWHUPHQVWUXDOEOHHGLQJJUHDWHULQGXUDWLRQRUDPRXQWWKDQXVXDOPHQVWUXDOF\FOH+HPRU[LOCATION_006]DJHZLWKOLIHWKUHDWHQLQJK\SRWHQVLRQ252SHUDWLYHLQWHUYHQWLRQ
LQGLFDWHG
8ULQDU\7UDFWREVWUXFWLRQ
HJVWRQH1$ 6LJQVRUV\PSWRPVRI
XULQDU\WUDFWREVWUXFWLRQZLWKRXWK\GURQHSKURVLVRUUHQDOG\VIXQFWLRQ6LJQVRUV\PSWRPVRIXULQDU\WUDFWREVWUXFWLRQZLWKK\GURQHSKURVLVRUUHQDOG\VIXQFWLRQ2EVWUXFWLRQFDXVLQJOLIHWKUHDWHQLQJFRQVHTXHQFHV
INFECTION
Grade 1 Grade 2 Grade 3 Grade 4
,QIHFWLRQDQ\RWKHUWKDQ+,9LQIHFWLRQ/RFDOL]HGQRV\VWHPLFDQWLÈELDOWUHDWPHQWLQGLFDWHG$1'6\PSWRPVFDXVLQJQRRUPLQLPDOLQWHUIHUHQFHZLWK
XVXDOVRFLDO	IXQFWLRQDO
DFWLYLWLHV6\VWHPLFDQWLÈELDOWUHDWPHQWLQGLFDWHG256\PSWRPVFDXVLQJJUHDWHUWKDQPLQLPDOLQWHUIHUHQFHZLWKXVXDOVRFLDO
	IXQFWLRQDODFWLYLWLHV6\VWHPLFDQWLÈELDOWUHDWPHQW
LQGLFDWHG$1'6\PSWRPVFDXVLQJLQDELOLW\WRSHUIRUPXVXDOVRFLDO	IXQFWLRQDO
DFWLYLWLHV252SHUDWLYH
LQWHUYHQWLRQRWKHUWKDQVLPSOHLQFLVLRQDQGGUDLQDJHLQGLFDWHG/LIHWKUHDWHQLQJFRQVHTXHQFHVHJVHSWLFVKRFN
Basic Self-care Functions: $FWLYLWLHVVXFKDVEDWKLQJGUHVVLQJWRLOHWLQJWUDQVIHUPRYHPHQWFRQWLQHQFHDQGIHHGLQJ
Usual Social & Functional Activities: $GDSWLYHWDVNVDQGGHVLUDEOHDFWLYLWLHVVXFKDVJRLQJWRZRUNVKRSSLQJFRRNLQJXVHRIWUDQVSRUWDWLRQSXUVXLQJDKREE\HW F
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\Appendix 5. Pregnancy Precautions, Definition for Female of Childbearing 
Potential, and Contraceptive Requirements
1) Definitions
a) Definition of Childbearing Potential
)RUWKHSXUSRVHVRIWKLVVWXG\DIHPDOHERUQVXEMHFWLVFRQVLGHUHGRIFKLOGEHDULQJSRWHQWLDO
IROORZLQJWKHLQLWLDWLRQRISXEHUW\7DQQHUVWDJHXQWLOEHFR PLQJSRVWPHQRSDXVDOXQOHVV
SHUPDQHQWO\VWHULOHRUZLWKPHGLFDOO\GRFXPHQWHGRYDULDQIDLOXU H
:RPHQDUHFRQVLGHUHGWREHLQDSRVWPHQRSDXVDOVWDWHZKHQWKH\ DUH!\HDUVRIDJHZLWK
FHVVDWLRQRISUHYLRXVO\RFFXUULQJPHQVHVIRU!PRQWKVZLWKRXW DQDOWHUQDWLYHFDXVH
3HUPDQHQWVWHULOL]DWLRQLQFOXGHVK\VWHUHFWRP\ELODWHUDORRSKRU HFWRP\RU
ELODWHUDOVDOSLQJHFWRP\LQDIHPDOHVXEMHFWRIDQ\DJH
b) Definition of Male Fertility
)RUWKHSXUSRVHVRIWKLVVWXG\DPDOHERUQVXEMHFWLVFRQVLGHUHGRIIHUWLOHDIWHUWKHLQLWLDWLRQRI
SXEHUW\XQOHVVSHUPDQHQWO\VWHULOHE\ELODWHUDORUFKLGHFWRP\RU PHGLFDOGRFXPHQWDWLRQ
2) Contraception Requirements for Female Subjects
a) Study Drug Effects on Pregnancy and Hormonal Contraception
7KHGDWDRIVWXG\GUXJVRQSUHJQDQWZRPHQLVOLPLWHGRUQRWDYD LODEOH7KHUHLVQRVXVSLFLRQRI
KXPDQWHUDWRJHQLFLW\EDVHGRQFODVVHIIHFWVRUJHQRWR[LFSRWHQW LDO5HOHYDQWQRQFOLQLFDO
UHSURGXFWLYHWR[LFLW\VWXGLHVIRUKXPDQSUHJQDQF\GRQRWLQGLFDWHDVWURQJVXVSLFLRQRIKXPDQ
WHUDWRJHQLFLW\IHWRWR[LFLW\'DWDIURPFOLQLFDOSKDUPDFRNLQHWLF LQWHUDFWLRQVWXGLHVRIVWXG\GUXJ
KDYHGHPRQVWUDWHGWKDWWKHUHLVQRUHGXFWLRQLQWKHFOLQLFDOHI ILFDF\RIKRUPRQDOFRQWUDFHSWLRQRU
WKDWWKHHIIHFWRQKRUPRQDOFRQWUDFHSWLRQLVLQVLJQLILFDQW3OHDVHUHIHUWRWKHODWHVWYHUVLRQRIWKH,QYHVWLJDWRUÂ¶V%URFKXUHIRUDGGLWLRQDOLQIRUPDWLRQ
b) Contraception Requirements for Female Subjects of Childbearing Potential
7KHLQFOXVLRQRIIHPDOHVXEMHFWVRIFKLOGEHDULQJSRWHQWLDOUHTX LUHVWKHXVHRIKLJKO\HIIHFWLYH
FRQWUDFHSWLYHPHDVXUHV7KH\PXVWDOVRQRWUHO\RQKRUPRQHFRQW DLQLQJFRQWUDFHSWLYHVDVDIRUP
RIELUWKFRQWUROGXULQJWKHVWXG\ 7KH\PXVWKDYHDQHJDWLYHVHUXPSUHJQDQF\WHVWDW6FUHHQLQJ
SULRUWRVWXG\HQUROOPHQW$SUHJQDQF\WHVWZLOOEHSHUIRUPHGDW DOOVWXG\YLVLWVDQGWKHHQGRI
UHOHYDQWV\VWHPH[SRVXUH,QWKHHYHQWRIDGHOD\HGPHQVWUXDOS HULRGRYHURQHPRQWKEHWZHHQ
PHQVWUXDWLRQVDVHUXPSUHJQDQF\WHVWPXVWEHSHUIRUPHGWRUXO HRXWSUHJQDQF\7KLVLVHYHQ
WUXHIRUZRPHQRIFKLOGEHDULQJSRWHQWLDOZLWKLQIUHTXHQWRULUU HJXODUSHULRGV)HPDOHVXEMHFWV
PXVWDJUHHWRRQHRIWKHIROORZLQJIURP6FUHHQLQJXQWLOGD\V IROORZLQJWKHHQGRIUHOHYDQW
V\VWHPLFH[SRVXUH
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\ï‚·&RPSOHWHDEVWLQHQFHIURPLQWHUFRXUVHRIUHSURGXFWLYHSRWHQWLDO$EVWLQHQFHLVDQDFFHSWDEOH
PHWKRGRIFRQWUDFHSWLRQRQO\ZKHQLWLVLQOLQHZLWKWKHVXEMHF WÂ¶VSUHIHUUHGDQGXVXDO
OLIHVW\OH
2U
ï‚·&RQVLVWHQWDQGFRUUHFWXVHRIRQHRIWKHIROORZLQJPHWKRGVRIELU WKFRQWUROOLVWHGEHORZ
ï‚¾,QWUDXWHULQHGHYLFH,8'ZLWKDIDLOXUHUDWHRISHU\HDU
ï‚¾7XEDOVWHULOL]DWLRQ
ï‚¾(VVXUHPLFURLQVHUWV\VWHPSURYLGHGFRQILUPDWLRQRIVXFFHVVPRQWKVDIWHUSURFHGXUH
ï‚¾9DVHFWRP\LQWKHPDOHSDUWQHUSURYLGHGWKDWWKHSDUWQHULVWKH VROHVH[XDOSDUWQHUDQG
KDGFRQILUPDWLRQRIVXUJLFDOVXFFHVVPRQWKVDIWHUSURFHGXUH
2U
ï‚·&RQVLVWHQWDQGFRUUHFWXVHRIRQHKRUPRQDOPHWKRGDQGRQHEDUULHUPHWKRG
ï‚¾%DUULHUPHWKRGV
o'LDSKUDJPZLWKVSHUPLFLGH
o&HUYLFDOFDSZLWKVSHUPLFLGH
o0DOHFRQGRPZLWKRUZLWKRXWVSHUPLFLGH
ï‚¾+RUPRQDOPHWKRGVWKHKRUPRQDOFRQWUDFHSWLYHVKRXOGFRQWDLQDWO HDVW
PFJRIHWKLQ\OHVWUDGLRO
o,QWUDXWHULQHKRUPRQHUHOHDVLQJV\VWHP,86ZLWKDIDLOXUHUDWH RISHU\HDU
o2UDOFRQWUDFHSWLYHVHLWKHUFRPELQHGRUSURJHVWHURQHRQO\
o,QMHFWDEOHSURJHVWHURQH
o,PSODQWVRIOHYRQRUJHVWUHO
o7UDQVGHUPDOFRQWUDFHSWLYHSDWFK
o&RQWUDFHSWLYHYDJLQDOULQJ
)HPDOHVXEMHFWVPXVWDOVRUHIUDLQIURPHJJGRQDWLRQDQGLQYLWURIHUWLOL]DWLRQGXULQJWUHDWPHQW
DQGXQWLODWOHDVWGD\VDIWHUWKHHQGRIUHOHYDQWV\VWHPLFH [SRVXUH
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\3) Contraception Requirements for Male Subjects
'XULQJWKHVWXG\PDOHVXEMHFWVZLWKIHPDOHSDUWQHUVRIFKLOGEHDULQJSRWHQWLDOVKRXOGXVH
FRQGRPVZKHQHQJDJLQJLQLQWHUFRXUVHRIUHSURGXFWLYHSRWHQWLDO 
4) Unacceptable Birth Control Methods
%LUWKFRQWUROPHWKRGVWKDWDUHXQDFFHSWDEOHLQFOXGHSHULRGLFDEVWLQHQFHHJFDOHQGDURYXODWLRQ
V\PSWRWKHUPDOSRVWRYXODWLRQPHWKRGVZLWKGUDZDOFRLWXVLQWH UUXSWXVVSHUPLFLGHVRQO\DQG
ODFWDWLRQDODPHQRU[LOCATION_006]HDPHWKRG/$0)HPDOHFRQGRPDQGPDOHFRQG RPVKRXOGQRWEHXVHG
WRJHWKHU
5) Procedures to be Followed in the Event of Pregnancy
6XEMHFWVZLOOEHLQVWUXFWHGWRQRWLI\WKHLQYHVWLJDWRULIWKH\EHFRPHSUHJQDQWDWDQ\WLPHGXULQJ
WKHVWXG\RULIWKH\EHFRPHSUHJQDQWZLWKLQ GD\VRIODVWVWX G\GUXJGRVH6XEMHFWVZKR
EHFRPHSUHJQDQWRUZKRVXVSHFWWKDWWKH\DUHSUHJQDQWGXULQJWKHVWXG\PXVWUHSRUWWKHLQIRUPDWLRQWRWKHLQYHVWLJDWRUDQGGLVFRQWLQXHVWXG\GUXJLPPH GLDWHO\,QVWUXFWLRQVIRU
UHSRUWLQJSUHJQDQF\DQGSUHJQDQF\RXWFRPHDUHRXWOLQHGLQ6HFWLRQ 
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\Appendix 6. Definitions of HIV-1 Related Disease (CDC Guidelines) {[ZIP_CODE]}
ï‚·%DFWHULDOLQIHFWLRQVPXOWLSOHRUUHFXUUHQW
ï‚·&DQGLGLDVLVRIEURQFKLWUDFKHDRUOXQJV
ï‚·&DQGLGLDVLVRIHVRSKDJXV
ï‚·&HUYLFDOFDQFHULQYDVLYHÂ‚
ï‚·&RFFLGLRLGRP\FRVLVGLVVHPLQDWHGRUH[WUDSXOPRQDU\
ï‚·&U\SWRFRFFRVLVH[WUDSXOPRQDU\
ï‚·&U\SWRVSRULGLRVLVFKURQLFLQWHVWLQDO!PRQWK
VGXUDWLRQ
ï‚·&\WRPHJDORYLUXVGLVHDVHRWKHUWKDQOLYHUVSOHHQRUQRGHVR QVHWDWDJH!PRQWK
ï‚·&\WRPHJDORYLUXVUHWLQLWLVZLWKORVVRIYLVLRQ
ï‚·(QFHSKDORSDWK\DWWULEXWHGWR+,9Â†
ï‚·+HUSHVVLPSOH[FKURQLFXOFHUV!PRQWK
VGXUDWLRQRUEURQFKLWLVSQHXPRQLWLVRU
HVRSKDJLWLVRQVHWDWDJH!PRQWK
ï‚·+LVWRSODVPRVLVGLVVHPLQDWHGRUH[WUDSXOPRQDU\
ï‚·,VRVSRULDVLVFKURQLFLQWHVWLQDO!PRQWK
VGXUDWLRQ
ï‚·.DSRVLVDUFRPD
ï‚·/\PSKRPD%XUNLWWRUHTXLYDOHQWWHUP
ï‚·/\PSKRPDLPPXQREODVWLFRUHTXLYDOHQWWHUP
ï‚·/\PSKRPDSULPDU\RIEUDLQ
ï‚·Mycobacterium avium FRPSOH[RU Mycobacterium kansasiiGLVVHPLQDWHGRUH[WUDSXOPRQDU\
ï‚·Mycobacterium tuberculosis RIDQ\VLWHSXOPRQDU\Â‚GLVVHPLQDWHGRUH[WUDSXOPRQDU\
ï‚·0\FREDFWHULXPRWKHUVSHFLHVRUXQLGHQWLILHGVSHFLHVGLVVHPLQDWHGRUH[WUDSXOPRQDU\
ï‚·3QHXPRF\VWLVMLURYHFLLSUHYLRXVO\NQRZQDV3QHXPRF\VWLVFDULQ LLSQHXPRQLD
ï‚·3QHXPRQLDUHFXUUHQWÂ‚
(9*&2%,)7&7$)
3URWRFRO*686 )LQDO
*LOHDG6FLHQFHV,QF 2ULJLQDO
&21),'(17,$/ 3DJH -XO\ï‚·3URJUHVVLYHPXOWLIRFDOOHXNRHQFHSKDORSDWK\
ï‚·Salmonella VHSWLFHPLDUHFXUUHQW
ï‚·7R[RSODVPRVLVRIEUDLQRQVHWDWDJH!PRQWK
ï‚·:DVWLQJV\QGURPHDWWULEXWHGWR+,9Â†

 2QO\DPRQJFKLOGUHQDJHG\HDUV
Â‚ 2QO\DPRQJDGXOWVDGROHVFHQWVDQGFKLOGUHQDJHGÂ•\HDUV
Â† 6XJJHVWHGGLDJQRVWLFFULWHULDIRUWKHVHLOOQHVVHVZKLFKPLJKWEHSDUWLFXODUO\LPSRUWDQWIRU+,9HQFHSKDORSDWK\
DQG+,9ZDVWLQJV\QGURPHDUHGHVFULEHGLQWKHIROORZLQJUHIHUH QFHV^`^ `